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EXECUTIVE SUMMARY (CORRECTED 06/05/2021) 
The Innovating for Maternal and Child Health in Africa (IMCHA) initiative is jointly funded by the 
International Development Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) 
and Global Affairs Canada (GAC). It was launched in March 2014 with a funding volume of C$ 36 million 
over seven years and supports 28 research grants (19 original research grants and 9 synergy grants) in 
11 African countries. All projects are led by a Principal Investigator (PI) affiliated with an African 
university, research institution or NGO. A decisionmaker working in local, regional or national 
government is embedded as Co-Principal Investigator (Co-PI) in each research team, as well as a Co-PI 
affiliated with a Canadian research institution. Two Health Policy and Research Organisations (HPROs) 
in West and East Africa are tasked with supporting knowledge translation and raising the profile of the 
research in order to facilitate the adoption of the results at scale in national and regional health 
policies, supporting capacity-building of research teams and facilitating mutual learning across IMCHA.  
IMCHA is expected to contribute to improved maternal, newborn and child health outcomes in 
programme countries through … 
1. enhanced production, analyses and syntheses of health systems implementation research 
prioritising gender and equity; 
2. enhanced partnering and collaboration between decisionmakers and researchers on health 
systems strengthening; and  
3. enhanced integration of health systems research findings into primary health care policies and 
practices. 
The summative evaluation was tasked with assessing the overall performance of IMCHA and the value-
added of its design and delivery. Evaluation questions were grouped under four headings: 
1. What are the achievements of IMCHA with regard to the performance measurement framework 
(PMF) as well as to policy uptake and scale up of successful interventions? 
2. How effective has the management of the initiative been and what difference has that made to 
IMCHA achievements? 
3. How well has IMCHA been operationalised and how could it be improved on in future 
undertakings?  
4. How is the work conducted under IMCHA documented for contributing to the legacy of the 
initiative? 
Data for the evaluation were collected through document reviews, and on-line survey of current and 
former members of IMCHA research teams and key informant interviews with IMCHA stakeholder 
during visits to programme countries and to Canada and through remote interviews using a voice over 
internet protocol (VOIP). 
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KEY FINDINGS  
IMCHA ACHIEVEMENTS OF ULTIMATE AND INTERMEDIATE OUTCOME TARGETS 
EXPECTED RESULTS INDICATORS AND TARGETS ASSESSMENT 
Ultimate Outcome 
Improved maternal, 
newborn and child 
health outcomes  
Proportion of funded implementation 
research that improved maternal and 
child health outcomes and access to 
primary health care services 
Target: 50% of the implementation 
research demonstrate improvement in 
any of the 11 accountability indicators 
The target was met: Project contributions 
or potential contributions to improved 
maternal and child health outcomes could 
not be measured directly for many projects, 
but the projects provided sufficient 









gender and equity 
Proportion of total projects that have at 
least 75% (three of four processes) 
adequate gender and equity dimensions 
Target: All research projects have >75 % 
(three of four processes) adequate gender 
and equity dimensions 
The target was not met: 15/28 projects 
(54%) integrated adequate gender 
dimensions, and 7/28 (25%) adequate 
equity dimensions in at least three research 
processes. 
Proportion of health systems research 
outputs and syntheses that are gender 
and equity focused 
Target: 75% of outputs include gender 
and equity focused analyses/syntheses 
The target is not likely to be met: Research 
outputs, including gender and equity 
analyses were still being generated at the 
time of the evaluation. Among 98 outputs 
from 22 projects that were available for 
analysis, 44 (46%) included a gender focus 






researchers on health 
systems 
strengthening  
Number of total projects per country that 
demonstrate high level of collaboration 
with decisionmaker (documented by 
project, country and regional levels) 
Target: Minimum of one per country 
The indicator as defined was not assessed: 
The decisionmaker is defined as the 
‘national focal point for MNCH’. Most 
projects communicated their activities and 
preliminary results at this level, but for 
others this was not the main respondent at 
national government level. 
3. Enhanced 
integration of health 
systems research 
findings into primary 
health care policies 
and practice  
Number (type) of influence of IMCHA 
research projects on policy and 
programming per project 
Target: 20 references to research findings 
or recommendations in country-led 
technical decision-making platforms 
The target was likely met: Although it was 
too early in the programme to assess this 
outcome, the target of 20 was already 
reached. All sampled projects had made 
presentations of research results in national 
fora and most had plans for further 
discussions once final research results were 
available.  
MANAGEMENT EFFECTIVENESS 
IMCHA management was described as responsive and flexible by interviewed researchers and online 
survey respondents. About two-thirds of survey respondents rated the support provided for the 
preparation of implementation plans, technical reports and financial reports as very helpful. The 
financial holdback policy for the last semester payment until project completion raised concerns 
among some African researchers who foresaw difficulties in pre-funding their final data collection, 
analysis, knowledge translation and documentation activities. 
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IMCHA DOCUMENTATION 
The research teams, the HPROs and IMCHA management generated a large number of materials that 
document the IMCHA initiative, some of excellent quality. A considerable number of documents were 
still in preparation at the time of the evaluation. The IMCHA website, managed by the East Africa HPRO 
has strong branding, however it is not regularly updated and presents primarily East African content. 
IDRC maintains a webpage for IMCHA that is more complete and up to date, but it is primarily 
presented under the IDRC brand.  
LESSONS LEARNT 
IMCHA funded implementation research projects that included the embedding of decisionmakers in 
the research teams and that also included South-South technical support and networking through the 
funding of HPROs. Additional characteristics of IMCHA were (1) a PMF that, at the ultimate outcome 
level, asked for measuring implementation outcomes rather than research and knowledge translation 
outcomes, and (2) a South-North partnership between African and Canadian research institutions in 
each project. The lessons from IMCHA are that it is possible to combine these design elements in a 
single programme, but that it does generate conceptual tensions: (1) The balance between the focus 
on interventions to generate health outcomes versus the focus on research to generate answers to the 
questions of whether these interventions are appropriate, feasible, effective and affordable in the local 
context, and how they can be best delivered. And (2) the balance between supporting local 
partnerships between researchers and decisionmakers within a Southern network, and the definition 
of a meaningful role of Canadian researchers within such a partnership.  
• In general, research teams of African and Canadian researchers who knew each other well and 
who had a record of past collaboration worked well within the IMCHA model. They did not 
necessarily change their established mode of cooperation, but they met their institutional 
objectives.  
• In the early phases of IMCHA, the role of HPROs was unclear to the research teams. As the 
initiative evolved, the appreciation of the HPRO model increased among African researchers but 
not among Canadian researchers. 
• Awarding synergy grants to allow selected research teams to expand scope and depth of their 
work was a positive experience. The launching of synergy grants also allowed a realignment of 
IMCHA with evolving Canadian policy priorities. Several researchers felt that the synergy grants 
were launched too early in the implementation of IMCHA. 
• The partnership between CIHR, GAC and IDRC allowed the three institutions to go above and 
beyond what they would be able to achieve on their own, while bringing a unique asset to 
Canadian researchers and the international research community. 
SUMMARISED RECOMMENDATIONS 
IMCHA is ending in 2021 and there are therefore no recommendations for the implementation of the 
initiative. One recommendation, however, addresses concluding activities: 
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1. Global experience and knowledge about the approach of embedding decisionmakers in 
implementation research is limited. IMCHA can potentially make an important contribution to 
this knowledgebase. At a time when IMCHA projects have completed their knowledge translation 
activities and generated a sufficient volume of publications to document them, a meta-analysis of 
the approach should be commissioned and published. 
For any future initiative 
2. The PMF for a future initiative should be more clearly linked to the objectives of implementation 
research. Improved maternal and child health and increased utilisation of quality health services 
are high level outcomes and therefore appropriate ultimate outcomes for a logic model. 
However, as stated in the IMCHA logic model, many factors contribute to these outcomes and it 
is therefore not appropriate to include them in the PMF. The PMF of an implementation research 
initiative should instead be used to monitor the extent to which funded projects are able to 
document or reject the effectiveness and feasibility of researched interventions in the 
implementation context, and the extent to which they are able to translate these findings into 
improvements in MNCH programmes and policies. 
3. The design of a future initiative should be clear about the scale at which it expects policy and 
programme changes to be generated by its grantees. If national MNCH policies are the primary 
targets, project grants should be of sufficient size to assure national visibility. As an alternative, 
multiple networked projects could be selected within countries to generate a critical volume of 
evidence. Scaling to national policy does not necessarily have to be the objective of all projects. 
Applicants should, however, be clear about the level of scaling they are targeting, and most 
importantly, this should also be reflected in the administrative position of the decisionmaker Co-
PI embedded in the project. 
4. Programme objectives in terms of promoting gender equality and health equity should be clearly 
spelled out in the call for proposals and in the monitoring frameworks of each project. Funded 
projects should include methodologies and plans on how they intend to address these objectives. 
Prior to finalising the implementation plans, all selected applicants should participate in 
workshops and webinars where their capacity and their approach to meeting the objectives are 
clarified and steps are taken to address any capacity gaps. 
5. HPROs should be selected and contracted early in a new initiative and should participate in the 
selection of research grantees. If they have early knowledge about what will be funded in which 
country, they will be in a better situation to develop their own workplan for supporting projects 
in knowledge translation and networking. 
6. In the grant selection process, care should be taken to avoid funding opportunistic partnerships 
between Canadian and African research institutions and between African research institutions 
and decisionmakers that are solely formed in response to the proposal call. While new 
partnerships should not be excluded per se, they should be subjected to additional scrutiny to 
assure that partners have common objectives and compatible ways of working.  
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7. The preparation phase of IMCHA prior to starting project activities was almost two years, 
considerably shortening the implementation time of projects. While this may be unavoidable, 
especially if capacity-building in gender and equity mainstreaming is included in the preparation 
phase of a new initiative, it should be factored into the overall duration of the initiative. 
Allocating additional time to the closing phase of projects for advocacy and knowledge 
translation activity may also be considered.  
8. A future initiative should, from the start, create a strongly branded internet presence through a 
single web portal that is independent of the IDRC web site. Management of the site could be 
outsourced, even to an HPRO, but the source contract should assure that the initiative is 
presented comprehensively and that the site provides timely access to all communications.  
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RÉSUMÉ (VERSION CORRIGÉE 06/05/2021) 
L’initiative ‘Innovation pour la santé des mères et des enfants d’Afrique’ (ISMEA) est financée 
conjointement par le Centre de recherches pour le développement international (CRDI), les Instituts 
de recherche en santé du Canada (IRSC) et Affaires mondiales Canada (AMC). Il a été lancé en mars 
2014 avec un financement de 36 millions de dollars canadiens sur sept ans et soutient 28 subventions 
de recherche (19 subventions de recherche originales et 9 subventions de synergie) dans 11 pays 
africains. Tous les projets sont dirigés par un chercheur principal (CP) affilié à une université africaine, 
un établissement de recherche ou une ONG. Un décideur travaillant au sein du gouvernement local, 
régional ou national est intégré à titre de co-chercheur principal (Co-CP) dans chaque équipe de 
recherche, ainsi comme Co-CP affilié à un établissement de recherche canadien. Deux Organisations 
de politique et de recherche en matière de santé (OPRS) en Afrique de l’Ouest et de l’Est sont chargées 
de soutenir l’application des connaissances et de mieux faire connaître la recherche afin de faciliter 
l’adoption des résultats à grande échelle dans les politiques nationales et régionales de santé, de 
soutenir le renforcement des capacités des équipes de recherche et de faciliter l’apprentissage mutuel 
dans l’ensemble de l’ISMEA. 
L’ISMEA devrait contribuer à l’amélioration des résultats en matière de santé des mères, des nouveau-
nés et des enfants dans les pays du programme grâce à :  
1. l’amélioration de la production, des analyses et des synthèses de la recherche sur la mise en 
œuvre des systèmes de santé en accordant la priorité au genre et à l’équité;  
2. le renforcement des partenariats et de la collaboration entre les décideurs et les chercheurs sur 
le renforcement des systèmes de santé; et  
3. l’intégration accrue des résultats de la recherche sur les systèmes de santé dans les politiques et 
les pratiques en matière de soins de santé primaires. 
L’évaluation sommative a été chargée d’évaluer la performance globale de l’ISMEA et la valeur ajoutée 
de sa conception et de sa prestation. Les questions d’évaluation ont été regroupées sous quatre 
rubriques:  
1. Quelles sont les réalisations de l’ISMEA en ce qui concerne le cadre de mesure du rendement 
(CMR) ainsi que l’adoption dans les politiques et la mise à échelle des interventions réussies?  
2. Dans quelle mesure la gestion de l’initiative a-t-elle été efficace et comment ceci a influencé les 
réalisations de l’ISMEA?  
3. Dans quelle mesure l’ISMEA a-t-elle été opérationnelle et comment ceci pourrait être amélioré 
dans les initiatives futures?  
4. Comment les travaux menés dans le cadre de l’ISMEA sont-ils documentés pour contribuer à 
l’héritage de l’initiative? 
Les données relatives à l’évaluation ont été recueillies par la revue de documents et d’un sondage en 
ligne auprès des membres actuels et anciens des équipes de recherche de l’ISMEA et des entrevues 
avec des intervenants de l’ISMEA lors de visites dans les pays du programme,  au Canada, et par le biais 
d’entrevues à distance à l’aide d’un protocole VOIP. 
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PRINCIPALES CONSTATATIONS 
RÉALISATIONS DE L’ISMEA EN MATIÈRE DE CIBLES DES RÉSULTATS FINAUX ET INTERMÉDIAIRES 
RÉSULTATS ATTENDUS INDICATEURS ET CIBLES EVALUATION 
Résultat final 
Amélioration des 
résultats en matière 
de santé maternelle, 
néonatale et infantile 
Proportion de la recherche (financée) sur 
la mise en œuvre qui améliore les 
résultats en matière de santé maternelle 
et infantile et l’accès aux services de soins 
de santé primaires 
Cible: 50 % de la recherche sur la mise en 
œuvre démontre une amélioration de l’un 
des 11 indicateurs de responsabilisation 
La cible a été atteinte: Les contributions 
des projets ou les contributions potentielles 
à l’amélioration des résultats en matière de 
santé maternelle et infantile n’ont pas pu 
être mesurées directement pour de 
nombreux projets, mais les projets ont 
fourni suffisamment d’information pour 
déduire ces contributions.  
Résultat 
intermediaire 
1. L’amélioration de 
la production, des 
analyses et des 
synthèses de la 
recherche sur la mise 
en œuvre des 
systèmes de santé en 
accordant la priorité 
au genre et à l’équité 
Proportion de l’ensemble de projets qui 
ont au moins 75 % (trois des quatre 
processus) de dimensions adéquates en 
matière de genre et d’équité 
Cible: Tous les projets de recherche ont au 
moins 75% (trois des quatre processus) 
des dimensions adéquates en matière de 
genre et d’équité  
La cible n’a pas été atteinte: 15/28 projets 
(54 %) ont intégré des dimensions 
adéquates en matière de genre, et 7/28 (25 
%) en matière d’équité dans au moins trois 
processus de recherche. 
Proportion des résultats et des synthèses 
de recherche sur les systèmes de santé 
axés sur le genre et l’équité 
Cible: 75 % des extrants comprennent des 
analyses/synthèses axées sur le sexe et 
l’équité 
Il est peu probable que la cible soit 
atteinte: les résultats de la recherche, y 
compris les analyses sur le sexe et l’équité, 
étaient encore en cours d’élaboration au 
moment de l’évaluation. Parmi les 98 
extrants de 22 projets qui étaient 
disponibles pour analyse, 44 (46 %) ont 
inclus une orientation sexospécifique et 21 
(22 %) une orientation vers l’équité. 
2. Le renforcement 
des partenariats et 
de la collaboration 
entre les décideurs et 
les chercheurs sur le 
renforcement des 
systèmes de santé 
Nombre de l’ensemble de projets par pays 
qui démontrent un niveau élevé de 
collaboration avec le décideur 
(documenté au niveau des projets, des 
pays et des régions) 
Cible: Minimum d’un par pays 
L’indicateur tel que défini n’a pas été 
vérifié ?: le décideur est défini comme le 
‘point focal national pour la SMNI’. La 
plupart des projets ont communiqué leurs 
activités et leurs résultats préliminaires à ce 
niveau, mais pour d’autres, ce n’était pas le 
principal répondant au niveau du 
gouvernement national. 
3. L’intégration 
accrue des résultats 
de la recherche sur 
les systèmes de santé 
dans les politiques et 
les pratiques en 
matière de soins de 
santé primaires 
Nombre (type) d’influence des projets de 
recherche de l’ISMEA sur les politiques et 
la programmation, par projet 
Cible: 20 références aux résultats de la 
recherche ou aux recommandations dans 
les plates-formes de prise de décisions 
techniques dirigées par le pays 
La cible a probablement été atteinte: bien 
qu’il soit trop tôt dans le programme pour 
évaluer ce résultat, l’objectif de 20 a déjà 
été atteint. Tous les projets échantillonnés 
avaient présenté les résultats de la 
recherche au niveau national et la plupart 
avaient des plans pour d’autres discussions 
une fois que les résultats définitifs de la 
recherche étaient disponibles. 
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EFFICACITE DE LA GESTION 
La gestion de l’ISMEA a été décrite comme réactive et flexible par les chercheurs interviewés et les 
répondants au sondage en ligne. Environ deux tiers des répondants au sondage ont jugé très utile le 
soutien fourni à l’élaboration des plans de mise en œuvre, des rapports techniques et des rapports 
financiers. La politique de retenue financière pour le paiement du dernier semestre jusqu’à 
l’achèvement du projet a soulevé des préoccupations chez certains chercheurs africains qui 
prévoyaient des difficultés à préfinancer leurs activités finales de collecte, d’analyse, d’application des 
connaissances et de documentation. 
DOCUMENTATION DE L’ISMEA 
Les équipes de recherche, les OPRS et la direction de l’ISMEA ont produit un grand nombre de 
documents qui documentent l’initiative ISMEA, dont certains sont d’excellente qualité. Un nombre 
considérable de documents étaient encore en préparation au moment de l’évaluation. Le site web de 
l’ISMEA, géré par l’OPRS d’Afrique de l’Est, a une forte image de marque, mais il n’est pas 
régulièrement mis à jour et présente principalement du contenu lié à l’Afrique de l’Est. Le CRDI tient à 
jour une page Web pour l’ISMEA qui est plus complète et à jour, mais elle est principalement présentée 
sous la marque du CRDI.  
LEÇONS APPRISES  
L’ISMEA a financé des projets de recherche de mise en œuvre qui comprenaient l’intégration de 
décideurs dans les équipes de recherche et qui comprenaient également le soutien technique sud-sud 
et le réseautage par le biais du financement des OPRS. D’autres caractéristiques de l’ISMEA étaient (1) 
un CMP qui, au niveau des résultats finaux, demandait de mesurer les résultats de la mise en œuvre 
plutôt que les résultats de la recherche et de l’application des connaissances, et (2) un partenariat Sud-
Nord entre les institutions de recherche africaines et canadiennes dans chaque projet. Les leçons tirées 
de l’ISMEA sont qu’il est possible de combiner ces éléments de conception dans un seul programme, 
mais qu’il génère des tensions conceptuelles: (1) l’équilibre entre l’accent mis sur les interventions 
visant à générer des résultats en matière de santé et l’accent mis sur la recherche pour générer des 
réponses aux questions de savoir si ces interventions sont appropriées, réalisables, efficaces et 
abordables dans le contexte local , et comment ils peuvent être mieux livrés ; et (2) l’équilibre entre le 
soutien aux partenariats locaux des chercheurs et des décideurs au sein d’un réseau du Sud et la 
définition d’un rôle significatif des chercheurs canadiens dans un tel partenariat.  
• En général, les équipes de recherche de chercheurs africains et canadiens qui se connaissaient 
bien et qui avaient une histoire de collaboration passée ont bien fonctionné dans le cadre du 
modèle ISMEA. Ils n’ont pas nécessairement modifié leur mode de coopération établi, mais ils 
ont atteint leurs objectifs institutionnels 
• Dans les premières phases de l’ISMEA, le rôle des OPRS n’était pas clair pour les équipes de 
recherche. Au fur et à mesure que l’initiative a évolué, l’appréciation du modèle OPRS a 
augmenté chez les chercheurs africains, mais pas chez les chercheurs canadiens. 
• L’octroi de subventions de synergie pour permettre à certaines équipes de recherche d’élargir la 
portée et la profondeur de leur travail a été une expérience positive. Le lancement de 
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subventions de synergie a également permis un réalignement de l’ISMEA avec l’évolution des 
priorités politiques canadiennes. Plusieurs chercheurs ont estimé que les subventions de 
synergie avaient été lancées trop tôt dans la mise en œuvre de l’ISMEA. 
• Le partenariat entre les IRSC, l’AMC et le CRDI a permis aux trois institutions d’aller au-delà de ce 
qu’elles seraient en mesure d’accomplir par elles-mêmes, tout en apportant un atout unique aux 
chercheurs canadiens et à la communauté internationale de la recherche. 
RECOMMANDATIONS 
L'ISMEA prend fin en 2021 et il n'y a donc pas de recommandation pour la mise en œuvre de l'initiative. 
Une recommandation, cependant, concerne les activités de clôture : 
1. L'expérience et les connaissances mondiales sur l'approche consistant à intégrer les décideurs 
dans la recherche sur la mise en œuvre sont limitées. L'ISMEA peut potentiellement apporter une 
contribution importante à cette base de connaissances. Lorsque les projets ISMEA auront 
terminé leurs activités d'application des connaissances et généré un volume suffisant de 
publications pour les documenter, une méta-analyse de l'approche devrait être commandée et 
publiée. 
Pour une initiative future 
2. Le cadre de mesure du rendement (CMR) d'une future initiative devrait être plus clairement lié 
aux objectifs de la recherche sur la mise en œuvre. L'amélioration de la santé maternelle et 
infantile et l'utilisation accrue de services de santé de qualité sont des résultats de haut niveau et 
donc des résultats finaux appropriés pour un modèle logique. Cependant, comme indiqué dans le 
modèle logique de l'ISMEA, de nombreux facteurs contribuent à ces résultats et il n'est donc pas 
approprié de les inclure dans le CMR. Le CMR d'une initiative de recherche sur la mise en œuvre 
devrait plutôt être utilisé pour surveiller d’une part dans quelle mesure les projets financés sont 
capables de documenter ou de rejeter l'efficacité et la faisabilité des interventions recherchées 
dans le contexte de la mise en œuvre, et d’autre part dans quelle mesure ils sont capables de 
traduire ces résultats en améliorations des programmes et des politiques de la santé de la mère, 
du nouveau-né et de l'enfant (SMNE). 
3. La conception d'une future initiative doit être clair et prendre en compte à quelle échelle les 
changements de politiques et de programmes seront générés par les bénéficiaires de 
subventions. Si les politiques nationales en matière de SMNE sont les cibles principales, les 
subventions des projets devraient être suffisamment importantes pour en assurer une visibilité 
nationale. Comme alternative, de multiples projets en réseau pourraient être sélectionnés dans 
un même pays afin de générer un volume critique de preuves. Le passage à l'échelle de la 
politique nationale ne doit pas nécessairement être l'objectif de tous les projets. Les candidats 
doivent cependant être clairs sur l’échelle qu'ils visent et, surtout, cela doit se refléter dans la 
position administrative du décideur ou du co-chercheur principal (co-CP) intégré au projet. 
4. Les objectifs du programme en termes de promotion de l'égalité des sexes et de l'équité en 
matière de santé doivent être clairement énoncés dans l'appel à propositions et dans les cadres 
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de suivi de chaque projet. Les projets financés doivent inclure des méthodologies et des plans de 
mise en œuvre sur la manière dont ils comptent atteindre ces objectifs. Avant de finaliser les 
plans de mise en œuvre, tous les candidats sélectionnés doivent participer à des ateliers et des 
séminaires en ligne au cours desquels leurs capacités et leur approche pour atteindre les 
objectifs sont clarifiées et des mesures sont prises pour combler les éventuelles lacunes en 
matière de capacités. 
5. Les organisations de recherche et de politique de santé (OPRS), devraient être sélectionnés et 
engagés dès le début d'une nouvelle initiative et devraient participer à la sélection des 
bénéficiaires de subventions de recherche. S'ils savent dès le début ce qui sera financé dans tel 
ou tel pays, ils seront plus à même de développer leur propre plan de travail pour soutenir les 
projets d'application des connaissances et de mise en réseau. 
6. Dans le processus de sélection des subventions, il faut veiller à éviter de financer des partenariats 
opportunistes formés uniquement en réponse à l'appel de propositions entre des institutions de 
recherche canadiennes et africaines et entre des institutions de recherche africaines et des 
décideurs. Bien que les nouveaux partenariats ne doivent pas être exclus a priori, ils doivent faire 
l'objet d'un examen plus approfondi afin de s'assurer que les partenaires ont des objectifs 
communs et des méthodes de travail compatibles. 
7. La phase de préparation de l'ISMEA avant le début des activités du projet a duré près de deux 
ans, ce qui a considérablement raccourci la durée de mise en œuvre des projets. Parce 
qu’inévitable, surtout si le renforcement des capacités en matière d'intégration du genre et de 
l'équité est inclus dans la phase de préparation d'une nouvelle initiative, il faut en tenir compte 
dans la durée globale de l'initiative. Il peut également être envisagé d'allouer du temps 
supplémentaire à la phase de clôture des projets pour les activités de plaidoyer et d'application 
des connaissances. 
8. Une initiative future devrait, dès le départ, créer une présence Internet de marque forte par le 
biais d'un portail Web unique, indépendant du site Web du CRDI. La gestion du site pourrait être 
déléguée, voire même à une OPRS, mais le contrat source devrait garantir que l'initiative est 
présentée de façon exhaustive et que le site fournit l’accès à toutes les communications 
efficacement.  
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1 INTRODUCTION 
1.1 THE IMCHA INITIATIVE 
The Innovating for Maternal and Child Health in Africa (IMCHA) initiative was launched in March 2014 
to issue grants for implementation research, a scientific discipline that ‘seeks to understand factors 
that determine why an evidence-based intervention may or may not be adopted within specific 
healthcare or public health settings and uses this information to develop and test strategies to improve 
the speed, quantity and quality of uptake’.[1] It is jointly funded by the International Development 
Research Centre (IDRC), the Canadian Institutes of Health Research (CIHR) and Global Affairs Canada 
(GAC) with a funding volume of C$ 36 million supporting 28 research grants (19 original research grants 
and 9 synergy grants) in 11 African countries. All 28 grant-funded projects are led by a Principal 
Investigator (PI) of an African university, research institution or NGO and have, in addition, a Co-
Principal Investigator (Co-PI) affiliated with a Canadian research institution and a Co-PI in a decision-
making position, generally in local, regional or national government. In addition, grants were awarded 
to two Health Policy and Research Organisations (HPROs) in West and East Africa that are tasked with 
supporting knowledge translation and raising the profile of the research in order to facilitate the 
adoption of the results at scale in national and regional health policies, supporting capacity-building of 
research teams and facilitating mutual learning across IMCHA. The West African Health Organisation 
(WAHO) in Burkina Faso was contracted for the HPRO role in West Africa. In East Africa, the role is 
shared among three institutions, the African Population and Health Research Centre (AHPRC) in Kenya, 
the East, Central and Southern African Health Community (ECSA) in Tanzania, and Partners in 
Population and Development (PPD) in Uganda. The IMCHA grants are listed in Annex 2. 
1.2 MONITORING AND EVALUATION OF IMCHA 
The IMCHA initiative has a logical framework (Annex 3) with a theory of change structure leading to 
the ultimate outcome of ‘Improved maternal, newborn and child health outcomes in targeted 
countries’ via three intermediate outcomes: 
1. Enhanced production, analyses and syntheses of health systems implementation research 
prioritising gender and equity. 
2. Enhanced partnering and collaboration between decision makers and researchers on health 
systems strengthening in the selected countries.  
3. Enhanced integration of health systems research findings into primary health care policies and 
practice in selected countries. 
The logical framework acknowledges that the ultimate outcome to which IMCHA is expected to 
contribute is dependent on other factors and ‘the IMCHA initiative is [therefore] not responsible for 
reporting on the ultimate outcome’. [2] The performance measurement framework (PMF) nevertheless 
includes an indicator for reporting against this outcome, with a target that ‘50% of the implementation 
research demonstrate improvement in any of the 11 accountability indicators’: [3] 
1. Maternal mortality ratio 
2. Under-five child mortality, with the proportion of newborn deaths 
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3. Children under five who are stunted 
4. Proportion of women aged 15-49 years who are married or in union and who have met their need 
for family planning, 
5. Antenatal care coverage 
6. Antiretroviral prophylaxis among HIV-positive pregnant women to prevent vertical transmission 
of HIV, and antiretroviral therapy for women who are treatment-eligible 
7. Percentage of live births attended by skilled health personnel 
8. Percentage of mothers and babies who received postnatal care visit within two days of childbirth 
9. Percentage of infants aged 0–5 months who are exclusively breastfed 
10. Percentage of infants aged 12–23 months who received three doses of 
diphtheria/pertussis/tetanus vaccine 
11. Percentage of children aged 0–59 months with suspected pneumonia receiving antibiotics 
Under the three intermediate outcomes and their associated immediate outcomes, the IMCHA PMF 
lists eight performance indicators and targets, and under the three output streams leading to the 
immediate outcomes a total of 14 output indicators. The indicators and targets are presented in 
Annex 4. According to the PMF, the summative evaluation is fully or partially responsible for reporting 
on all but one of the outcome-level indicators.1 Annual performance reports to GAC provide data on 
two of the four immediate outcome and all 14 output indicators.  
1.3 THE MIDTERM EVALUATION OF IMCHA 
A midterm formative evaluation of IMCHA was conducted in 2017/18. The evaluation report includes 
annotated status reports on all performance indicators presented in Annex 15. It issued 21 
recommendations presented in Annex 7. In summary, the main recommendations are: 
• For the remainder of IMCHA the evaluation recommended encouraging country-level meetings 
in countries with more than one research team; holding a final meeting to share lessons learnt; 
building more capacity among the teams in gender and equity analysis; providing access to a 
vetted roster of gender and equity experts; maintaining clarity on the differences and overlaps 
between gender analysis and equity analysis; assisting teams in developing knowledge-
translation plans promoting scale-up and to secure future funding; and encouraging more 
knowledge sharing among East and West Africa HPROs. 
• For future initiatives, the evaluation recommended support and training for researchers at the 
pre-proposal stage; management training for grantees at the beginning of the initiative; separate 
gender and equity training at the onset of the project; and a clear definition of roles and 
expectations of an HPRO-like component at the outset. 
1.4 TERMS OF REFERENCE OF THE SUMMATIVE EVALUATION 
The purpose of the evaluation was to assess the overall performance of the initiative and the value-
added of its design and delivery. Specifically, the evaluation was expected to … 
                                                                        
1 All except Indicator 100.2: ‘Proportion of recommendations from formative analysis of HPROs acted upon’ 
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1. examine IMCHA performance in relation to the PMF, in particular progress made towards 
achieving the immediate, intermediate and ultimate outcomes;  
2. evaluate how the recommendations of the midterm evaluation were addressed and what 
difference they made in IMCHA achievements; 
3. assess IMCHA management, and the value added by the initiative; 
4. inform future partnerships and undertakings; and 
5. evaluate how the work conducted under IMCHA is being documented for contributing to the 
legacy of the Initiative. 
The terms of reference list 82 evaluation questions and sub-questions under four main headings:  
1. What are the achievements of IMCHA with regard to the Performance Measurement Framework 
(in particular in terms of immediate, intermediate and ultimate outcomes) as well as policy 
uptake and scale up of successful interventions? 
2. How effective has the management of the initiative been and what difference has that made to 
IMCHA achievements? 
3. How well has IMCHA been operationalised and how could it be improved on in future 
undertakings?  
4. How [is] the work conducted under IMCHA documented for contributing to the legacy of the 
initiative? 
The questions were reorganised by the evaluation team in an evaluation matrix into four areas of 
enquiry, ten main evaluation questions and 30 evaluation sub-questions. The terms of reference and 
the evaluation matrix are provided in Annex 1 and Annex 8. 
Findings responding to sub-questions on the effects of the midterm evaluation and on unpredicted 
outcomes were aggregated in Section 3.2 and Section 3.4 respectively. Responses to the evaluation 
questions of ‘how well has IMCHA been operationalised and how could it be improved on in future 
undertakings’ were merged into the section on conclusions and lessons learnt. (Section 4)  
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2 APPROACH AND METHODOLOGY 
The evaluation adopted a results-oriented approach, assessing the performance of IMCHA against the 
targets of the PMF, as well as a reflexive approach, drawing lessons from the processes of project and 
programme implementation. The approach and methodology are described in detail in Annex 9. 
Data to answer the evaluation questions were collected between December 2019 and May 2020 
through document reviews, an online survey of researchers and decisionmakers, and key informant 
interviews conducted during site visits or by remote voice over internet protocol (VOIP).  
A library of technical and administrative documents was provided by IMCHA including annual 
programme reports, project approval documents (PADs), implementation plans, project progress 
reports, workshop reports and presentations, monitoring and financial databases, and reports of 
project monitoring visits. Additional documents were provided by interviewed key informants. In total, 
the evaluation collected 385 documents and entered them into the analysis. 
An online survey of IMCHA grantees was 
launched in English and French on January 6th 
on the SurveyMonkey platform. Invitations 
were sent and received by 163 current and 
former researchers and decisionmakers 
identified by the PIs. Of these, 59 completed 
the survey for a valid response rate of 36 
percent. HPRO staff was not included in the 
survey. (Annex 10) 
The evaluation team interviewed 97 
stakeholders in individual or group interviews 
in person or via VOIP. (Annex 12) The 
interviews were semi-structured on the basis 
of the evaluation questions, adapted to each 
of the four main stakeholder groups, and 
further adapted to each individual interview 
context and position of the informant. 
Key informants in each group were sampled by purposive sampling that aimed at reaching data 
saturation for each evaluation question. Researchers, decisionmakers and HPRO staff were 
interviewed during project visits or in VOIP interviews. All current IDRC staff involved in IMCHA 
management as well as all current members of the IMCHA M&O Committee were interviewed 
individually or in groups during a mission to Ottawa. Only one member of the Governance Committee 
was available for an interview. 
Ten of the 19 research teams among whom six had obtained additional synergy grants were included 
in site visits or VOIP interviews, as well as all three East Africa HPRO partners and the West Africa 
HPRO. (Table 1) During site visits, additional interviews were conducted with three decisionmakers at 
 Stakeholder groups 
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national level who were not Co-PIs. Three Co-PI decisionmakers, two PIs and one Canadian Co-PI did 
not respond to requests for interviews.  
 Project interviews 
GRANT COUNTRY PI INSTITUTION  
108020 / 108546 Tanzania Ifakara Health Institute On-site 
108022 Tanzania Ifakara Health Institute On-site 
108023 Tanzania University of Dar es Salaam On-site 
108024 / 108547 Tanzania Catholic University of Health and Allied Sciences On-site 
108027 / 108548 Tanzania Tanzanian Training Centre for International Health On-site 
108028 Ethiopia Jimma University VOIP 
108033 / 108550 Uganda BRAC Africa On-site 
108037 / 108553 Burkina Faso Société d'Etudes et de Recherche en Santé Publique VOIP 
108040 / 108552 Nigeria University of Ibadan On-site 
108041 Nigeria Women's Health and Action Research Centre On-site 
107892 (HPRO) Burkina Faso West African Health Organisation VOIP 
107893 (HPRO) Kenya African Population and Health Research Centre On-site 
107893 (HPRO) Uganda Partners in Population and Development On-site 
107893 (HPRO) Tanzania ECSA Health Community  On-site 
Fifteen Canadian Co-PIs and researchers participating in the ten original research and six synergy 
projects listed in Table 1 were interviewed during the mission to Ottawa, in the context of the IMCHA 
learning workshop, or using VOIP. 
The online survey responses included Likert and ranking scales as well as narrative responses. The data 
derived from scales were tabulated, proportions were calculated where appropriate and compared to 
proportions reported in the midterm survey. The narrative survey responses, the interview transcripts 
and the collected documents were analysed using the qualitative content analysis software MAXQDA.  
2.1 LIMITATIONS 
The response rate of decisionmakers to the online survey was low with only 5/29 invited 
decisionmakers responding. Requests for VOIP interviews with three decisionmaker Co-PIs in Ethiopia 
and Burkina Faso also remained unanswered. As a consequence, 5/5 decisionmakers who responded 
to the survey and 7/8 interviewed decisionmaker Co-PIs were from either Tanzania or Nigeria. A 
selection bias in this group can therefore not be excluded.  
All teams of the sampled projects were engaged in final data collection and analysis at the time of the 
evaluation and could not share data on MNCH or service outcomes. The same applied to research 
publications, with all teams still working on planned or draft documents. 
All projects undertook initiatives to generate policy influence, but most of these were still ongoing at 
the time of the evaluation or waiting for the analysis and documentation of research results. It was 
arguably too early in the programme to evaluate the success of knowledge translation and scaling 
initiatives.  
The unit of analysis of stakeholder perceptions and experiences in the final evaluation comprised all 
individuals listed in the four stakeholder groups in Figure 1. During site visits, interviews were held 
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with all project staff. Current and former researchers and decisionmakers who were identified by the 
PIs were invited to participate in the online survey. While the survey respondents could not be 
disaggregated by project, a disaggregation by affiliation with African or Canadian research institutions 
and by project countries indicates a relatively equal representation of all projects. The survey 
responses are, however, not strictly comparable to those obtained in the midterm survey which only 
invited responses from PIs and Co-PIs. This is further discussed in Annex 11.   
Further details on limitations are provided in Annex 9. 
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3 FINDINGS 
3.1 IMCHA PERFORMANCE AND OUTCOMES 
3.1.1 EVALUATION QUESTION 1 
What is the outcome of IMCHA in terms of improved maternal, newborn and child health 
in targeted countries? 
(a) What are the achievements of IMCHA in relation to the eleven indicators on MNCH? 
(b) What have been the main strategies to obtain these achievements? And how appropriate are they 
for achieving the intended outcomes? 
It is highly likely that the IMCHA PMF target that ‘50% of the implementation research demonstrate 
improvement in any of the 11 accountability indicators’ was surpassed. However, only a small 
number of projects monitored performance on these indicators and none of them had yet completed 
their final analysis and could report results. Nevertheless, there is qualitative evidence that the 
majority of projects had potentially direct or indirect effects on improving MNCH indicators in their 
project areas.  
A strategy applied by all IMCHA-funded projects to achieve outcomes was the embedding of 
decisionmakers in the research teams as Co-PIs. Beyond this common strategy, projects differed 
substantially in theme, focus and scope of the MNCH issues they addressed, each with its distinct 
strategic approach. On a conceptual level, the main lines of differentiation that distinguished projects 
was the weighting of research versus programme implementation activities. There was no common 
understanding of the concept of implementation research among stakeholders interviewed by the 
evaluation team. 
IMCHA ACHIEVEMENTS IN RELATION TO THE ELEVEN MNCH INDICATORS 
Interviews and survey responses by researchers and decisionmakers indicated that all research teams 
perceived that their projects contributed to improvements in MNCH, although not all of them directly 
and in the same manner. In the online survey, 43/54 researchers (80%) selected at least one indicator 
that according to their assessment was improved by the project, and three more stated that they had 
collected data on these indicators that were still being analysed.  
A review of the monitoring and evaluation sections of the 16 implementation plans that were provided 
to the evaluation team for the 19 original research projects found that only four planned to monitor 
or evaluate any of the eleven indicators, all of them related to maternal health services. In interviews, 
all PIs stated that data were still being analysed, and results could not yet be communicated.  
Among the projects, there were large differences in the populations covered by the researched 
interventions and by the potential level of contribution of the interventions to the IMCHA ultimate 
outcome indicators. This renders an aggregation of data for these indicators meaningless and in many 
cases impossible as illustrated by two examples: 
• One project researching the impact of supply and demand-side interventions on access, 
utilisation and outcome of maternity services in primary health care (PHC) facilities covered a 
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population of about 10,000 served by three PHC centres. The project reported indicator changes 
of several hundred percent based on highly unstable fluctuations of single or double-digit 
indicator values. Another project researched changes in service availability, quality, access and 
utilisation due to the national introduction of a free maternity care policy. The research 
population was more than ten million and the changes may have affected thousands of women. 
They could, however, not be attributed to the project although the research results may well 
lead to a more effective and equitable application of the policy. 
The perceptions by 85 percent of researchers who responded to the online survey and by all 
interviewed researchers that their project contributed to an improvement of at least one IMCHA 
ultimate outcome indicator is plausible. It is highly likely that the PMF target that ‘50% of the 
implementation research demonstrate improvement in any of the 11 accountability indicators’ was met 
and largely surpassed. However, for many projects the effect on any of the indicators was indirect and 
not reflected in the projects’ M&E plans. Data were therefore not collected and reported. A quantified 
result that is based on a measurement of the indicators in the 28 IMCHA projects can therefore not be 
reported. 
MAIN STRATEGIES AND THEIR APPROPRIATENESS 
The strategies implemented by the project teams to generate intended outcomes were outlined in the 
project implementation plans of the original research projects. These were generated on the basis of 
the research proposals after extensive feedback by technical reviewers, in many cases requiring major 
revisions of the proposed activities. For projects funded with synergy grants, implementation plans 
were not prepared because they were conceptualised as complementary to existing projects, although 
some of them addressed new research questions. 
A strategic concept that characterised all IMCHA-funded projects was the approach to knowledge 
translation by embedding decisionmakers in the research teams as Co-PIs. This was pursued by all 
projects and is further discussed under evaluation questions three and four. 
Beyond this common characteristic, projects differed substantially in theme, focus and scope of the 
MNCH issues they addressed, each requiring distinct strategic approaches that were only comparable 
among small clusters of similar projects. On a conceptual level, the main lines of differentiation that 
distinguished projects was the weighting of research versus programme implementation activities. 
There was no clear dividing line, but rather a continuous positioning on a scale with a range illustrated 
by the assessment of one PI who classified the original project he led as 20 percent research and the 
subsequent synergy project as 80 percent. 
The conceptual tension between the research objectives and programme implementation objectives 
was well known at the time IMCHA was launched and, according to a senior IDRC executive, generated 
discussions at that time. Interviews with stakeholders including researchers, IMCHA programme 
managers and staff of funding agencies indicated that this tension is still not fully resolved and that 
there is no common understanding of the concept of implementation research among members of 
project teams and among staff of funding agencies and IMCHA programme staff. 
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While there was consensus among interviewed stakeholders on the strategy for generating uptake and 
scale-up of project results, the views on the strategies of how these results were to be generated 
differed widely. They ranged from implementing and monitoring interventions to research strategies 
that were built around policy-relevant research question such as ‘what is the mechanism of impact of 
home visits on maternal outcomes?’ or ‘how do activities of CHWs differ with alternative modes of 
income support?’   
3.1.2 EVALUATION QUESTION 2 
Has IMCHA enhanced the production, analysis and synthesis of health systems 
implementation research prioritising gender and equity? 
(a) How were gender and equity dimensions integrated by the IMCHA research teams?  
(b) How did HPROs contribute to the integration of gender and equity in research activities, capacity 
strengthening and knowledge translation?  
(c) How did IMCHA management contribute to the integration of gender and equity? 
The targets for the two PMF indicators for measuring the intermediate outcome of integrating gender 
and equity in IMCHA research were not met. Integrating adequate gender dimensions in at least three 
research processes was achieved by 54 percent and for adequate equity dimensions by 25 percent of 
projects against targets of 100 percent. However, several interviewed PIs stated that they planned to 
do additional equity analyses prior to closure of the project. Of a sample of 95 research outputs 
reviewed, 44 (46%) included a gender focus and 21 (22%) an equity focus against targets of 75 percent. 
The HPROs supported the integration of gender dimensions through formative studies, training and 
encouraging the research teams to include a focus on gender in their outputs. They analysed the equity 
orientation of MNCH policies in programme countries but did not contribute to the integration of 
equity considerations in IMCHA projects. IMCHA management required researchers to integrate 
gender and equity dimensions in the implementation plans and the technical reports.  
INTEGRATION OF GENDER DIMENSIONS 
The first indicator (Indicator 1.1) for measuring the outcome of ‘implementation research prioritising 
gender and equity’ in the IMCHA PMF is the ‘proportion of total projects that have at least 75% (three 
of four processes) adequate gender and equity dimensions’ with a target that this should be met by all 
funded projects. Research processes, according to the PMF, include the project design, data collection, 
data analysis, and dissemination. We assessed the extent to which gender was integrated in these 
processes by analysing research protocols, technical reports and research outputs. Overall, only 15/28 
projects (54%) were assessed as having integrated adequate gender dimensions in three of four 
research processes. 
Since ‘adequate gender dimensions’ were not defined in the PMF, we applied the WHO Gender 
Responsiveness Assessment Scale [4] to assess whether methods were used and information was 
presented in a way that was gender unequal, gender blind, gender sensitive, gender specific or gender 
transformative at each stage of the research process (see textbox). Although the scale was developed 
for assessing health programmes rather than research projects, it could be applied to the IMCHA 
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projects as they all included an 
implementation component. The 
research process was considered to 
‘adequately’ integrate a gender 
dimension if it was gender-sensitive 
or gender-specific or gender-
transformative.  
Project design 
A review of the 28 accepted grant 
proposals found that gender was 
integrated by all research teams, 
although to varying degrees. All 
proposed projects aimed at 
ultimately benefitting women and 
girls, 21 proposals (75%) intentionally 
targeted a specific group of women, 
but only 12 (43%) included research 
questions explicitly referring to 
gender issues. Gender issues were 
mentioned in the objectives of the 
research by 20/28 proposals (71%), 
with 17 including gender differences 
in the context analysis. About half of 
the research proposals also proposed to address gender-based inequities created by norms, roles 
and/or relationships. 
 Integration of gender in IMCHA research proposals 
 YES NO % YES 
Women/girls beneficiaries 28 0 100% 
Intentionally targets specific group of women/men 21 7 75% 
Gender in objectives 20 8 71% 
Considers differences for men and women 17 11 61% 
Women/girls consulted during design 15 13 54% 
Addresses inequities created by norms, roles and relationships 14 14 50% 
Gender research question 12 16 43% 
This assessment is confirmed by the online survey in which respondents were asked about the extent 
to which six aspects or activities related to gender equality were included in their projects, for instance 
including gender in a research question or consulting women and girls during project implementation. 
(Annex 11) At midterm the same questions were asked. The responses to both surveys indicate an 
awareness of respondents about actions to strengthen the integration of gender in their research 
projects. At midterm, 64 percent of respondents declared that they had conducted gender sensitivity 
WHO Gender Responsiveness Assessment Scale 
1. GENDER UNEQUAL 
- Reinforces unbalanced norms, roles, and relations 
- Privileges men over women (or vice versa) 
- Often leads to one sex enjoying more rights or opportunities than the 
other 
2. GENDER BLIND  
- Very often reinforces gender-based discrimination 
- Ignores differences in opportunities and resource allocation for 
women and men 
- Constructed based on the principle of being “fair” by treating 
everyone the same 
3. GENDER-SENSITIVE  
- Does not address inequality generated by unequal norms, roles or 
relations 
- Indicates gender awareness, although often no remedial action is 
developed 
4. GENDER-SPECIFIC  
- Considers women’s and men’s specific needs 
- Intentionally targets and benefits a specific group of women or men 
to achieve certain policy or programme goals or meet specific needs 
- Makes it easier for women and men to fulfil duties that are ascribed 
to them based on their gender roles 
5. GENDER TRANSFORMATIVE  
- Addresses the causes of gender-based health inequities 
- Includes ways to transform harmful gender norms, roles, and 
relations 
- The objective is often to promote gender equality 
- Includes strategies to foster progressive changes in power 
relationships between women and men 
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training and 91 percent that women or girls were the beneficiaries of their projects. In the final 
evaluation survey, these two aspects also received the lowest and highest proportion of positive 
responses, but by a higher proportion of respondents of 75 and 95 percent respectively. Seventeen 
research teams also included specific gender expertise in their project team and several teams sought 
to achieve a gender balance among researchers in their project. 
Applying the Gender Responsiveness Assessment Scale, 12/28 research proposals (43%) were designed 
to be gender transformative, four were gender specific (14%), eight were gender sensitive (29%) and 
four were gender blind (14%). Of the 12 gender transformative proposals, seven were for original 
research grants and five for proposals funded with synergy grants. All of these were submitted by 
teams that included a researcher with gender expertise. However, one of the four proposals rated as 
gender blind was also submitted by a team that reported gender expertise. Researchers may highlight 
gender expertise in their profile, however this does not automatically assure that gender is integrated 
in the proposals they submit 
Project implementation 
In the first year, the research teams (RTs) were asked to refine the implementation plans, for example 
by specifying how the intervention would address gendered power imbalances. Consequently, 14/19 
original research projects (74%) addressed gender more comprehensively in the implementation plans. 
Most projects for which information was available on data collection, analysis and dissemination 
(21/28) included a focus on gender in these processes. For example, three out of four projects with a 
gender-blind design improved the integration of gender in subsequent research processes. The 
majority of processes used were gender aware (15/21 - 71%) and included conducting surveys of 
women, including sub-analyses on gender in the baseline survey, including a women’s economic 
empowerment survey tool in the end-line survey, separating focus group discussions by sex, and 
including monitoring and evaluation indicators assessing the level of participation of women and men. 
Gender transformative processes (5/21 projects 24%) included assessing the level of gender norms and 
gender relations in baseline surveys, analysing key barriers for women and identifying strategies to 
overcome these, assessing the level of women’s decision-making power in the household, and 
monitoring the impact of the intervention on behaviours among both men and women. 
Implementation strategies 
The research teams implemented a number of strategies to address gender issues: 
• Targeting women as main beneficiaries. (either as health workers or as clients of health services)  
• Strengthening women’s participation and capacity in health either as service providers or 
community members. (women’s support groups) 
• Conducting gender sensitivity training for health workers to provide respectful maternity care. 
• Implementing male involvement and male engagement strategies. (male champions to deliver 
health messages; joint analysis and assessment of barriers to health seeking behaviours; 
encouraging men to accompany women to antenatal care visits; involving the spouses of female 
community health workers) 
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As noted by the midterm evaluation, framing gender as a women’s health issue, focusing primarily on 
women in the context of reproductive health and childbearing, does not in itself guarantee an 
improved status of women. Several projects analysed the barriers for women’s health or health seeking 
behaviours and found that lack of autonomy and decision making were root causes.  
Male involvement in women’s health issues featured prominently in several projects. One project 
included an indicator for male involvement, monitoring the number of male partners who 
accompanied women to antenatal visits. While there is evidence that the involvement of men in their 
partners’ reproductive health strengthens gender equality, policies that establish reward or 
punishment systems to promote this involvement may also decrease the autonomy of women in 
making decisions about their own health. A project in Tanzania, for instance, found that a policy that 
gave preferential treatment to women in antenatal clinics who were accompanied by their spouse 
discriminated against single women and against women whose partners were reluctant to accompany 
them. Some of them delayed first antenatal care attendance or enlisted other men to accompany 
them, defying the purpose of increased spousal engagement in the pregnancy. 
Shared decision-making was encouraged by some projects, for example in home visits of pregnant 
women by community health workers (CHWs) during which pregnancy risks were discussed with both 
partners. Encouraging shared decision-making is acknowledged as a successful strategy when women 
are simultaneously empowered with more knowledge, confidence, and capacity to claim their 
rights. [e.g.5,6,7] The combination of empowering women and encouraging them to discuss their 
issues with men to find joint solutions was adopted by the four projects that were rated as gender 
transformative.  
Research outputs 
The second indicator (Indicator 1.2) for measuring the outcome of ‘implementation research 
prioritising gender and equity’ in the IMCHA PMF is the ‘proportion of health systems research outputs 
and syntheses that is gender and equity focused’. In May 2020, the IMCHA monitoring database listed 
151 IMCHA project outputs of which 86 were accessible to the evaluation team. An additional nine 
were collected during field visits for a total of 95 outputs from 22/28 projects. Among the 22 projects, 
18 had produced at least one output that addressed gender issues, some quite superficially. Overall, 
54 percent of outputs were assessed as gender blind. The majority of these were journal articles (15), 
policy briefs (15), other outputs (9), presentations (7), mentions in the media (4) and blogs (1). The 
remaining 46 percent had a gender focus, ranging from gender sensitive (17%), to gender specific (12%) 
and gender transformative (16%) in the categories of the WHO Gender Responsiveness Assessment 
Scale. The PMF target of 75 percent was therefore not met. 
Barriers to gender integration 
Researchers and decisionmakers who responded to the online survey expressed considerable 
insecurity and differences in understanding concepts such as gender analysis, gender integration or 
gender equality. One interviewed HPRO informant noted: ‘The barriers to the incorporation of gender 
and equity analysis were primarily in the area of expertise and understanding. For most researchers 
gender just means an acknowledgment that there are males and females.’ Five online survey 
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respondents also noted that they lacked training or guidance on how to integrate gender 
considerations. 
The lack of clarity about gender integration in the conceptualisation of the projects was mentioned by 
two survey respondents, one of them adding that ‘the design was not clear on gender issues since the 
beginning. It was a big challenge to introduce gender issues along the way’. A similar view was 
expressed by an interviewed PI: ‘If gender equality and social equity had been missed at the early stages 
during the design phase and sampling strategy, how could you mainstream it at a later stage or add it 
to the analysis? It would require additional research’.  
INTEGRATION OF EQUITY DIMENSIONS 
The IMCHA call for research proposals requested that the proposals integrate health equity 
dimensions, described as ‘differences in health status [which] typically relate to inequalities and 
inequities across racial groups, rural/urban status, socio-economic status, gender, age, and 
geographical region’. [8] The midterm evaluation highlighted that most of the projects had not 
incorporated equity considerations to any significant degree, that the integration of equity 
consideration was not well understood and that it was often conflated with the integration of gender 
considerations.  
In the IMCHA PMF, the indicators and targets for measuring the outcome of equity integration are 
merged with those for integrating gender, i.e. Indicators 1.1 and 1.2 cited above. The indicators and 
targets for equity integration do not define an ‘adequate equity dimension’. For the evaluation of 
Indicator 1.1, we analysed project documents as well as survey and interview responses to determine 
the extent to which the projects (i) identified and focused on disadvantaged or vulnerable groups; (ii) 
collected data that were stratified according to factors of disadvantage and vulnerability; (iii) analysed 
these data to document health inequities; and (iv) addressed recognised inequities in their knowledge 
translation activities. While evaluation data were being collected, the research teams were introduced 
to equity analysis in the IMCHA learning workshop in January 2020. In interviews, several PIs stated 
that they planned to conduct equity-focused data analyses and knowledge translation activities after 
attending the workshop. A final assessment of the performance on Indicator 1.1 (adequate equity 
dimension in three of four processes) could therefore not be made. A preliminary assessment, 
however, indicated that the 100% target will not be met, as only 7/28 projects (25%) were found to 
have integrated equity in at least three processes. 
Project design 
At least one equity dimension was addressed in 20/28 research proposals or implementation plans 
 Primary equity dimension in 20 IMCHA research proposals 
 NUMBER OF PROJECTS 
Place of residence (focusing on rural populations or distance to a health facility) 13 
Socio-economic position (focusing on the most vulnerable women and children) 4 
Age (focusing on adolescents) 3 
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One proposal referred to using the GRADE tool [9] for random sampling and increasing participation 
rates of marginalised groups. Another proposal referred to the PROGRESS framework [10] for 
identifying social factors affecting health opportunities and outcomes. Several key informants stated 
that social equity was not a primary concern of their research. As one PI stated: ‘Social equity has not 
been integrated or we have not yet thought about it. But we can probably do it in the final analysis, 
because the data is there.’ 
Interviews conducted with researchers and decisionmakers in Africa and Canada found that they 
understood the integration of equity as a call to conduct their project among disadvantaged 
populations with the aim of improving their access and utilisation of MNCH services. They did not plan 
to analyse how interventions reach or affect groups or individuals with differential vulnerabilities 
within their project areas. This is reflected in statements such as ‘equity aspects were taken into 
consideration when a decision was made about the project sites.’ 
Project implementation 
Evidence that data were collected that included social parameters such as wealth, ethnicity, religion, 
education, age, occupation, place of residence, or marital status was found for 8/28 projects (29%). 
For 7/28 (25%) there was evidence that these data were analysed to understand the needs and effects 
of the intervention on different groups or sub-groups. However, several interviewed PIs stated that 
they planned to do such an analysis in future. One project went a step further and found that 
traditional equity criteria based on levels of income were insufficient for identifying vulnerabilities that 
affect access to MNCH services. Additional factors of vulnerability in the project area were alcohol 
consumption by either partner, a history of home deliveries, having only given birth to girls, living in 
fishing sites, and being accused of practicing witchcraft.  
Implementation strategies 
When asked about what strategies were used for addressing inequities in access to health, the 
responses in the online survey varied widely but could be grouped into two categories:  
• Ensuring equal coverage of the intervention through universal coverage, promoting messages 
of equal care for all, ensuring all pregnant women were covered by home visits using GPS 
location and tracking, and providing knowledge to all beneficiaries. 
• Addressing health inequities of specific groups by establishing a fund to ensure that pregnant 
women at the time of delivery could afford to get a pregnancy kit a and pay for transport to the 
health facility, encouraging male involvement in women’s health seeking behaviour, or 
strengthening women’s participation. 
These strategies again highlight how equity dimensions were understood and integrated in different 
ways across the projects. In the online survey, only 42 percent of respondents agreed with the 
statement that there were differences among beneficiaries and efforts were made to focus on the 
most vulnerable. The remaining either considered equity not as an issue (10%) or that it was addressed 
automatically because all beneficiaries were vulnerable (47%).  
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Equity expertise and training were reported by few respondents and the information was difficult to 
corroborate with available documentation. One survey respondent commented that ‘we worked with 
a consultant and conducted formative research with vulnerable women to identify the important issues 
to look at in the study’. One project included a junior equity expert in the team which reportedly helped 
mainstreaming equity analysis throughout the research processes. 
Project outputs 
For Indicator 1.2, the ‘proportion of health systems research outputs and syntheses that is gender and 
equity focused’, only 21/95 reviewed research outputs (22%) included a focus on equity, for example 
by presenting how different equity parameters (e.g. education, occupation, household wealth) affect 
women’s health seeking behaviours, documenting how age and public participation are correlated 
with maternal deaths, assessing how institutional deliveries are correlated with socio-demographic 
factors, focusing on what factors influence health seeking behaviour of nomad women, assessing how 
performance-based financing of health services would affect services to vulnerable populations and 
analysing how the social capital of community health workers can be improved.  
Barriers to integrating equity 
In response to the online survey question about barriers to the integration of equity considerations, 
most researchers and decisionmakers mentioned financial and logistical barriers for reaching 
vulnerable groups. This reflected the findings reported in the equity issue brief of the midterm review. 
Some teams understood inequity as a matter of geography and stated that more time and funding 
would have allowed the project to reach remote and vulnerable populations. A lack of interest in 
exploring social equity issues in MNCH services by some project partners was also mentioned by three 
respondents. The main barrier, however, was that capacity and knowledge on how to integrate equity 
considerations in the implementation of the project and the analysis of research data was low. One 
HPRO respondent noted, ‘[equity analysis] was new to many people. This type of analysis needs more 
technical input and qualified people to do it.’ 
CONTRIBUTION OF HPROS TO GENDER AND EQUITY INTEGRATION  
As per the call for proposals, the HPROs were expected to (i) conduct a comprehensive analysis of the 
differential effects of health policies and interventions and make sure that discussions on gender 
equality and equity are integrated in these analyses, (ii) offer capacity strengthening support to the 
RTs, including on gender and equity analysis and (iii) ensure a strong gender and equity focus in 
dissemination products. [11]  
Formative research 
The two HPROs conducted formative research that focused on policy uptake and context mappings. 
The East Africa HPRO (EA-HPRO) commissioned a rapid review of the MNCH resolutions passed by the 
East, Central and Southern Africa Health Community which found that gender and health equity issues 
were not effectively addressed in the countries covered by the IMCHA initiative. Additionally, the EA-
HPRO conducted a situation analysis for Uganda, Ethiopia, Malawi, Mozambique, South Sudan and 
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Tanzania highlighting equity and gender issues in relation to health policies, health services, health 
system gaps, other barriers to access and national policies related to MNCH.  
In West Africa, WAHO commissioned a study on the role of gender and equity in MNCH programs in 
West Africa in 2016 focusing on six countries (Benin, Burkina Faso, Ghana, Mali, Nigeria and Senegal). 
The report assessed how programmes in the region aim to reduce gender inequalities and inequities 
in terms of education, socio-economic status, distance to health facilities, etc. It found that very few 
programmes address gender norms, roles and relations and that there is a lack of diversity in the equity 
focus, with the majority of initiatives focusing on removing geographic, knowledge related, and 
economic barriers. In February 2016, WAHO organised a regional workshop to discuss the findings.  
Capacity strengthening 
The EA-HPRO organised a four-day gender equity course in November 2018 that focused on gender 
frameworks and intervention processes. It addressed gender issues that affect health system 
components and proposed solutions to address them and strengthen health systems in general. The 
EA-HPRO also supported a one-day gender training for researchers and decisionmakers in Uganda. 
WAHO organised a regional five-day training on gender integration and analysis in May 2019 and 
assisted one research team in identifying a consultant to conduct a three-day raining on the UNICEF 
EQUIST model. Neither HPRO organised or supported capacity-building activities on equity integration 
of analysis. 
In the online survey, 15/28 (54%) African and 7/24 (29%) Canadian researchers stated that they had 
participated in a training workshop on gender. Training on equity was reported by 10/24 (42%) African 
and 4/24 (17%) Canadian researchers. These included workshops organised by HPROs as well as those 
organised by IMCHA management. 
Knowledge translation 
HPROs were also expected to support the RTs in integrating gender and equity dimensions in the 
dissemination and translation of the evidence. Three researchers confirmed, either in the online survey 
or in interviews that they received HPRO support in including gender considerations in their knowledge 
translation outputs. Three other researchers, however, were less positive about HPRO support.  
CONTRIBUTION OF IMCHA MANAGEMENT TO GENDER AND EQUITY INTEGRATION 
The first call for proposals required the HPROs and the research teams to address gender equality and 
equity in the grant application. While this approach was helpful for ensuring that none of the projects 
were gender neutral, informants voiced concerns that the focus on gender and equity in the proposals 
was mainly a ‘box-checking exercise’. Technical reviewers requested several applicants to refine their 
approach in the implementation plan but only six teams made significant changes. As one HPRO 
informant stated: ‘The way [gender equality and equity] were integrated into IMCHA [by IMCHA 
management] was not well articulated and almost came in as a retrofit because it was not at the basis 
of the way the country teams were developing their research methodologies or doing their political 
economy analyses.’ This was confirmed in an interview with IMCHA management staff: ‘What I see as 
a really big barrier is that when we issued the calls for proposals, there were sections on gender and 
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equity considerations with some wonderful words around them. But when a project does not really 
have concrete questions that touch on these issues and if they just mention that gender aspects will be 
considered, it does not happen.’ 
This was, however, different for the synergy projects in which gender was more explicitly addressed 
during the research design. The call encouraged proposals with a gender focus on research topics that 
addressed root causes of high maternal and child mortality (e.g. early and forced marriage, unmet 
need for family planning, adolescent pregnancy) and promotion of sexual and reproductive health 
(SRH) services and information. In terms of the research design, the projects funded with synergy 
grants were more likely to integrate gender considerations than those funded with the original 
research grants.  
Orientation sessions on gender were included in the IMCHA inception meeting in 2015 and the 
midterm workshop in 2017, and a session on equity in the learning workshop in 2020. While the 
sessions were much appreciated and were reported to have improved the understanding of gender 
and equity, the timing of the health equity session came too late for the evaluation to assess changes 
in the approach to equity integration by the research teams. 
3.1.3 EVALUATION QUESTION 3 
To what extent has there been enhanced partnering and collaboration between 
researchers and decisionmakers on health systems strengthening? 
(a) How have the research teams and/or HPROs demonstrated collaboration with decisionmakers?  
(b) How has IMCHA management contributed to this work? 
The IMCHA model of embedding decisionmakers as Co-PIs in the research team was rated as 
successful or very successful by 90 percent of researchers. The contribution of the decisionmaker Co-
PIs was particularly appreciated for grounding the research in the local context and for encouraging 
the use of research in policy and practice. The HPROs provided an important contribution to linking 
the projects to national high-level health authorities and to introducing the project results in national 
and regional discussions of MNCH policy. Constraints mentioned in interviews and survey responses 
included: (i) Continued engagement of the decisionmaker Co-PI was not always achieved; (ii) the high 
mobility of decisionmakers resulted in frequent changes of Co-PIs; and (iii) not all projects included a 
decisionmaker Co-PI who occupied a position of influence in the policy or programme area where the 
project sought to affect change.  
COLLABORATION OF RESEARCHERS AND DECISIONMAKERS 
The inclusion of a Co-PI decisionmaker in the research teams was a key design feature of the IMCHA 
initiative. It was an innovative approach that is sometimes referred to as ‘embedded implementation 
research’ and that was recently analysed in a multi-country study in Latin America and the Caribbean. 
The study concluded that ‘embedding research into real world policy and practice bears the potential 
to improve implementation and scale-up of effective health interventions, thus contributing to the 
relevance of research to support universal health coverage schemes globally’. [12]  
The research teams collaborated with decisionmakers at various levels in the health system. In addition 
to the identified Co-PI who was part of the research proposal, several projects established 
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collaborations with decisionmakers at community, district and regional levels in order to obtain buy-
in and ownership of the research findings and with policymakers at national level to share research 
results, to advocate for policy change or to scale up research findings. 
In the online survey, all decisionmakers and 90 percent of researchers rated the collaboration as very 
successful or somewhat successful. There was a difference between the Canadian and African 
respondents. Four of 19 Canadian researchers were ambivalent about the success of the collaboration, 
and one even rated it as unsuccessful. Since the midterm survey, however, the proportion of 
researchers who rated the collaboration as very or somewhat successful increased from 75 to 90 
percent, primarily due to increased ratings by Canadian researchers.  
Some survey respondents and interviewed informants highlighted the need to involve decisionmakers 
at the appropriate level. One HPRO informant noted that the choices of the Co-PI were often 
opportunistic, and many projects did not choose policymakers at the appropriate level. ‘Before you 
start a project, you need a strategic objective of what change you want to affect, and this objective 
informs who your policymakers are’. The initial situation and stakeholder analyses conducted by the 
HPROs could have informed the choice of Co-PI by clarifying the processes and the levels at which 
policy and programmatic decisions are 
made. However, as noted by the informant: 
‘By the time we were able to engage with the 
research teams, the policymakers were 
already there. Many did not have the right 
profile and seniority.’ This was also reflected 
in an interview with a project PI: ‘We 
partnered with provincial health but in the 
end, it would have been better to involve a 
national health decisionmaker’.  
Policy processes differ greatly among the 
IMCHA programme countries. In some 
countries all health policy decisions are made 
at national level, while others are highly 
decentralised and policy change, even at the 
national level, can only be achieved in 
alliance with decentralised health 
authorities. This is illustrated in the textbox 
on strategic choices. 
The mobility of decisionmakers was a challenge experienced by several projects. One PI in Tanzania 
reported that the Co-PI changed four times over the lifetime of the project. When there were 
transitions, it took time to rebuild the relationship, trust and buy-in. One positive effect of the mobility 
was reported from Tanzania where a decisionmaker Co-PI moved from a decentralised to a central 
position in the ministry of health, and the project was therefore provided with a direct link to influence 
national policy. 
Strategic Choices 
The free maternity care policy in Burkina Faso was 
introduced by the national Ministry of Health. In order to 
monitor the impact of this decision on equity, quality, 
cost, etc. the ministry needed information and analyses 
that were provided by an IMCHA project. Embedding a 
national decisionmaker in the research team was an 
obvious choice for assuring that research findings were 
translated into policy decisions. 
In Nigeria, the institutions responsible for delivering 
primary care health services are the State Primary Health 
Care Development Agencies (PHCDA). The highest policy-
making body for health in Nigeria is the National Council 
on Health in which the States and the Federal Ministry of 
Health are represented as equal partners. The IMCHA 
project that aimed at introducing services for the 
diagnosis and treatment of perinatal depression at the 
primary health care level, therefore appropriately 
engaged with the PHCDA decisionmaker who was the link 
of the project to the State health authorities which, in 
turn, prepared a submission to the National Council on 
Health and will defend it in order to translate the research 
findings into national health policy. 
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Some decisionmakers were too busy to engage closely with the project activities. The expectations of 
some Co-PIs, especially in terms of available funds to implement programmes and training 
opportunities were not always met as indicated by the constraint of ‘insufficient funds’ selected most 
frequently by decisionmakers in response to questions about implementation barriers in the online 
survey. Building partnerships of trust across the research/policy divide takes time and effort, 
something that was achieved by many IMCHA projects but that was not always evident from the start. 
The researchers who reported successful cooperation with their Co-PIs noted that an existing 
relationship and early involvement were key contributing factors: 
In the online survey, the research teams were asked to rate the contribution of decisionmakers to 
different areas of cooperation. 
 Researchers ratings of decisionmakers’  contributions 
AREAS OF COOPERATION SOMEWHAT HELPFUL VERY HELPFUL 
Grounding research in local context 22% 75% 
Encouraging the use of research findings in policies and practices 31% 60% 
Connecting to other decisionmakers 32% 52% 
Scaling up of research results 42% 44% 
Integrating equity considerations 40% 40% 
Integrating gender considerations 33% 35% 
Overall, the researchers rated the contributions of the decisionmaker Co-PIs highly, especially for 
grounding the research in local context and for encouraging the use of research findings in policies and 
practices. The rating for all areas of cooperation was considerably higher than at midterm. Across all 
six areas, an average of 84 percent of researchers rated the contribution as very or somewhat helpful, 
compared to only 69 percent at midterm. This suggests that despite constraints and challenges, the 
teams did grow together across the research/policy divide. 
Collaboration between HPROs and decisionmakers 
HPROs were tasked to ‘catalyse mechanisms to support the uptake and integration of research and 
research evidence into practice and policies.’ [11] They did so by strengthening the capacity of research 
teams in knowledge translation through training workshops, by facilitating meetings between 
individual research teams and policymakers and by organising national conferences.  
As regional institutions, the HPROs were directly linked to regional political institutions. WAHO is a 
Specialised Agency of the Economic Community of West African States (ECOWAS) and ECSA is 
governed by the Ministers of Health of the East, Central and Southern African member states. In this 
role, HPROs were able to implement initiatives in regional policy development. 
CONTRIBUTIONS OF IMCHA MANAGEMENT 
The contributions of IMCHA management to the achievements of the IMCHA initiative is discussed in 
Section 3.2.1 responding to Evaluation Question 8. Management provided support for the uptake of 
research findings in programmes and policies in the IMCHA inception, midterm and learning workshops 
in which the Co-PI decisionmakers participated and during which various aspects of knowledge 
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translations were discussed. IMCHA management also supported the research teams and HPROs by 
promoting, publishing and presenting research, and by providing contacts for networking with other 
institutions and actors in the region. More than 80 percent of respondents to the online survey noted 
that they had received support in these areas. Beyond this, the task of promoting and supporting 
knowledge translation at national and regional level was largely devolved to the HPROs without direct 
involvement by IMCHA management.  
3.1.4 EVALUATION QUESTION 4 
To what extent has there been enhanced integration of health systems research findings 
into primary health care policies and practice in the selected countries, and scale up? 
(a) How have research teams and HPROs demonstrated influence on policy and programming? 
(b) How successful have research teams and HPROs been in scaling the research results? 
(c) How has IMCHA management contributed to this work? 
Integrating research findings into policies and programmes was the third high level outcome 
objective of IMCHA pursued by all funded projects. Success in terms of documented instances of 
influence on policy decisions were reported by some projects, but for the majority it was too early to 
ask for such documentation because policy processes have their own timelines which are generally 
quite long. However, by the way the projects were designed within the IMCHA conceptual 
framework, all succeeded in engaging the research teams in health policy and programme decision 
processes that are likely to directly or indirectly affect primary health care policies in the longer term. 
IMCHA INFLUENCE ON POLICY AND PROGRAMMING 
‘Enhanced integration of health systems research findings into primary health care policies and practice 
in selected countries’ is the heading of the third arm of the IMCHA logic model at the intermediate 
outcome level. Among the respondents to the online survey, 27/53 researchers (51%) stated that their 
research findings were already translated into policies or practices and 26/53 (49%) that there were 
prospects for translation in the future. Among the 27 who already reported knowledge translation, 11 
mentioned the regional level, ten mentioned the national level and six a sub-national level. Among the 
five decisionmakers who responded, four stated that they had used information provided by the 
research in their work. However, in all cases this was limited to dissemination of research findings. 
Twenty-four researchers provided details on how their research findings were translated into policies 
or practice. While many of them noted that policy changes were still under discussion or in preparation, 
several mentioned early results that included: 
• The State adopted the practice of home visits by community extension workers and developed a 
micro-plan for state-wide roll-out. (Nigeria) 
• The Ministry of Health adopted the curriculum for training of care providers in comprehensive 
emergency maternal and neonatal care. (Tanzania) 
• The district health management teams are supervising the training of community distributors for 
malaria chemo-prevention delivered by head nurses. (Burkina Faso) 
• The district adopted the distribution of birth kits. (Tanzania) 
• The State integrated mental health into PHC services. (Nigeria) 
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Interviews with researchers and decisionmakers confirmed that they were active in knowledge 
translation from research evidence to policy and practice. In most cases, however, decisionmakers 
were still waiting for the final analysis and documentation of the evidence, and several informants 
noted that processes of policy change have their own timeline and dynamic and are not instant 
reactions to new evidence.  
The IMCHA PMF includes two outcome and three output indicators to measure progress on integration 
of project findings in policies and programmes. The data reported in the monitoring (‘trackify’) 
database by February 2020 raised some questions:  
• The intermediate outcome indicator 3.1 ‘Number (type) of influence of IMCHA research projects 
on policy and programming per project’ has a target of 20. The number is not monitored. It has 
certainly been reached as almost all 29 projects can document an influence on policies and 
programmes, although the number that can actually document an attributable change in policies 
is likely smaller, at least within the timeframe covered by the evaluation. 
• The immediate outcome indicator 300.1 ‘Proportion of [decisionmaker Co-PIs] who follow up on 
recommendations from research into health systems planning forums’ has a target of 100 
percent. This target is likely not met since not all decisionmaker Co-PIs remained engaged with 
the projects throughout. It is also not clear what is understood under a ‘health systems planning 
forum’. The IMCHA trackify database lists 22 events of follow-up reported by 12 projects, five of 
them by one project. While they may be considered ‘follow-ups on recommendations’, the 
relevance in terms of ‘health systems planning’ is questionable for some. 
• Reports on output indicators for ‘number of policies promoted’ and ‘frequency of knowledge 
translation activities’ are highly inflated. For instance, one project is listed as having promoted 
81 evidence-based policies and practices based on the number of recommendations that were 
included in policy briefs prepared by the project. The policy briefs themselves are counted as 
individual knowledge translation activities to the effect that the project reported 40 knowledge 
translation activities. Another project is listed as having generated 50 knowledge translation 
activities, most of them presentations and posters at conferences, many of them delivered by 
students in Canada. 
SUCCESS IN SCALING RESEARCH RESULTS 
In the online survey, 35 respondents reported success in scaling of research findings in 55 instances 
whereby multiple answers were allowed in terms of scaling to district, provincial, national or regional 
level. Only 15 respondents stated that scaling was not an objective of their project or that they did not 
succeed in scaling their project. However, when asked about their approaches to scaling, almost all 
who reported success mentioned presentations of their findings to decisionmakers or including 
decisionmakers in their research activities. Respondents apparently made no distinction between 
approaches to knowledge translation and approaches to scaling.  
CONTRIBUTION OF IMCHA MANAGEMENT 
IMCHA management strengthened the participation of decisionmakers as Co-PIs in research teams by 
inviting them to the three IMCHA workshops at inception, midterm and the final learning event. This 
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validated their position and exposed them to the concepts of embedded implementation research. To 
questions in the online survey about the helpfulness of IMCHA management, workshops were 
mentioned by several respondents, but none mentioned support for knowledge translation. This task 
was, after all, delegated to the HPROs. 
3.1.5 EVALUATION QUESTION 5 
To what extent was the capacity of researchers and research organisations strengthened to 
conduct gender and equity informed implementation research? 
How have the HPROs acted on the recommendations from the formative/situation analyses they 
conducted? 
To address the gaps and needs in terms of knowledge translation the two HPROs commissioned 
situation analyses for each of the IMCHA countries and for the West-Africa region. The quality of the 
analyses varied. Most of the analyses presented recommendations, although not always directed to 
specific actors. The recommendations that were relevant for the HPROs touch upon (1) capacity 
strengthening of researchers and decisionmakers in systematic reviews, gender and equity 
integration, knowledge translation and evidence-based decision making, (2) national research uptake 
by developing frameworks and guidelines for systematic use of evidence, and by supporting 
platforms for knowledge transfer and to facilitate discussions between researchers and decision 
makers and (3) the dissemination of results. The two HPROs acted on these recommendations using 
slightly different approaches. The online survey confirmed that more than two-thirds of the 
researchers and decision makers believed that the HPRO support was effective, in particular for 
supporting national research uptake and capacity strengthening.  
HPRO RESPONSE TO THE FORMATIVE/SITUATION ANALYSES 
The two HPROs conducted situation analyses or context mappings for each of the countries in their 
region.  
WAHO commissioned three types of formative analyses: (1) a regional analysis of the state of 
knowledge transfer and use of evidence in the field of MNCH in ECOWAS and the institutional capacity 
of WAHO to act as HPRO; [17] (2) a regional gender and equity analysis (discussed in section 3.1.2) and 
(3) six country-specific analyses in Benin, Burkina Faso, Ghana, Mali, Nigeria and Senegal focusing on 
contextual and health system factors, gender and equity, and knowledge transfer processes. [15,16] 
The results of the situation analyses were discussed in a regional workshop in 2016. [13,14] 
The EA-HPRO conducted context mapping studies in Ethiopia, Malawi, Tanzania, Uganda, 
Mozambique, and South Sudan. The reports describe the health system gaps, equity concerns and 
other barriers to service access and national policies related to MNCH. They also describe the processes 
by which policies are formulated and the opportunities for knowledge translation in each country. The 
reports were shared with the respective research teams and initial findings were presented at the 
IMCHA midterm workshop in 2017. Following the workshop, the EA-HPRO developed country 
strategies to encourage country teams to work more collaboratively and strategically in order to 
maximise engagements with national-level policymakers.  
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Recommendations of the situation analyses are presented in Annex 6. Those that are relevant to the 
work of the HPROs and the actions taken by them are summarised in the Table 5. 
 Actions taken by HPROs in response to situation analyses 
RECOMMENDATION ACTIONS TAKEN BY WAHO ACTIONS TAKEN BY EA-HPRO 
Capacity-building 
Improve the capacity 
of researchers to 
prepare data 
syntheses, systematic 
reviews and strategic 
or policy briefs 
• Regional training on implementation 
research (all teams)  
• Sessions on knowledge translation at IMCHA 
midterm workshop  
• Training in developing key messages in 
Tanzania 
• Regional training in systematic reviews  
• Regional training in qualitative analysis  
• Regional training in scientific writing  
• South Sudan research methods training 
• Regional training in qualitative systematic 
review 
• Regional knowledge translation training  
Improve the capacity 
of researchers on 
gender analysis and 
equity integration, 
focusing on the most 
disadvantaged 
populations 
• Training of WAHO and Senegal research 
staff in gender issues.   
• Training of project M&E officers in 
gender 
• Training in gender analysis and 
integration for 4 research teams 
• Regional gender training  
Improve the capacity 
of decision makers to 
request, access, 
evaluate, adapt and 
use evidence 
• Training of the Bauchi research team in 
knowledge transfer  
• Training of the Benin City research team 
in EQUIST and knowledge transfer 
• Training sessions on MoH in Burkina Faso 
on evidence-based decision making 
• Training on evidence-based decision 
making for MoH in Mali 
• Gender training for 6 policy makers from 
Uganda and South Sudan (with BRAC Uganda) 




systematic use of 
evidence 
• Development of guide for use of 
evidence in MNCH for decisionmakers in 
West Africa sub-region and technical 
validation 
• Development and adoption of an accountability 
framework for monitoring commitments on 
MNCH in East Africa 
Support existing 
platforms for transfer 




and decision makers  
• 2 Nigeria Research Days to sensitise 
policy makers on use of evidence and 
provide exchange between researchers 
and users 
• MNCH Research Day in Burkina Faso 
• Presentation of preliminary findings from 3 
projects at a meeting of the African 
Parliamentary Committees on Health 
• Meeting with Ethiopia PIs and policy makers 
• Stakeholder meeting with all Tanzanian teams 
on ‘how to steer innovation and evidence use 
to improve maternal and child health in 
Tanzania’  
• Meeting with Uganda MNCH technical working 
group.  
• Meeting with decisionmakers in Tanzania 
(Morogoro project) 
• Meeting with decision makers in Uganda (BRAC 
project) 
• Forum to share lessons from the IMCHA 
Nampula project with MoH  
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RECOMMENDATION ACTIONS TAKEN BY WAHO ACTIONS TAKEN BY EA-HPRO 
Dissemination of results 
Advocate for better 
use of evidence 
• Documentary film on project in Senegal 
• Television spot on Nigeria Research Days 
• Publication of 10 journal articles, 12 
presentations at events, 6 policy briefs, 3 
posters, 2 infographics, newsletter 
• Launch of the IMCHA website. To date it 
includes 7 news articles, 16 
publications/reports, 9 videos, 4 toolkits, 5 
infographics and presentations of the inception 
and midterm workshops 
• Bi-monthly newsletter   
• Presentation on context mapping and political 
economy at the ‘Towards a Pan-African 
Transformation’ conference 
The two HPROs acted on the main recommendations identified by the formative analyses. According 
to the IMCHA PMF indicator 100.2, HPROs should have acted on more than 75 percent of 
recommendations. The evaluation finds it difficult to quantify the proportion of recommendations that 
were acted on because the analyses did not address specific recommendations to the HPROs. 
However, the table documents that the six main recommendations were acted on.  
The HPROs used slightly different approaches in responding to the recommendations. WAHO placed a 
stronger focus on strengthening the capacity of decisionmakers, while the EA-HPRO organised more 
training opportunities for the research teams. To promote national uptake of the research, WAHO 
organised national research days (twice in Nigeria and once in Burkina Faso) which were formal and 
highly publicised events where policy makers were sensitised on evidence-based decision making and 
researchers were able to present their findings. The EA-HPRO facilitated meetings between 
researchers and policymakers in several countries. Both HPROs supported the dissemination and 
communication of the IMCHA research projects and findings through newsletters, presentations at 
events, development of videos and infographics. WAHO published ten papers in peer-reviewed 
journals, whereas EA-HPRO produced several online blog posts and news items.  
In the online survey, researchers and decisionmakers were asked about the effectiveness of HPRO 
support. Overall, a greater proportion of researchers rated HPRO support as very effective or 
somewhat effective in the final evaluation survey compared to the midterm survey (71% versus 64%). 
However, nine percent of respondents at midterm anticipated that effectiveness of HPRO support 
would improve over time. At the final evaluation, HPRO support for ‘connecting the team to decision-
makers’ and ‘contribution to knowledge translation’ was ranked highest, closely followed by ‘research 
methods training’. Support for ‘equity sensitivity training’ received the lowest scores. Decisionmakers 
responding to the final and midterm survey found the support of the HPROs generally effective. The 
effectiveness of gender sensitivity training was scored lowest, but the number of decisionmakers 
responding to the survey was too small to allow any inferences. 
Researchers and decisionmakers in East Africa generally perceived the HPRO support to be more 
effective than in West Africa. However, there were nuances. For instance, the gender training provided 
in West Africa was perceived as more effective. The largest differences were reported for research 
methods and implementation science training which was perceived as more effective in East Africa 
where more training of this nature was provided than in West Africa.   
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3.1.6 EVALUATION QUESTION 6  
To what extent were partnerships and alliances between African researchers, decision 
makers and Canadian researchers strengthened? 
How has the collaboration between African and Canadian researchers evolved since the midterm 
evaluation? 
IMCHA provided opportunities for strengthening partnerships between African and Canadian 
researchers as already documented by the midterm evaluation. Interactions between Canadian 
researchers and decisionmakers were more limited as these partnerships were primarily active at the 
project implementation level. Pre-existing collaborations, clear definitions of roles and 
responsibilities and effective communication structures contributed to strong partnerships. Limited 
opportunities for face-to-face meetings and working sessions constituted challenges for some teams 
but were overcome by effective use of internet conferencing platforms by others. The opportunities 
to engage and build the capacity of emerging researchers were highlighted by interviewed PIs and 
Co-PIs.  
COLLABORATION OF AFRICAN AND CANADIAN RESEARCHERS 
In the online survey Canadian and African researchers were asked ‘How successful is/was your 
collaboration with your Canadian or African research partner?’. Fifty-three researchers in African and 
Canadian research institutions rated the collaboration equally with 74 percent of African researchers 
rating it as very successful and 26 percent as somewhat successful compared to 73 and 27 percent of 
Canadian researchers. No respondent selected a lower rating. 
 Survey respondents’  rating of African/Canadian collaboration 






Very successful 23 (74%) 16 (73%) 39 (74%) 
Somewhat successful 8 (26%) 6 (27%) 14 (26%) 
Total 31 22 53 
Thirty-eight respondents provided additional comments in answer to this question, mostly confirming 
the ratings of successful cooperation. There were only two negative comments on the collaboration, 
both from African researchers who had rated the collaboration as ‘somewhat successful’. 
In interviews, PIs and Co-PIs echoed the positive statements about their collaboration. Some, however, 
also expressed that the collaboration did not fully meet their expectations.  
• It has been mostly an administrative relationship and not real collaboration. (African PI) 
• I am appreciative of the idea of collaborating, but a real collaboration has not been possible. 
There were no funds for planning together at the stage of proposal development and at the stage 
of elaboration of other plans. The implementation has been full responsibility of the local partner. 
This was not a real partnership. We were contracted partners rather than intellectual partners. 
The project did not have an optimal start. (Canadian Co-PI) 
The patterns of collaboration were already well established at midterm and further clarified and 
strengthened during the midterm workshop in 2017. The survey responses to questions related to this 
collaboration did not change significantly from those of the midterm evaluation survey in 2018. In this 
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survey, 27/36 respondents (75%) rated the collaboration as very successful and 7/36 (19%) as 
somewhat successful. However, two respondents rated it as somewhat unsuccessful.  
Three main factors for successful cooperation were mentioned by key informants and survey 
respondents: 
1. An existing working relationship 
Previous experience of working together on research projects was mentioned as a facilitating factor 
for successful collaboration. Trust had already been built, there was a common culture for 
collaboration, and partners knew their respective capabilities. ‘Because we had been working together 
for a few years, we already had an established way of working together and knew where we wanted 
to go with the project. I would say “I think we need to work on this”, and he would say, “yes, and plus 
this” sort of thing.’ (African PI) 
New partnerships, on the other hand, faced more difficulties, in part also because there were no 
opportunities to work face-to-face in jointly developing the research proposal and the implementation 
plan. ‘This is the first time we collaborate. There has been a reasonable exchange with the PI. Ideally 
what should have happened was that the two researchers sat together, elaborate the proposal and 
have a clear sense of their capacities. This did not happen in this project. We developed everything long-
distance, which is a bit of a handicap. They had already made up their mind on what they wanted to 
do. I could have predicted the problems we faced.’ (Canadian Co-PI) 
2. A clear understanding of roles and responsibilities 
The African PIs had the overall responsibility for project implementation. Start-up delays experienced 
by most projects compressed the timeframe available for research activities and made it even more 
important that the partners agreed on their roles. The roles of the Canadian Co-PIs varied from project 
to project, with some taking on specific tasks such as the statistical data analysis or leading the writing 
teams for research publications, while others worked according to a traditional North-South technical 
assistance model. An equitable and mutually beneficial collaboration as specified in the call for 
proposals was, however, achieved by most projects, if not from the start, then at least during 
implementation: ‘I was concerned that this was going to be top-down collaboration. However, this 
concern disappeared when good communication and collaboration developed over time and both sides 
showed true commitment to the project, were eager to share and learn from each other. In addition to 
good communication between researchers, time-lines were clear to all and deadlines were respected 
by both parties.’ (African PI) 
3. Effective communication and face-to-face interaction 
Several teams reported communication challenges because of time differences, difficult internet 
connections and delayed email responses due to travel or busy schedules. The importance of face-to-
face meetings and working sessions was mentioned by several interviewed PIs and Co-PIs. Budgets to 
finance travel of Canadian researchers to the implementation sites were limited, and two Canadian 
Co-PIs noted that funds from their own institutions were used to fill this gap. Missions of African 
researchers to conferences or other meetings in Canada were also used to conduct working meetings 
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with one African team mentioning Canadian visa policies as another challenge. Some of the teams, 
however, mentioned that they were able to conduct regular virtual team meetings using an internet 
conferencing platform. 
Collaboration of Canadian researchers and decisionmaker Co-PIs 
Responses to questions about the cooperation between Canadian researchers and decisionmaker Co-
PIs differed between the interviews and the on-line survey. In the on-line survey, Canadian researchers 
rated the collaboration with decisionmakers as very successful (16/22 – 73%), somewhat successful 
(5/22 – 23%), and unsuccessful (1/22 – 5%). The interviewed Canadian Co-PIs strongly endorsed the 
association of decisionmakers with the projects, but only two claimed frequent contacts and a direct 
working relationship. Others recounted that they met the decisionmakers only during field visits and 
IMCHA workshops. This was confirmed by seven of the eight interviewed decisionmaker Co-PIs who 
stated that their main collaboration was with the local project teams, and that they only had occasional 
contacts with Canadian researchers. The eighth had been newly appointed and did not yet know the 
Canadian partner in the project. The mobility of decisionmakers was the most frequently cited 
constraint by interviewed Canadian Co-PIs.  
3.1.7 EVALUATION QUESTION 7 
To what extent are decisionmakers better aware and able to use research evidence? 
How were the findings of IMCHA research communicated to the project Co-PI decisionmaker? 
The evaluation confirmed the findings at midterm that the integration of decisionmakers as Co-PIs in 
research teams were generally seen as a successful element of the IMCHA model. The mobility of 
decisionmakers within their administrative structures was noted as the most important constraint.  
WORKING WITH DECISIONMAKERS IN THE RESEARCH TEAMS 
Communication of research results to decisionmaker Co-PIs, as stated in the evaluation question, 
should not be an issue in the IMCHA model: They are Co-PIs and therefore members of the research 
teams. In reality, the application of the model was not uniform. Many Co-PIs assumed a more 
traditional role in the teams, as recipients of information rather than contributors to its generation. 
The five decisionmakers who responded to the online survey stated that they were either informed 
about progress every month, or whenever they required this information. 
Survey responses and interviews confirmed findings reported by the midterm evaluation. Those 
decisionmakers who responded to the survey, and those who made themselves available for 
interviews during site visits were positive about the success of the collaboration and stated that they 
provided an important contribution to the projects. However, only 5/29 decisionmakers (current and 
former Co-PIs) responded to the survey invitation, and interviews could only be scheduled and 
conducted with eight of the 11 Co-PIs of sampled projects. Four of them had been involved with the 
project since inception. This supports the findings of both the midterm and the final evaluation that 
the mobility of decisionmakers within their government structures was a constraint to the IMCHA 
approach of embedded research. Those decisionmakers who were involved in the projects from the 
start, and potentially also in the conception and development of the intervention, were also most likely 
to be the most engaged. 
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All African researchers and decisionmakers who responded to the online survey rated the collaboration 
with the decisionmaker Co-PIs as either very or somewhat successful. However, in a ranking exercise 
of the importance of barriers to scaling of the project results, they ranked insufficient connection to 
decision-making authorities in first, and insufficient engagement of the decisionmaker Co-PI in third 
place among seven potential barriers. This represents a change from midterm where these barriers 
were ranked in fifth and fourth place respectively.  
 Rankings of barriers to scaling 2018 and 2020 
 
3.1.8 UNPREDICTED OUTCOMES OF IMCHA 
Sub-evaluation questions on unpredicted outcomes of IMCHA, especially gender-related outcomes, 
were included in the terms of reference of the evaluation under several of the main evaluation 
questions. Findings are aggregated in this section.  
Respondents to the online survey and interviewed key informants were asked about unpredicted 
outcomes with specific prompting for outcomes affecting gender equality. Many of the outcomes 
mentioned were, in fact, not unpredicted but based on the research question and on outcomes listed 
in the IMCHA logic model. Truly unpredicted outcomes included: 
• Quality improvements of services including improvements in data collection, management and 
use was mentioned four times. 
• Three researchers working in projects that focused on CHWs in two projects reported findings 
that point to the importance of the role of male partners in programmes that are mostly 
implemented by female CHWs. They can be enablers providing support, encouraging autonomy 
and agency of the women, or they can be a hinderance. The role of partners has been a blind 
spot in the development of CHW programmes. 
• Male involvement in pregnancy and maternity care was mentioned by three informants. Two of 
them reported the findings of their project that policies requiring men to accompany their 
partners attending ANC services can lead to discrimination of single women or women who do 
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not have a supportive partner and who are therefore pushed to the back of the line. Policy 
changes were initiated on the basis of this evidence. 
• Three informants mentioned that support to women’s groups provided by their project resulted 
in women becoming more active and effective in decision-making at the community level and in 
increasing women’s autonomy. 
• Other positive outcomes reported by single informants included increased networking among 
research institutions, NGOs and health departments; effects of individual capacity-building 
including the promotion of decisionmakers, researchers or health workers involved in the project 
to higher positions in their institution or organisation; and effects of institutional capacity-
building reported by one HPRO that used its role in IMCHA as a model for the development of 
initiatives funded by other donor organisations. Several research teams also reported that work 
in IMCHA contributed to successful applications for grants from other sources. 
No negative outcomes were reported. Some interviewed PIs and Co-PIs mentioned that their projects 
failed to achieve expected positive outcomes. For instance a project that focused on training and 
quality improvement in maternity care was not able to demonstrate an improvement in perinatal 
mortality. Another informant reported that the modalities of organising and paying for the transport 
of pregnant women for maternity services piloted by the project did not work well and needed to be 
reviewed. The same informant also reported less than satisfactory outcomes of a mobile phone 
network for CHWs. 
3.2 IMCHA MANAGEMENT 
3.2.1 EVALUATION QUESTION 8 
How has support from the IMCHA management team and the M&O Committee 
contributed to the efforts of the research teams, the HPROs, and the initiative overall? 
(a) How has IMCHA management implemented the recommendations of the midterm evaluation? 
(b) What difference has this made in IMCHA achievements? 
(c) How has the M&O Committee influenced IMCHA management and achievements? 
Support by IMCHA management was rated positively by the research teams with 71 percent of online 
survey respondents rating the IMCHA meetings as ‘very helpful’. Positive ratings in the final 
evaluation survey were considerably higher than at midterm.  
The midterm evaluation issued seven recommendations for a follow-up initiative and 14 for IMCHA, 
most of them within the scope of the HPRO role. Most of the recommendations validated steps that 
had already been initiated in 2017. Additional recommendations were acted on in the agenda of the 
2020 IMCHA learning workshop in Kigali.  
The M&O Committee provided inputs into programmatic issues at key decision points such as the 
launching of the synergy grants or the commissioning of programme evaluations. It did not get 
involved in grant management issues. It provided a functional and appreciated cooperation platform 
for the three funding organisations.  
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SUPPORT BY THE IMCHA MANAGEMENT TEAM  
The IMCHA grants were managed by programme staff engaged by IDRC for the IMCHA initiative. The 
team was strengthened by three members of the core IDRC programme staff who managed six grants. 
Leadership of the team was provided by the IDRC Programme Leader for Maternal and Child Health, 
and financial management by the IDRC Grant Administration Officer. 
Most respondents to the online survey reported that they received support from IMCHA management 
for a number of tasks, most frequently for promoting, publishing and presenting the research (88%), 
for networking with other institutions (85%), for financial reporting (81%), for refining the research 
protocol and implementation plan (79%), and for addressing gender equality issues (77%).  
Less support was reported for addressing equity issues (61%), solving technical or ethical issues (55%), 
and for seeking additional research funding (55%). The IMCHA inception workshop in 2015 and the 
midterm workshop in 2017 were rated a very helpful by 71 percent of respondents, while about two-
thirds of respondents rated the support provided for the preparation of implementation plans, 
technical reports and financial reports as very helpful. Monitoring visits by IMCHA Programme Officers 
received the lowest approval scores with only half of the respondents (53%) rating them as very 
helpful. However not all projects were visited because of Canadian Government travel restrictions.  
Overall, the proportion of survey respondents who reported that they received support from IMCHA 
management as well as the proportion who rated this support as very helpful increased substantially 
between the midterm and the final evaluation surveys. There were, however, outlier responses that 
rated the support as minimally or not helpful, ranging from three for IMCHA workshops to seven for 
the preparation of implementation plans, technical support and monitoring visits.  
Interviews with grantees generally confirmed the positive assessment of the support provided by the 
IMCHA management team. Responsiveness and flexibility were mentioned most often. Several of the 
researchers stated that their relationship with IMCHA management was initially quite strained but 
improved after the midterm. The main source of initial tensions mentioned by two interviewed 
Canadian Co-PIs was due to differences in expectations: ‘There was a disconnect between the 
objectives of the programme and what the researchers were trying to do. A lot of the negotiation was 
around the outcomes to be achieved, we couldn’t agree to put improvements in maternal health in the 
contract, so it was about the framing and what we could realistically achieve within the time and 
budget.’  
More immediate concerns were raised by one PI about the policy of scheduling fund transfers for the 
final semester of project activities until project completion.  
IMPLEMENTATION OF THE MIDTERM EVALUATION RECOMMENDATIONS 
The midterm evaluation issued 21 recommendations (Annex 7) of which seven addressed plans for 
initiatives that may follow IMCHA. Most of the remaining 14 recommendations were directed at the 
HPROs or were within the scope of the HPRO mandate. The evaluation report was widely distributed 
among HPROs and RTs as well as discussed in a conference and a webinar, however most interviewed 
PIs and Co-PIs did not remember the recommendations, nor any action taken in response.  
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In the management response to the evaluation report, IMCHA management accepted the 
recommendations and aggregated them into four groups:  
• Recommendations on knowledge-sharing among research teams 
• Recommendations on the integration of gender and equity consideration in the programme. 
• Recommendations on knowledge translation and scale-up 
• Recommendation of knowledge sharing between East and West Africa HPROs 
Knowledge-sharing among research teams 
The recommended country-level meetings of researchers and decisionmakers, especially in countries 
with several IMCHA projects, were organised by HPROs since 2017. In interviews, HPROs reported 
meetings in Tanzania, Nigeria, Uganda, Burkina Faso and Senegal. Especially the regular meetings in 
Tanzania were reported as highly effective in contributing to recognition and knowledge translation. 
The annual ‘Nigeria Maternal Newborn and Child Health Research Days’ hosted by the Federal Ministry 
of Health, WAHO and IMCHA also provided an opportunity for the three Nigerian IMCHA teams to 
present their findings to an audience of national stakeholders. The recommended learning meeting of 
the IMCHA initiative was organised by IMCHA management in January 2020 in Kigali. 
Integration of gender and equity considerations 
Training workshops on gender analysis were organised by the HPROs. Both HPROs acknowledged that 
they did not address the recommendation for capacity-building in equity analysis. Methods and 
approaches to equity analysis were introduced in the IMCHA learning workshop in 2020. Some 
projects, for instance those examining how access and utilisation of services were affected by the 
introduction of performance-based financing or free maternity care policies had already included 
equity analyses by design. Interviews conducted for the final evaluation suggested that the 
understanding of the distinction between integrating gender and equity had improved since midterm. 
Knowledge translation and scale-up 
Workshops to develop knowledge translation plans were conducted by the two HPROs in 2018 as well 
as country-level training workshops for researchers and decisionmakers. The concept of scaling science 
in research for development was developed by IDRC concurrently with the implementation of the 
IMCHA initiative. A handbook on ‘Scaling Impact’ was published by IDRC in 2019 [18] and a ‘Playbook’ 
with practical guides for researchers in 2020. [19] One IMCHA project in Nigeria is cited as an example 
in the guide. The concept of scaling science and the tools for integrating it into research were presented 
at the IMCHA learning workshop in 2020. In interviews with research teams, HPROs and IMCHA 
programme officers, there was unanimous agreement that these were new concepts that had not been 
integrated in IMCHA, and that would only be relevant for a follow-up initiative.  
In the IMCHA initiative, ‘scale-up’ was less formally understood as increasing the range of project 
impact. In the online survey, 20 researchers responded that they had successfully scaled their research 
findings to district, national or regional levels. However, the narrative responses to the survey question 
indicate that ‘successful scaling’ by most respondents meant successful communication of findings to 
health authorities. It may, in fact, be too early to assess the policy impact of most projects at scale. 
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Knowledge sharing between East and West Africa HPROs 
IMCHA management responded to recommendations about increased sharing of knowledge between 
East and West Africa by stating that (i) it would continue encouraging the HPROs to conduct more 
knowledge sharing activities, (ii) continue supporting the IMCHA website, (iii) share information in 
quarterly newsletters and update its communication strategy. In interviews, HPRO staff mentioned 
that the two HPROs cooperated in identifying experts, for instance for capacity-building workshops in 
gender mainstreaming. One interviewed HPRO staff, however, noted that there was much room for 
increasing the collaboration between East and West Africa HPROs. A bilingual (English/French) IMCHA 
website continues to be maintained by APHRC in Nairobi. West African content is, however, limited. 
The IMCHA communications strategy was developed in 2015 and an update was prepared in 2017. [20] 
Further updates were not available to the evaluation team. Neither the original strategy nor the update 
addressed knowledge sharing between the East and West Africa HPROs.  
What difference has the midterm evaluation made to IMCHA achievements? 
Most of the recommendations were in line with directions that were already established and 
implemented by the HPROs and the IMCHA management team. Although they confirmed these 
directions, they may or may not have reinforced them which would be difficult to assess post hoc. At 
the time the evaluation report was submitted, project implementation plans and research protocols 
were already being implemented and the margins for adjustments were limited. Key recommendations 
on scaling and equity analysis were acted on at the IMCHA learning workshop in 2020. Their impact on 
the current initiative could therefore not be assessed by the evaluation but will presumably be limited. 
M&O COMMITTEE ROLE AND INFLUENCE 
Information about the M&O Committee was collected in interviews of current committee members 
and the review of the minutes of ten M&O Committee meetings between May 2015 and March 2020 
as well as the minutes of two Governance Committee (GC) meetings. The interviewed M&O Committee 
members representing GAC and CIHR had joined the committee within 12 months preceding the 
evaluation. 
The M&O Committee met every six to eight weeks to discuss programme-wide issues while the 
management of grants was the responsibility of IDRC. Review of the minutes confirm that there were 
periods of intensive deliberation such as at the start of IMCHA, at the time of launching the synergy 
grants, in relation to the midterm and final IMCHA evaluations and, most recently, for the discussion 
of new cooperation initiatives. At other times, the committee meetings served primarily to update the 
funding partners on programme-wide activities such as IMCHA field visits and learning workshops. The 
CIHR and GAC representatives also interacted with IMCHA grantees during visits to Canada and in 
workshops organised by IMCHA management. 
Committee members described their participation as a great opportunity for three organisations with 
shared goals but different mandates to work together. They acknowledged that the differing mandates 
of the three funding partners had at times been difficult to negotiate, but that the regular contacts in 
the M&O Committee provided a good platform to resolve differences. The Governance Committee, 
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which had been quite active at the launch of IMCHA, had since assumed a more ceremonial role while 
programme oversight by the funding partners was primarily provided by the M&O Committee. 
3.3 DOCUMENTATION OF IMCHA 
3.3.1 EVALUATION QUESTION 10 2 
How have the research teams, HPROs, the IMCHA management team and the donor 
partners documented their work to contribute to the IMCHA legacy? 
(a) How have the research teams, HPROs, the IMCHA management team and the donor partners 
documented their work (beyond publications and regular reporting) to contribute to the IMCHA 
legacy? 
(b) How could this be improved in a future initiative? 
IDRC, the HPROs and some grantees generated a considerable number of quality communications 
outputs and built an audience for IMCHA. There are two main online portals for external audiences 
to access information about IMCHA. The IMCHA site launched by APHRC in Nairobi has a strong 
brand, but it is primarily focused on the programme in East Africa and presents a very incomplete 
picture of the programme in West Africa. The IMCHA pages on the IDRC site provide a balanced and 
comprehensive view and they are updated more regularly, but they are somewhat hidden under the 
IDRC brand. Not having a single comprehensive access site with a clear brand, may have limited the 
ability of IMCHA communications reaching an even wider external audience. 
DOCUMENTATION TO CONTRIBUTE TO THE IMCHA LEGACY 
The 2015 IMCHA communications strategy set out five objectives .‘(1) create awareness and visibility 
for IMCHA with prioritised audiences, (2) clearly communicate the programme’s value, uniqueness and 
positioning, (3) highlight the results achieved with IMCHA funding, (4) highlight the achievements of 
Canadian researchers and Canadian institutions in the context of IMCHA and (5) work with the media 
and other opinion influencers to disseminate IMCHA-supported breakthroughs and stories of 
success.’ [21] The strategy identifies key audiences and messages as well as communication products 
to be produced, such as a one pager, project profiles, stories of impact, newsletter, monthly email, 
media releases, photo and video library, website, blog posts and twitter account. The strategy was 
updated in 2017 to outline the approach of a quarterly newsletter. [20] 
There are two main online portals presenting the IMCHA initiative, its successes, and results. IDRC has 
a dedicated project website for IMCHA which presents all research projects, including the duration, 
total funding, project leader, leading institution and published outputs. In addition, it has uploaded 
different types of communication materials such as journal articles, news items, perspectives, research 
in action articles, reports, stories and videos, training materials. The projects and stories that are 
featured on the opening page are easily accessible and include links to published articles, videos, or 
external websites, such as the websites of the research institutions. When expanding the search by 
clicking the ‘view all’ or ‘view more’ links, descriptions, stories and materials from all projects can be 
accessed, however through a standard IDRC digital library menu that may not appeal to all audiences 
                                                                        
2 Evaluation question 9 is primarily about lessons learnt in the implementation of the IMCHA model. It was integrated into 
Section 4 (Lessons Learnt) 
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and that, through its search links, easily takes the viewer out of the IMCHA environment into a more 
general IDRC web environment. The website was regularly updated between February 2016 and May 
2020. 
The top hit in a Google search of the term ‘IMCHA’, however, is the website that was launched by the 
AHPRC as a ‘culmination of a close collaborative process with the West-Africa HPRO as well as 
IDRC’. [22] The aim of the website is to become a reference point for IMCHA research work, and to 
serve as a bilingual resource for anyone interested in MNCH in sub-Saharan Africa and how research 
evidence can help save lives. The website presents the IMCHA initiative, the HPRO model and the work 
of the 19 RTs. The West African content on this site is, however, limited and the predominant language 
is English, even in the French version of the site. Some of the project information posted on the site 
does not correspond with information listed on the IDRC website. Updates had been irregular, and the 
site has sometimes been static. For instance between August 2018 and May 2019 there was a time-lag 
of eight months between two blog posts. 
Searching for ‘IMCHA’ on the Global Affairs Canada page of the Government of Canada website yielded 
no results, although a profile for IMCHA can be found on GAC’s Project Browser website. On the CIHR 
webpage, IMCHA is listed under ‘recent CIHR global health initiatives’ with a link to the IDRC IMCHA 
page. 
Some of the research teams have also featured their participation in IMCHA and their outputs on their 
institutional websites. Three examples are Miseli (miselimali.org), Health Bridge Canada 
(healthbridge.ca) or the Women’s Health and Action Research Centre (wharc-online.org).  
Eight E-newsletters were published by IMCHA between October 2017 and January 2020. The number 
of times they were opened fluctuated between 20 and 50. Subscribers to the newsletter increased by 
64 percent between 2017 and 2020. The newsletters start with a personal introduction from the 
IMCHA management team, followed by news items detailing what conferences IMCHA participated in, 
presenting details about ongoing research as well as featured publications. There is no link to the 
newsletter on the IDRC IMCHA site. Only one issue of the newsletter (of April 2018) features on the 
APHRC IMCHA site which also does not include a link to register requests for subscription. 
AHPRC and WAHO also published quarterly newsletters with reference to IMCHA. According to the 
technical reports, AHPRC issued at least six quarterly newsletters between January 2018 and January 
2020 but the evaluation team could not find copies of these newsletters. WAHO issued project specific 
newsletters on IMCHA, called MEP news. The evaluation team was able to access five newsletters 
issued between 2015 and 2018 (three of which were available on the WAHO website and two which 
were shared as part of the 2018 technical report).  
The evaluation team was able to access a total of ten short videos covering the initiative or projects 
funded by IMCHA. Not all of these videos are, however, available on either the IDRC or the IMCHA 
website.   
In terms of creating visibility of the work, IMCHA management facilitated the presence of IMCHA 
research teams at events such as the Canadian Conferences on Global Health, the Women Deliver 
events and the Global Symposia on Health Systems Research. Similarly, the HPROs encouraged 
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research teams to present their findings on different occasions. Besides these events, the evaluation 
team was able to find several references to IMCHA success stories on other online platforms. The work 
of the Mozambican and one of the Nigerian research teams was reported on the Canadian Geographic 
Charting Change website. The work of the Nigerian team was also referenced in the ‘Charting Changes’ 
issue of November/December 2018. The research on social enterprise models to improve women’s 
livelihoods and health was reported in the Huffington Post (huffingtonpost.ca), while the work of two 
Tanzanian teams was featured on the website of the Canadian Partnership for Women and Children’s 
Health (canwach.ca), although only one made a reference to IMCHA. An article on how research 
addresses key obstacles to maternal health in rural Africa was published by a Canadian Co-PI on the 
Conversation Africa website, without however referencing IMCHA. Finally, some of the research 
projects were featured in news outlets in their country of implementation.  
The @IMCHA_ISMEA twitter account issued 203 tweets between October 2017 and May 2020, an 
average of eight tweets per month with repeated peaks associated with international conferences, 
meetings or campaigns. By May 2020, the account had 681 followers, mostly individuals but also 
including research institutions and NGOs working in MNCH, global health or health research.   
IMPROVEMENT FOR A FUTURE INITIATIVE 
IMCHA management, the HPROs and some grantees have conducted communications work within 
their networks and audiences and have generated outputs of considerable quality. These are, however, 
somewhat dispersed which may have limited their visibility to a wider audience. Stronger branding and 
stronger control of the brand would assure, for instance, that the top result for an internet search 
would be an entry portal to all programme communications outputs with links to journal publications 
and conference presentations. 
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4 LESSONS LEARNT 
The lessons of the IMCHA initiative presented in this section respond to the sub-questions under 
Evaluation Question 9 of the terms of reference: ‘How did the IMCHA model contribute to the 
performance of the initiative?’ 
• What new lessons can be learnt regarding the design and implementation of the model of the 
research teams? 
• What new lessons can be learnt regarding the design and implementation of the model of 
HPROs?  
• What worked well in the Synergy Grants? What were the challenges? 
• What new lessons can be learnt regarding the design and implementation of the partnership 
between CIHR, GAC and IDRC? 
• How relevant would an initiative such as IMCHA continue to be to address the needs of the donor 
partners and their alignment with Government of Canada priorities? 
IMCHA tested an approach to implementation research that included the embedding of 
decisionmakers in the research teams and that also included South-South technical support and 
networking through the funding of HPROs. While neither of these two characteristics of the model is 
unique, there is little existing analysis and documented experience about their joint application. The 
IMCHA model had two additional characteristics. (1) A PMF that, at the ultimate outcome level, 
measured implementation outcomes rather than research and knowledge translation outcomes; and 
(2) a South-North partnership between African and Canadian research institutions in each project. The 
reasons for including these two components were institutional rather than conceptual. 
• While all implementation research projects have to document the effect of interventions on 
service delivery or health outcomes as the evidence base for programme and policy 
improvement, these outcomes are the subject of research and not their objective. They are, 
however, the strategic objectives of GAC and, according to interviewed GAC staff, their inclusion 
as ultimate outcomes in the IMCHA PMF was a requirement to make IMCHA fundable by GAC. 
• There is a lot of experience in funding North-South research collaboration, and IMCHA also 
contributed examples of highly successful collaborations between African and Canadian 
researchers. The evaluation did not find evidence that North-South research collaboration fits 
well in a model based on embedded decisionmakers and HPROs. Supporting the Canadian 
research community is, however, a mandate of CIHR.  
The lessons from IMCHA are that it is possible to combine these characteristics in a single programme, 
but that this invariably generates lines of tension. The word ‘tension’ in this context is used as a 
descriptive term not implying a conflict. It is used to communicate the findings of the evaluation 
confirming the ‘long-recognised organisational wisdom that the pursuit of multiple and competing 
values, ends, and benefits inevitably gives rise to challenges about how to achieve balance.’ [23] 
• The balance between the focus on interventions to generate health outcomes versus the focus 
on research to generate answers to the questions of whether these interventions are 
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appropriate, feasible, effective and affordable in the local context, and how they can be best 
delivered. 
• The balance between generating strong local alliances between researchers and decisionmakers 
supported by a Southern network, and the requirement of defining a meaningful role of 
Canadian researchers within such a partnership.  
 Line of tension in the IMCHA model 
 
The IMCHA experience documented that some projects negotiated these tensions better than others. 
Characteristics of these projects included a longstanding relationship of trust between the African and 
Canadian research institutions; a good understanding and a solid commitment to the research 
objective by both partners; and a willingness of the Canadian Co-PI to engage and maintain contact 
with the HPRO and with the decisionmaker Co-PI in the project. Only three original research projects 
had unified single funding agreements managed by the PI institutions. One of them was sampled by 
the evaluation. In this project, the Canadian researchers were well integrated in all project activities 
and a strong collaboration was established. This is, however, a lesson founded on a small sample and 
it is uncertain that such an arrangement would have been feasible and acceptable in all cases. 
At the origin of these tensions is the funding partnership between the three Canadian government 
agencies that have congruent goals but differing mandates. IMCHA effectively managed the balance 
between these mandates in the M&O Committee. The tensions were, however, not restricted to this 
level. They were also reflected in the design of the initiative and ultimately experienced by the projects. 
THE RESEARCH TEAMS 
In general, research teams of African and Canadian researchers knew each other well and who had a 
record of past collaboration worked well within the IMCHA model. They did not necessarily change 
their established mode of cooperation, but they met their institutional objectives. For Canadian 
partners, these tended to be more academic in terms of opportunities for junior researchers to work 
on their theses and degrees, and for senior researchers on their record of publications. Most African 
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partners had the same objectives, but in addition a much stronger focus on generating evidence to 
influence policies and systems in their countries.  
THE HPROS  
In the early phases of IMCHA, the role of HPROs was unclear to the research teams. As the initiative 
evolved, the appreciation of the HPRO model increased among African researchers but not among 
Canadian researchers as illustrated in the ratings of HPROs by respondents to midterm and final 
evaluation surveys. 
 Researchers rating HPRO support as somewhat or very effective 
African Researchers Canadian Researchers 
 
Note: The responses to the two surveys are not strictly comparable because at midterm only PIs and Co-PIs were invited to 
respond while responses were solicited from all researchers for the final evaluation survey 
The question whether to include an HPRO component in a future initiative yielded an affirmative 
response by 76 percent of African researchers at midterm growing to 100 percent in the final survey. 
It did not change among Canadian researchers among whom 54 percent answered affirmative at 
midterm and 53 percent in the final evaluation survey.  
THE SYNERGY GRANTS 
African and Canadian researchers reflected positively on the ability to use the synergy grants to fill 
gaps identified during implementation of their main research project. Others mentioned that it allowed 
the research teams to work more specifically on gender and equity issues or leadership and 
management issues that were missing in the original projects. In terms of challenges, a minority of 
researchers felt that the timing of the synergy grant call for proposals could have been improved. 
Several respondents stated that they were unable to apply because they were too busy with 
implementation activities to develop a strong proposal. While nearly everyone agreed that synergy 
grants were a good idea, some felt that they should have been informed about them from the outset 
to allow for adequate preparation and planning. 
HPRO respondents felt that they could have added value to developing and allocating synergy grants 
if they had been kept appraised of developments.  
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THE PARTNERSHIP BETWEEN CIHR, GAC AND IDRC 
Although not a universal opinion, most interviewees reflected positively on the partnership between 
CIHR, GAC and IDRC. Key informants mentioned that the three institutions are working collaboratively 
on other global health issues. The partnership allowed the three institutions to go above and beyond 
what they would be able to achieve on their own, while bringing a unique asset to Canadian 
researchers and the international research community. ‘It is complementary. CIHR has more experience 
in working with Canadian researchers, GAC provides connections with the Canada´s development 
policies and global agendas. IDRC brings experience in research for development.’  
The issue of measuring the ultimate outcomes in the IMCHA PMF in terms of health status and service 
improvements elicited comments by funding partners and grantees. Funding partners acknowledged 
that this was a GAC requirement, and, as acknowledged by interviewed GAC staff, served primarily to 
make the initiative fundable under the GAC strategy. Several researchers expressed frustration and 
confusion about the focus on these outcomes, one of them stating that the label ‘research’ was 
misused for what was primarily an agenda to fund implementation projects and that research quality 
was lost to the demand for generating service outputs. One Canadian Co-PI commented that ‘IMCHA 
is a hybrid programme which is not sure what it is… IDRC has a fundamental challenge, some sort of 
identity crisis. Is it a developmental organisation like GAC, or is it a research organisation?’ Others were 
more comfortable with the merged objectives: ‘I think we need to not forget the research agenda when 
looking for outputs, but also not forget the outputs, because I think we also want to have an impact’. 
Such statements illustrate the conceptual tension in IMCHA due to the differing mandates of partners, 
but they also illustrate that these tensions can be overcome when they are acknowledged and 
addressed. 
THE ALIGNMENT WITH GOVERNMENT OF CANADA PRIORITIES 
The IMCHA initiative was developed during the first phase of the Canadian Muskoka Initiative. The 
IMCHA call for research proposals was addressed to the seven African priority countries of this 
initiative plus Ghana and Senegal. The high-level outcomes of the IMCHA logic model were closely 
aligned with the logic model of the Muskoka Initiative.  
At the time the proposal call for synergy grants was launched, the Government of Canada had made a 
second commitment under the Muskoka Initiative and was about to launch its new ‘Feminist 
International Assistance Policy’. [24] The call reflected the new priorities of the commitment and the 
policy by requesting proposals that included ‘interventions, research and knowledge translation 
activities that seek to address some of the root causes of high maternal and child mortality such as, 
early and forced marriage, unmet need for family planning and adolescent pregnancy and the 
promotion of sexual and reproductive health services and information’. [25] This was reflected in the 
themes of 3/9 projects funded with synergy grants and strengthened the focus on gender-
transformative approaches which were applied in more than half of the synergy projects (5/9) 
compared to only a third (7/19) original research projects. 
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5 CONCLUSIONS 
The conclusions are structured according to the objectives of the evaluation as per the TORs: (Annex 1) 
1. To examine IMCHA performance in relation to the PMF, in particular progress made towards 
achieving the immediate, intermediate and ultimate outcomes.  
2. To evaluate how the recommendations of the midterm evaluation were addressed and what 
difference they made in IMCHA achievements.  
3. To assess IMCHA management, and the value added by the initiative.  
4. To inform future partnerships and undertakings.  
5. To evaluate how the work conducted under IMCHA is being documented for contributing to the 
legacy of the Initiative. 
5.1 IMCHA PERFORMANCE 
IMCHA performance as assessed on the basis of outcome indicators is summarised in Annex 14.  
Ultimate outcome - Improved maternal, newborn and child health outcomes in targeted countries:  
All projects could document an effect or a potential effect on improved MNCH indicators, although 
with differences in terms of the size and attributability of effect. Projects that implemented and 
researched interventions at the community and primary health care service level were able to 
document a direct effect in their project areas. Final data were, however, not yet available at the time 
of the evaluation. Projects that researched issues at a more upstream health systems level could 
potentially generate larger effects, although the attribution of the project cannot be measured. 
Intermediate outcome 1 - Enhanced production, analyses and syntheses of health systems 
implementation research prioritising gender and equity: 
The outcome is measured by two indicators: ‘The proportion of projects that have at least three of four 
processes with adequate gender and equity dimensions’, and ‘the proportion of health systems 
research outputs and syntheses that are gender- and equity-focused.’ 
15/28 projects (54%) integrated adequate gender dimensions, and 7/28 (25%) adequate equity 
dimensions in at least three research processes. Performance on gender integration improved over 
time and was considerably higher among projects funded with synergy grants than among those 
funded with the original research grants. Among 98 outputs from 22 projects that were available for 
analysis, 44 (46%) included a gender focus and 21 (22%) an equity focus. Approaches to equity analysis 
were introduced to the research teams at the IMCHA learning workshop in January 2020. At the time 
of data collection several PIs stated that they intended to use collected data to conduct equity 
analyses. The proportion of equity-focused outputs are therefore likely to increase. 
Intermediate outcome 2 - Enhanced partnering and collaboration between decisionmakers and 
researchers on health systems strengthening in the selected countries/regions: 
The indicator for this outcome defines the decisionmaker as the ‘national focal point for MNCH’. 
Although national MNCH focal points were generally not the decisionmakers associated as Co-PIs with 
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the projects, most projects communicated their activities and preliminary results at this level, either 
systematically by participating in national technical working groups on MNCH, through direct contacts 
with the ministry of health or during HPRO-facilitated national consultations. For some projects, the 
national MNCH coordinator was not the main government respondent and the projects worked more 
directly with departments for universal health coverage, health financing or health information. The 
evaluation team therefore considers that the framing of the indicator definition was too narrow to 
capture the entire IMCHA initiative and did not assess the performance against this indicator. 
The embedding of decisionmakers as Co-PIs in research projects was an effective contribution to 
knowledge translation in IMCHA. Low levels of engagement by decisionmakers in some projects were 
mostly attributed to high mobility within their government structures. Those decisionmakers who had 
an existing professional relationship with the PIs, who were involved in the projects from the start, and 
potentially also in the conception and development of the project, were also most likely to be the most 
engaged. 
Intermediate outcome 3 - Enhanced integration of health systems research findings into primary 
health care policies and practice in selected countries: 
The outcome is monitored by the ‘reference to research findings or recommendations in country-led 
technical decision-making platforms’. Although the evaluation team considers that it is too early to 
assess the outcome against this indicator, the target of 20 was likely already reached. All interviewed 
PIs mentioned presentations and discussions of research results in national fora and most had plans 
for further discussions once final research results were available. The evaluation was, however, not 
able to identify any formal document from a national decision-making forum that specifically referred 
to research conducted by an IMCHA project. 
Immediate outcome 100 - Strengthened capacity of researchers and research organisations to 
conduct gender and equity informed health systems implementation research: 
The first indicator to measure this outcome is the ‘proportion of total research projects that have 
adequately detailed gender and equity dimensions’. Sufficient information on research design and 
research tools to address gender and equity was available for 20/28 projects. Among these 19 (95%) 
included data collection plans or tools for gender analysis and seven (35%) for equity analysis, albeit 
with varying depths. Outputs from 22/28 projects were available for analysis. Among these 18/22 
(82%) had produced at least one output that included a gender dimension and 5/22 (23%) an equity 
dimension. However, in interviews several PIs stated that they were conducting or planning gender 
analyses, and some noted that they could use available data to perform a secondary equity analysis. A 
final assessment of performance against this indicator was therefore not possible. 
The second indicator is the ‘proportion of recommendations from formative analysis of HPROs acted 
upon’. The 46 recommendations and sub-recommendations of the formative research reports 
commissioned by the HPROs include recommendations that are either not relevant or not actionable. 
For instance, a recommendation that the ministry of health increase its budget allocation to MNCH or 
its dialogue with donors. All recommendations that were actionable by HPROs were grouped by the 
evaluation team in six groups, under the headings of capacity strengthening, national research uptake 
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and dissemination of results. They were all acted on by the HPROs except for the recommendation on 
equity training. 
Immediate outcome 200 - Strengthened partnerships and alliances between African researchers, 
decisionmakers and Canadian researchers: 
The PMF indicator for monitoring this outcome ‘proportion of implementation research projects that 
demonstrate effective collaboration and management’ is a compound indicator because the outcome 
focuses on cooperation among three partners. The indicator, in addition, refers to project 
management while the target only refers to project governance. Project governance was provided by 
IMCHA management and is addressed under a different heading. Management issues among some 
projects were primarily identified in the initial phases of IMCHA and were addressed effectively with 
support of IMCHA management. Among the reviewed projects, management issues related to the 
cooperation between Canadian and African researchers were raised in relation to the splitting of 
project grants between the two institutions and the lack of sharing financial information among them.  
The collaboration between African and Canadian researchers was rated as successful by 74 percent of 
African and 73 percent of Canadian researchers. Partnerships between African and Canadian 
researchers was rated as strong where a working relationship had existed prior to the IMCHA project. 
Engagement between PIs and Canadian Co-PIs in all sampled projects (16/28 projects; 9/20 Canadian 
Co-PIs; 10/21 PIs) ranged from strong to acceptable. In all sampled projects there was at least regular 
information exchange between PIs and decisionmaker Co-PIs. None of the eight interviewed 
decisionmaker Co-PIs stated that they had a direct engagement with Canadian Co-PIs and only 2/9 
interviewed Canadian Co-PIs mentioned a strong engagement with decisionmaker Co-PIs other than 
meetings during field visits and IMCHA workshops. 
Immediate outcome 300 - Increased awareness and understanding of research evidence by 
decisionmakers at the primary healthcare level 
The PMF indicator for monitoring this outcome is the ‘proportion of Co-PI decision-makers’ follow up 
on recommendations from research into health systems planning fora’. Among the 29 current and 
former decisionmakers Co-PIs who were invited to the online survey only five responded (17%), and 
only 8/11 decisionmaker Co-PIs of sampled projects (73%) were available for interviews. All except one 
who was recently appointed stated that they followed up on evidence generated by their project, 
mostly by presenting it in policy fora and discussions. Some also stated that they were still waiting for 
final documentation of the evidence prior to following up. It is plausible that those who responded 
were more closely engaged in their project than the non-responders, and whether the target of 100 
percent was reached could therefore not be confirmed.  
5.2 FOLLOW-UP ON THE MIDTERM RECOMMENDATIONS 
The midterm evaluation was implemented after the IMCHA midterm workshop in 2017 where many 
issues that affected the partnerships between HPROs and research teams as well as between 
researchers and decisionmakers in the teams were addressed. Following the workshop, HPROs and 
research teams engaged in activities that largely anticipated the recommendations of the midterm 
report which were then accepted as ‘a confirmation that we were on track’.  
IMCHA Summative Evaluation 
hera / 25.09.2020 43 
Most of the 14 recommendations on the current IMCHA initiative were directed at the HPROs or 
addressed issues that were within the HPRO mandate. All were implemented with the exception of the 
recommendation on equity training which was addressed later in the IMCHA learning workshop in 
2020, arguably too late to be integrated in project implementation but with possibly some effect on 
the way project data are analysed. 
5.3 IMCHA MANAGEMENT 
IMCHA management was described as responsive and flexible by interviewed researchers and online 
survey respondents. The proportion of survey respondents who reported that they received support 
from IDRC as well as the proportion who rated this support as very helpful increased between the 
midterm and the final evaluation surveys. About two-thirds of respondents rated the support provided 
for the preparation of implementation plans, technical reports and financial reports as very helpful. 
The financial holdback policy for the last semester payment until project completion raised concerns 
among some African researchers who foresaw difficulties in pre-funding their final data collection, 
analysis, knowledge translation and documentation activities. 
The M&O Committee was assessed by committee members as a successful mechanism for the three 
funding organisations to work together. They acknowledged that the differing mandates of the three 
partners had at times been difficult to negotiate, but that the regular contacts in the M&O Committee 
provided a good platform to resolve them. Frequent changes of delegates to this committee were 
mentioned as a constraint. 
5.4 IMCHA DOCUMENTATION 
The research teams, the HPROs and IMCHA management generated a large number of materials that 
document the IMCHA initiative, with a considerable volume of documents still in preparation. They 
range from research papers in peer-reviewed journals, to policy briefs, conference presentations, news 
stories, newsletters, blogs, and short films, some of excellent quality. The main access portals are the 
IMCHA website launched by APHRC and the IMCHA pages on the IDRC website. The IMCHA website 
has the stronger branding, however it is incomplete by presenting primarily East African content, and 
it is also not updated with sufficient regularity. The IDRC website is more up to date and more complete 
although it also misses some content, for example the IMCHA newsletters.  
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6 RECOMMENDATIONS 
6.1 FOR IMCHA 
IMCHA is ending in 2021 and there are therefore no recommendations for the implementation of the 
initiative. One recommendation, however, addresses concluding activities: 
1. Global experience and knowledge about the approach of embedding decisionmakers in 
implementation research is limited. IMCHA can potentially make an important contribution to 
this knowledgebase. At a time when IMCHA projects have completed their knowledge translation 
activities and generated a sufficient volume of publications to document them, a meta-analysis of 
the approach should be commissioned and published. 
6.2 FOR ANY FUTURE INITIATIVE 
2. The PMF for a future initiative should be more clearly linked to the objectives of implementation 
research. Improved maternal and child health and increased utilisation of quality health services 
are high level outcomes and therefore appropriate ultimate outcomes for a logic model. 
However, as stated in the IMCHA logic model, many factors contribute to these outcomes and it 
is therefore not appropriate to include them in the PMF. The PMF of an implementation research 
initiative should instead be used to monitor the extent to which funded projects are able to 
document or reject the effectiveness and feasibility of researched interventions in the 
implementation context, and the extent to which they are able to translate these findings into 
improvements in MNCH programmes and policies. 
3. The design of a future initiative should be clear about the scale at which it expects policy and 
programme changes to be generated by its grantees. If national MNCH policies are the primary 
targets, project grants should be of sufficient size to assure national visibility. As an alternative, 
multiple networked projects could be selected within countries to generate a critical volume of 
evidence. Scaling to national policy does not necessarily have to be the objective of all projects. 
Applicants should, however, be clear about the level of scaling they are targeting, and most 
importantly, this should also be reflected in the administrative position of the decisionmaker Co-
PI embedded in the project. 
4. Programme objectives in terms of promoting gender equality and health equity should be clearly 
spelled out in the call for proposals and in the monitoring frameworks of each project. Funded 
projects should include methodologies and plans on how they intend to address these objectives. 
Prior to finalising the implementation plans, all selected applicants should participate in 
workshops and webinars where their capacity and their approach to meeting the objectives are 
clarified and steps are taken to address any capacity gaps. 
5. HPROs should be selected and contracted early in a new initiative and should participate in the 
selection of research grantees. If they have early knowledge about what will be funded in which 
country, they will be in a better situation to develop their own workplan for supporting projects 
in knowledge translation and networking. 
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6. In the grant selection process, care should be taken to avoid funding opportunistic partnerships 
between Canadian and African research institutions and between African research institutions 
and decisionmakers that are solely formed in response to the proposal call. While new 
partnerships should not be excluded per se, they should be subjected to additional scrutiny to 
assure that partners have common objectives and compatible ways of working.  
7. The preparation phase of IMCHA prior to starting project activities was almost two years, 
considerably shortening the implementation time of projects. While this may be unavoidable, 
especially if capacity-building in gender and equity mainstreaming is included in the preparation 
phase of a new initiative, it should be factored into the overall duration of the initiative. 
Allocating additional time to the closing phase of projects for advocacy and knowledge 
translation activity may also be considered.  
8. A future initiative should, from the start, create a strongly branded internet presence through a 
single web portal that is independent of the IDRC web site. Management of the site could be 
outsourced, even to an HPRO, but the source contract should assure that the initiative is 
presented comprehensively and that the site provides timely access to all communications.  
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ANNEX 1. TERMS OF REFERENCE 
INTRODUCTION AND PROJECT OVERVIEW 
The Innovating for Maternal and Child Health in Africa (IMCHA) Initiative seeks to improve maternal, 
newborn and child health (MNCH) outcomes by strengthening health systems, using primary health 
care as an entry point. It is a seven-year partnership between the Canadian Institutes of Health 
Research (CIHR), Global Affairs Canada (GAC), and Canada's International Development Research 
Centre (IDRC). IMCHA was launched in 2014 with a budget of CA$36 million. It will end on December 
31, 2020. 
The IMCHA model is comprised of 19 Research Teams (RTs) and two African regional health policy and 
research organizations (HPROs). The research teams, composed of leading African researchers as 
Principal Investigators (PI), along with Canadian researchers and African Decision-makers as co-PIs 
have tested practical solutions to health system challenges, generating new knowledge to ensure that 
mothers and their children have better access to quality care they need. The RTs have also explored 
how successes can be scaled up to improve health equity for women and children across priority 
research themes including i) high impact, community-based interventions; ii) quality facility- based 
interventions; iii) enabling the policy environment to improve healthcare services and outcomes; and 
iv) human resources for health. The HPROs lead capacity building and knowledge translation efforts in 
collaboration with the research teams. They foster uptake of research findings by high-level 
policymakers to ensure that evidence informs decision-making and strengthens health systems. All 19 
RTs received an original grant. In addition, nine RTs were awarded a Synergy Grant on a competitive 
basis, for a total of 28 research projects conducted by the 19 RTs. 
The IMCHA management team is composed of a dedicated core team and several Program Officers 
within the Maternal and Child Health (MCH) Program at IDRC. The governance structure of the 
partnership consists of a Governance Committee and a Management and Operations (M&O) 
Committee. With representation from the three partner organizations, the role of the Governance 
Committee is to focus on strategic decision-making. The role of the M&O Committee is to conduct 
ongoing oversight of the progress of IMCHA and explore synergies to promote the communication and 
use of the findings from IMCHA. 
DESCRIPTION AND SCOPE OF WORK 
Project Scope 
The purpose of the evaluation is to assess the overall performance of the Initiative and the value-added 
of its design and delivery. The evaluation will complement other monitoring activities conducted by 
the IMCHA management team to report on the Performance Measurement Framework (PMF). 
Specific Objectives 
The specific objectives are as follows: 
1. To examine IMCHA performance in relation to the PMF, in particular progress made towards 
achieving the immediate, intermediate and ultimate outcomes. 
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2. To evaluate how the recommendations of the midterm evaluation were addressed and what 
difference they made in IMCHA achievements. 
3. To assess IMCHA management, and the value added by the initiative. 
4. To inform future partnerships and undertakings. 
5. To evaluate how the work conducted under IMCHA is being documented for contributing to 
the legacy of the Initiative. 
Intended Users of the Evaluation 
Primary Users: 
• IMCHA management team 
• IMCHA governance structure (Governance Committee and M&O committee – including all 
funding partners IDRC, GAC and CIHR) 
Secondary users: 
• IMCHA grantees: (RTs and HPROs) 
• Other external stakeholders, such as research organizations and donors, interested in the IMCHA 
model to improve MCH and/or working in similar settings 
• Policy makers and program managers in Canada and all participating countries 
Evaluation Questions 
1. Performance of the Initiative: What are the achievements of IMCHA with regard to the 
Performance Measurement Framework (in particular in terms of immediate, intermediate and 
ultimate outcomes) as well as policy uptake and scale up of successful interventions (triangulation 
of evidence from IMCHA databases based on technical reports received and on field visits)? 
A. Improved maternal newborn and child health outcomes in targeted countries. 
• What are the achievements of IMCHA in relation to the eleven indicators on MNCH? (Provide 
data in relation to the baseline and target identified in the PMF for the indicator “Proportion of 
funded implementation research that improved maternal and child health outcomes and access 
to primary health care services”). 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR]? 
• What have been the main strategies to obtain these achievements? And how appropriate are 
they for achieving the intended outcomes? 
B. Enhanced production, analyses and syntheses of health systems implementation research 
prioritizing gender and equity. 
Expressed in data, assess progress on indicators 1.1 “Proportion of total projects that have at least 75% 
(three of four processes) adequate gender and equity dimensions” and 1.2 “Proportion of health 
systems research outputs and syntheses that is gender and equity focused” in relation to the 
baseline/targets identified in PMF. 
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Integration of gender dimension? 
• How have the IMCHA RTs integrated gender dimensions? What strategies have been used? 
Which ones have proven successful, and why? Which ones have not, and why? What have been 
helping or hindering factors? 
• How have the HPROs contributed to the integration of gender in the research projects’ activities, 
capacity building, and knowledge translation? What strategies have been used? Which ones have 
proven successful, and why? Which ones have not, and why? What have been helping or 
hindering factors? 
• How has the IMCHA management team contributed to this integration? 
• How have the recommendations from the midterm evaluation influenced this integration? 
Integration of equity dimension? 
• How did the IMCHA RTs integrate equity dimensions? What strategies were used? Which ones 
have been proven successful, and why? Which ones have not, and why? 
• How did the HPROs contribute to the integration of equity in the research projects’ activities, 
capacity building, and knowledge translation? What strategies have been used? Which ones have 
proven successful, and why? Which ones have not, and why? What have been helping or 
hindering factors? 
• How has the IMCHA management team contributed to this integration? 
• How have the recommendations from the midterm evaluation influenced this integration? 
The midterm evaluation highlighted some confusions between the concepts of “gender” and “equity”. 
Has there been any change in the understanding of these concepts since then? If yes, what has 
changed, and what has contributed to this change? 
What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic Model? 
C. Enhanced partnering and collaboration between decision makers and researchers on health 
systems strengthening in the selected countries/regions 
Expressed in data, assess progress on indicator 2.1 “Number of total projects per country that 
demonstrate high level of collaboration with decision maker (documented by project, country and 
regional levels)” in relation to the baseline/target identified in PMF. 
• How have RTs and/or HPROs demonstrated collaboration with decision makers, and at what level 
of decision making (overall, by project, and at country and regional levels)? What have been 
helping or hindering factors? 
• How has the IMCHA management team contributed to this work? 
• How did the recommendations from the midterm evaluation influence this work? 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR]? 
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D. Enhanced integration of health systems research findings into primary health care policies and 
practice in the selected countries & scale up 
Expressed in data, assess progress on indicator 3.1 “Number (type) of influence of IMCHA research 
projects on policy and programming per project” in relation to the baseline/target identified in PMF. 
• How have RTs and/or HPROs demonstrated influence on policy and programming (overall, by 
project, and at country and regional levels)? What have been helping or hindering factors? 
• How have RTs and HPROs been scaling? What have been helping or hindering factors? 
• How has the IMCHA management team contributed to this work? 
• How did the recommendations from the midterm evaluation influence this work? 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model? [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR] 
E. Strengthened capacity of researchers and research organizations to conduct gender and equity 
informed implementation research 
Expressed in data, assess progress on indicator 100.2 “Proportion of recommendations from formative 
analysis of HPROs acted upon” in relation to the baseline/target identified in PMF. 
• How have the HPROs acted upon the recommendations from the formative/situation analyses 
they conducted? 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model? [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR] 
F. Strengthened partnerships and alliances between African researchers, decision-makers and 
Canadian researchers 
• Since the midterm evaluation, how has the collaboration between African and Canadian 
researchers evolved? What factors are helping this collaboration? Why is that? What factors are 
hindering the collaboration? Why is that? How have these factors been addressed? 
• How has the collaboration between researchers and African decision-makers evolved? What 
factors are helping this collaboration? Why is that? What factors are hindering the collaboration? 
Why is that? How have these factors been addressed? 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR]? 
G. Increased awareness and undertaking of research evidence by decision makers at the primary 
healthcare level 
• How have recommendations from IMCHA research been communicated to the project co-PI 
decision maker? How has the co-PI decision maker used this information? 
• What, if any, outcomes have been achieved that were not predicted in the PMF or IMCHA Logic 
Model [PROMPT FOR GENDER-RELATED OUTCOMES IN PARTICULAR]? 
IMCHA Summative Evaluation 
hera / Volume 2 (Annexes)/ 25.09.2020 5 
2. Assessment of the IMCHA management: how effective has the management of the Initiative 
been and what difference has that made to IMCHA achievements? 
• How has the support from the management team contributed to the efforts of the RTs, the 
HPROs, and the Initiative overall? 
• How has the IMCHA management team implemented the recommendations of the midterm? 
What difference has this made in IMCHA achievements? 
• [Only for IMCHA donor partners] How has the Management and Operations Committee 
influenced IMCHA management and achievements? 
3. Assessment of the value-added of the IMCHA Initiative (building up on findings from the 
midterm evaluation, and focusing on findings for the period thereafter: How well has IMCHA been 
operationalized and how could it be improved on in future undertakings)? How can the evaluation 
inform the design of the IMCHA model for future undertakings? 
• How did the IMCHA model contribute to the performance of the initiative? What new lessons can 
be learned regarding the design and implementation of the model of the RTs (African PIs and 
Canadian researcher co-PIs and African Decision-maker co-PI)? What new lessons can be learned 
regarding the design and implementation of the model of HPROs? What new lessons can be 
learned regarding the collaboration between research teams and HPROs? How could the IMCHA 
model be improved on when designing future initiatives? 
• The Synergy Grants are also an opportunity for RTs to expand on their original grant, explore new 
(but related) issues and/or engage in scale-up: What worked well in the Synergy Grants? What 
were the challenges? How could this be improved on in a future Initiative? 
• What are other recommendations for designing any such future initiative? 
• [Only for IMCHA donor partners] What new lessons can be learned regarding the design and 
implementation of the partnership between CIHR, GAC and IDRC? How relevant would an 
initiative such as IMCHA continue to be to address your need and alignment with the 
Government of Canada and your own organizational priorities? How could a similar donor 
partnership be strengthened in designing such future initiative? 
4. To evaluate how the work conducted under IMCHA is being documented for contributing to 
the legacy of the Initiative 
• How have the RTs and HPROs documented their work, beyond publications, indicators 
performance and impacts, to contribute to IMCHA legacy? How could this be improved on in a 
future Initiative? 
• How has the IMCHA management team documented the work of IMCHA, beyond publications, 
indicators performance and impacts, to contribute to the legacy of the Initiative? How could this 
be improved on in a future Initiative? 
• [Only for IMCHA donor partners] How have the 3 donor partners documented the work of 
IMCHA, beyond publications, indicators performance and impacts, to contribute to the legacy of 
the Initiative? How could this be improved on in a future Initiative? 
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Methodology 
The proposed evaluation methodology will be judged on its suitability for addressing the evaluation 
questions. It should employ mixed data collection methods and multiples data sources. One source to 
be considered will be data already collected by IMCHA as a part of other monitoring activities. 
IMCHA expects that the methodology will include the following components, although we invite 
proponents to propose other valid approaches that, in their view, would yield informative findings: 
• Document Review: to include but not be limited to: IMCHA core documents (calls for proposals, 
workplan, logic model, documents analysing performance against the PMF, midterm evaluation 
report and other outputs, etc.); IMCHA grantees documents (abstracts, technical reports, impact 
statements, and IDRC projects monitoring visit reports and relevant trip reports); IMCHA annual 
reports to donor partner GAC; and any other available capacity building, knowledge translation 
and research uptake products. 
• Quantitative data collection/analysis: The consultants will conduct an online survey to solicit 
input from all Principal Investigators (PIs) and co-PIs. The consultants will also have access to 
IMCHA databases compiling information gathered from the Technical Reports. 
• Qualitative data collection/analysis: The consultants will conduct in-depth interviews to solicit 
perspectives from IMCHA grantees, IMCHA management team and other relevant IDRC staff, 
CIHR and GAC focal points (and others as specified), and other key external stakeholders. If 
possible, the consultants will also solicit perspectives from beneficiaries of the projects 
(communities, human resources for health, decision makers and other stakeholders) through 
interviews and/or focus group discussions. 
• Scope: Proponents are expected to cover the entire IMCHA Initiative, including the 2 HPROs and 
28 research projects (composed of the 19 original Implementation research grants and 9 Synergy 
grants). 
Proponents will provide an overview of the limitations of their proposed approach and articulate 
mitigation strategies. 
Tasks and Responsibilities 
• Proponents will produce an evaluation design report. This report will include: the evaluation 
questions to be addressed, the methodology to be implemented, a work plan including a 
schedule of expected dates, and a framework (cross-listing questions, methods and data sources) 
which will be shared with and approved by IDRC. The proponents should also submit a plan of 
proposed travels for fieldwork. 
• Proponents will engage in data collection and analysis as outlined in the evaluation design. 
• Proponents will produce an outline of the key sections of the evaluation report, for feedback and 
approval by IDRC. The report should respond to the questions outlined above and include a 
summary table displaying progress data on each PMF indicator for the immediate (with the 
exception of 200.1 and 300.1), intermediate, and ultimate outcomes. 
• Proponents will produce a presentation of preliminary findings and present to IMCHA donor 
partners for review, sense-making and discussion. 
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• Proponents will produce a draft evaluation report for review by the IMCHA donor partners. The 
report should take into account observations from the presentation of the preliminary findings. 
• Proponents will integrate feedback received and produce a revised report. After review by the 
IMCHA partners, and possible additional revisions, the final report will be submitted to IDRC. The 
report should be a maximum of 25 pages (excluding annexes and executive summary). It should 
include an executive summary in English and French. The final evaluation report will be a publicly 
accessible document. 
• Proponents will also produce two Issue Briefs on specific areas of interest (each maximum of four 
pages). The Briefs will synthesize IMCHA-wide lessons learned from the Evaluation Questions. 
The areas of interest will be decided upon discussions during the presentation of preliminary 
findings to IDRC and donor partners. 
IMCHA will: provide relevant documentation, including core documents, projects documentation and 
other products to the consultant as needed; facilitate contact with grantees, staff at IDRC and donor 
partners, and other relevant stakeholders; and will interact closely with the consultants and provide 
input and feedback as needed. 
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ANNEX 2. IMCHA GRANTS 
Implementation Research Grants 
Grant Country PI Institution Canadian Co-PI Institution Start End
1 Grant Amount 
108020: Quality Improvement for 
Maternal and Newborn Health At 
District-level Scale in Mtwara 
Region 
Tanzania Ifakara Health Institute 
SickKids Centre, 
Toronto 10/15 03/20 980,834 
108022: An mHealth Strategy to 
Reduce Preeclampsia-Eclampsia 
and Maternal and Infant Deaths in 
Tanzania 
Tanzania Ifakara Health Institute 
Queen's 
University 03/16 04/20 999,350 
108023: Integrating Demand and 
Supply Sides of Health Systems 
Governance to Improving 
Maternal, Newborn and Child 
Health in Tanzania 
Tanzania University of Dar es Salaam HealthBridge 03/16 03/20 995,940 
108024: Replicating MamaToto In 
Rural Tanzania  Tanzania 




Calgary  03/16 05/20 987,800 
108026: Building an Enhanced 
Cadre of Community Health 
Workers to Improve Maternal and 
Newborn Health in Rural Tanzania 
Tanzania Shirati District Hospital 
Bruyere Research 
Institute, Ottawa 03/16 09/20 944,450 
108027: Accessing Safe Deliveries 






University 10/15 04/20 991,920 
108028: Promoting Safe 
Motherhood in Jimma Zone, 
Ethiopia 
Ethiopia Jimma University 
University of 
Ottawa 09/15 09/20 999,560 
108029: Community-Based Cause 
of Death Study Linked to Maternal 
and Child Health Programmes and 
Vital Statistics in Ethiopia 
Ethiopia Addis Ababa University 
Centre for Global 
Health Research, 
Toronto 
01/16 09/20 986,896 
108030: Integrating a Neonatal 




British Columbia 02/16 08/20 981,153 
108031: Improving the Standards-
Based Management Recognition 
Initiative to Provide High Quality, 
Equitable Maternal Health Services 
in Malawi 
Malawi University of Malawi 
University of 
Alberta 01/16 07/20 999,632 









Montréal 10/15 04/20 999,660 
108033: Incentives and Social 
Enterprise models for Community 
Health Workers 
Uganda / 
South Sudan BRAC Africa 
Cape Breton 
University 10/15 04/20 997,962 
                                                                        
1 Status in February 2020. End-dates for most projects have since been extended because of the impact of COVID-19 
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Implementation Research Grants 
Grant Country PI Institution Canadian Co-PI Institution Start End
1 Grant Amount 
108034 / 108508: Alert Community 
to Prepared Hospital Care 
Continuum (Phase 1 & 2) 









108035: Bajenu Gox: une porte 
d’entrée pour soutenir une 
approche communautaire intégrée 





Diop de Dakar 
Institut national 
de santé publique 
du Québec 
08/15 06/20 852,400 
108037: Des interventions 
innovantes et réalistes pour 
améliorer la santé des mères, des 
nouveau-nés et des enfants en 
Afrique de l’Ouest 







Université Laval 06/15 09/19 999,859 
108038: Financement basé sur les 
résultats en santé maternelle et 
infantile et l'équité au Mali et 
Burkina Faso 
Burkina Faso / 
Mali MISELI, Mali 
Université de 
Montréal 10/15 10/20 989,190 
108039: Video Edutainment at the 
Doorstep: Impact on Maternal and 
Infant Outcomes in Toro Local 







McGill University 08/15 05/20 943,520 
108040: Scaling Up Care for 
Perinatal Depression for Improved 
Maternal and Infant Health in 
Nigeria  




08/15 02/20 999,400 
108041: Increasing Women's 








Ottawa 11/15 05/20 999,880 
Synergy Grants 
Grant Country PI Institution Canadian Co-PI Institution Start End 
Grant 
Amount 
108545: Enhancing Community 
Health Workers support for 
Maternal, Adolescent and 
Newborn Health Project plus 
Contraception in Rural Tanzania 
Tanzania Shirati District Hospital 
Bruyere Research 
Institute, Ottawa 07/17 05/20 491,200 
108546: Bridging the know-do 
gap among healthcare workers 
and decision-makers through 
improved routine measurement 
of the quality of maternal and 
newborn care 
Tanzania Ifakara Health Institute 
SickKids Centre, 
Toronto 10/17 10/20 483,300 
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Implementation Research Grants 
Grant Country PI Institution Canadian Co-PI Institution Start End
1 Grant Amount 
108547: Mama na Mtoto: 
Barriers and Enablers to Gender, 














Calgary 10/17 10/20 487,400 
108548: Leadership and 
Managerial Capacity 
Strengthening for Quality 
Pregnancy and Newborn 







University 09/17 09/20 492,700 
108549: Statistical Alliance for 
Vital Events: Strengthening 
Reporting and Program uses of 
Facility-based Child and Maternal 






Centre for Global 
Health Research, 
Toronto 
10/17 10/20 500,000 
108550: How Can a Gender Lens 
Enhance Maternal and Child 
Health Social Enterprises in 
Africa? 
Uganda / 
Kenya BRAC Africa 
Cape Breton 
University 10/17 09/20 487,900 
108551: Synergies in video 
edutainment: child spacing and 








McGill University 09/17 09/20 484,700 
108552: Responding to the 
challenge of Adolescent Perinatal 
Depression 
Nigeria University of Ibadan 
Jewish General 
Hospital, Montreal 10/17 10/20 401,600 
108553: Examen des effets de 
l'abolition des frais d’utilisateurs 








Université Laval & 
Université de 
Montréal 
10/17 10/20 490,300 
HPRO Grants 
Grant Region Institution Start End Grant Amount 
107892: Moving Maternal, 
Newborn and Child Health 
Evidence into Policy in West Africa 
West Africa West ROealth Organisation (WAHO) (Burkina Faso) 11/14 10/20 2,600,000 
107893: Moving Maternal, 
Newborn and Child Health 
Evidence into Policy in East Africa 
East Africa 
African Population and Health 
Research Centre (APHRC) (Kenya) 
Partners in Population and 
Development (PPD) (Uganda) 
East, Central and Southern African 
Health Community (ECSA) 
(Tanzania)  
11/14 10/20 2,600,000 
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ANNEX 4. IMCHA PMF INDICATORS AND TARGETS2 
Expected Results Indicators Targets 
Ultimate Outcome   
Improved maternal, newborn and 
child health outcomes in targeted 
countries. 
Proportion of funded implementation 
research that improved maternal and 
child health outcomes and access to 
primary health care services 
50% of the implementation 
research demonstrate 
improvement in any of the 11 
accountability indicators 
Intermediate Outcomes   
1. Enhanced production, analyses 
and syntheses of health systems 
implementation research prioritizing 
gender and equity 
1.1 Proportion of total projects that have 
at least 75% (three of four processes) 
adequate gender and equity dimensions.   
All research projects have > 75 % 
(three of four processes) adequate 
gender and equity dimensions. 
1.2 Proportion of health systems research 
outputs and syntheses that is gender and 
equity focused. 
75% of outputs include gender and 
equity focused analysis/synthesis  
2. Enhanced partnering and 
collaboration between decision 
makers and researchers on health 
systems strengthening in the 
selected countries/regions. 
2.1 Number of total projects per country 
that demonstrate high level of 
collaboration with decision maker 
(documented by project, country and 
regional levels). 
Minimum of one per country 
3. Enhanced integration of health 
systems research findings into 
primary health care policies and 
practice in selected countries. 
3.1 Number (type) of influence of IMCHA 
research projects on policy and 
programming per project 
20 
Immediate Outcomes   
100. Strengthened capacity of 
researchers and research 
organizations to conduct gender and 
equity informed health systems 
implementation research 
100.1 Proportion of total research 
projects that have adequately detailed 
gender and equity dimensions 
75 percent of research projects 
have adequate mechanisms 
identified to support gender and 
equity analysis. 
100.2 Proportion of recommendations 
from formative analysis of HPROs acted 
upon. 
>75 % of total recommendations 
acted on 
200. Strengthened partnerships and 
alliances between African 
researchers, decision-makers and 
Canadian researchers. 
200.1 Proportion of implementation 
research projects that demonstrate 
effective collaboration and management. 
75 percent of research projects 
demonstrate good practices in 
governance and coordination  
300. Increased awareness and 
understanding of research evidence 
by decision makers at the primary 
healthcare level. 
300.1 Proportion of IRT decision-makers’ 
follow up on recommendations from 
research into health systems planning 
forum(s). 
100 % of decision makers follow up 
on recommendations from 
research  
Outputs   
110. Funding provided to IRTs to 
conduct policy relevant gender and 
equity sensitive health systems 
implementation research. 
110.1 Number (and title) of health systems 
analysis and synthesis that is gender 
and/or equity focused produced by IRTs. 
20 
                                                                        
2 The indicators identified in the PMF to be reported against by the Summative Evaluation are bolded 
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Expected Results Indicators Targets 
120. Funding provided to research 
teams that include emerging 
researchers. 
120.1 Number of funded IRTs housed in 
research institutions.  20 
120.2 Number of emerging researchers 
involved in the IRT research. 35 
130. Synergistic research 
opportunities identified and 
supported. 
130.1 Number of synergistic research 
opportunities identified and funded (West 
and East Africa separately)  
WA: three funded 
EA: three funded 
140. Training, networking and 
exchanges of HPROs and IRTs is 
undertaken to strengthen the 
capacity of organizations funded 
through IMCHA 
140.1 Number of individuals who received 
training/networking and exchange 
opportunities (by type and by participant). 
40 
140.2 Number of networking and 
exchange opportunities supported 
through IMCHA 
10 
210. Collaborative mechanisms 
established between IRTs and 
HPROs. 
210.1 Number of type of communication 
between IRTs and HPROs. Quarterly contact 
220. HPROs and IRTs facilitate 
regional and national decision 
makers to engage in IMCHA 
implementation research. 
220.1 Number of new 
partnerships/collaborations between 
decision-makers and researchers on health 
systems strengthening. 
20 
220.2 Number of existing 
partnerships/collaborations enhanced 
between decision-makers and researchers 
on health systems strengthening. 
15 
230. Linkages formed outside of the 
IMCHA initiative by HPROs, IRTs with 
like-minded organizations 
230.1 Number of times HPROs and/or IRTs 
established connection with organizations 
outside of IMCHA (West and East Africa 
separately). 
Number not defined – to track 
cumulative efforts 
240. Research teams lead by African 
researchers and decision makers and 
Canadian co-PIs are funded. 
240.1 Number of IRTs with at least one 
Canadian researcher, one African 
researcher and one African decision 
maker.  
100 % aligned representation 
310. Evidence based policy and 
practice promoted by IRTs and 
HPROs 
310.1 Number (and description) of 
evidence-based policy and practice 
promoted by IRTs and HPROs (for East and 
West Africa). 
Minimum of one per research 
project funded 
320. Knowledge translation activities 
and products targeting relevant 
local, national and regional decision 
makers conducted. 
320.1 Frequency (by type) of knowledge 
translation activities (at national and 
regional levels). 
Yearly exchange at country and 
regional levels. 
320.2 Number (by type) of activities 
organised by HPROs to promote IRT 
research (for East and West Africa 
separately). 
One or more regional exchange 
platform per year 
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ANNEX 5. IMCHA RESEARCH PUBLICATIONS (05/2020) 
PROJECT PUBLICATION JOURNAL YEAR 
107892 An assessment of maternal, newborn and child health 
implementation studies in Nigeria: implications for evidence 
informed policymaking and practice 
Health Promotion Perspectives 2016 
107892 An Assessment of National Maternal and Child Health Policy-
Makers’ Knowledge and Capacity for Evidence- Informed 
Policy-Making in Nigeria 
International Journal of Health 
Policy Management 
2016 
107892 Improving maternal and child health policymaking process in 
Nigeria: an assessment of policymakers’ needs, barriers and 
facilitators of evidence-informed policymaking. 
Health Research Policy and 
Systems  
2017 
107892 Promoting research to improve maternal, newborn, infant 
and adolescent health in West Africa: the role of West African 
Health Organisation.  
Health Research Policy and 
Systems  
2017 
107892 Spanning maternal, newborn and child health (MNCH) and 
health systems research boundaries: conducive and limiting 
health systems factors to improving MNCH outcomes in West 
Africa. 
Health Research Policy and 
Systems  
2017 
107892 An assessment of policymaker’s engagement initiatives to 
promote evidence informed health policy making in Nigeria. 
The Pan African Medical Journal  2017 
107892 Assessment of policy makers’ individual and organizational 
capacity to acquire, assess, adapt and apply research 
evidence for maternal and child health policy making in 
Nigeria: a cross-sectional quantitative survey.  
African Health Sciences 2017 
107892 Using equitable impact sensitive tool (EQUIST) to promote 
implementation of evidence informed policymaking to 
improve maternal and child health outcomes: a focus on six 
West African Countries 
Globalization and Health 2018 
107892 A review of the process of knowledge transfer and use of 
evidence in reproductive and child health in Ghana 
Globalization and Health 2018 
107892 Promoting evidence informed policymaking for maternal and 
child health in Nigeria: lessons from a knowledge translation 
workshop 
Health Promotion Perspectives 2018 
108023 Perceptions on male involvement in pregnancy and childbirth 
in Masasi District, Tanzania: a qualitative study 
Reproductive Health 2018 
108023 Why do pregnant women in Iringa region in Tanzania start 
antenatal care late? A qualitative analysis 
BMC pregnancy and childbirth 2020 
108026 Promoting Respectful Maternity Care in Rural Tanzania:  
Nurses’ Experiences of the “Health Workers for Change” 
Program 
BMC Health Services Research 2018 
108026 Community member and policy maker priorities in improving 
maternal health in rural Tanzania 
International Journal of 
Gynecology and Obstetrics 
2018 
108027 Knowledge acquisition of Helping Babies Survive in rural 
Tanzania. 
International Health  2018 
108028 Perceptions and experiences related to health and health 
inequality among rural communities in Jimma Zone, Ethiopia: 
a rapid qualitative assessment 
BMC International Journal for 
Equity in Health  
2018 
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PROJECT PUBLICATION JOURNAL YEAR 
108028 Narrative depictions of working with language interpreters in 
cross-language qualitative research 
International Journal of 
Qualitative Methods 
2018 
108028 Talking health: Identifying trusted health messengers and 
effective ways of delivering health messages in rural Ethiopia 
Archives of Public Health 2019 
108028 Maternity waiting areas – serving all women? Barriers and 
enablers of an equity-oriented maternal health intervention 
in Jimma Zone, Ethiopia 
Global Public Health 2019 
108028 Subnational health management and the advancement of 
health equity: a case study of Ethiopia 
Global Health Research and 
Policy 
2019 
108028 A quality assessment of Health Management Information 
System (HMIS) data for maternal and child health in Jimma 
Zone, Ethiopia 
PLOS One 2019 
108028 Factors associated with maternity waiting home use among 
women in Jimma Zone, Ethiopia: a multilevel 
cross-sectional analysis 
BMJ Open 2019 
108030 Barriers and enablers of implementing bubble Continuous 
Positive Airway Pressure (CPAP): Perspectives of health 
professionals in Malawi 
PLOS One 2020 
108030 Assessing quality of newborn care at district facilities in 
Malawi 
BMC Health Services Research 2020 
108030 Health workers’ views on factors affecting caregiver 
engagement with bubble CPAP 
BMC Paediatrics 2020 
108030 Barriers and facilitators to implementing bubble CPAP to 
improve neonatal health in sub-Saharan Africa: a systematic 
review 
Public Health Reviews 2020 
108031 Improving the standards-based management recognition 
initiative to provide high quality, equitable maternal services 
in Malawi: an implementation research protocol  
BMJ Global Health 2016 
108032 Mothers' perceptions of the practice of kangaroo mother for 
preterm neonates in sub-Saharan Africa: A qualitative 
systematic review protocol 
JBI Database of systematic 
reviews and implementation 
reports 
2019 
108032 Health policy mapping and system gaps impeding the 
implementation of reproductive, maternal, neonatal, child, 
and adolescent health programs in South Sudan: a scoping 
review 
Conflict and Health 2020 
108032 “Midwives do not appreciate pregnant women who come to 
the maternity with torn and dirty clothing”: institutional 
delivery and postnatal care in Torit County, South Sudan: a 
mixed method study 
BMC pregnancy and childbirth 2020 
108033 Knowledge, Attitude, and Practice and service barriers in a 
tuberculosis programme in Lakes State, South Sudan: a 
qualitative study 
South Sudan Medical Journal 2018 
108033 How culture shapes the sexual and reproductive health 
practices among adolescent girls in Eastern Equatoria, South 
Sudan. 
South Sudan Medical Journal 2018 
108033 Using livelihoods to support primary health care for South 
Sudanese refugees in Kiryandongo, Uganda 
South Sudan Medical Journal 2019 
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PROJECT PUBLICATION JOURNAL YEAR 
108033 Gender and health social enterprises in Africa: a research 
agenda 
International Journal of Equity 
in Health 
2019 
108037 Effect of interrupting free healthcare for children: Drawing 
lessons at the critical moment of national scale-up in Burkina 
Faso. 
Social Science and Medicine. 2017 
108037 Sociocultural determinants of nomadic women’s utilization of 
assisted childbirth in Gossi, Mali: a qualitative study 
BMC pregnancy and childbirth 2018 
108037 Impact evaluation of seasonal malaria chemoprevention 
under routine program implementation: A quasi-
experimental study in Burkina Faso 
American Journal of Tropical 
Medicine and Hygiene 
2018 
108037 Analysis of the quality of seasonal malaria chemoprevention 
provided by community health Workers in Boulsa health 
district, Burkina Faso 
BMC Health Services Research 2019 
108037 Longitudinal analysis of the capacities of community health 
workers mobilised for seasonal malaria chemoprevention in 
Burkina Faso 
Malaria Journal  2020 
108038 Improving quality of maternal health services in Malawi’s 
Public Health sector 
Health Policy and Planning Sep-
19 
108038 Donor-funded project's sustainability assessment: a 
qualitative case study of a results-based financing pilot in 
Koulikoro region, Mali 
BMC Globalization and health 2017 
108039 Impact of universal home visits on maternal and infant 
outcomes in Bauchi state, Nigeria: protocol of a cluster 
randomized controlled trial 
BMC Health Services Research 2018 
108039 The impact of universal home visits with pregnant women 
and their spouses on maternal outcomes: a cluster 
randomised controlled trial in Bauchi State, Nigeria  
BMJ Global Health 2019 
108041 Systematic review of obstetric care from a women-centred 
perspective in Nigeria 
International Journal of 
Gynecology and Obstetrics 
2016 
108041 Unlocking the Benefits of Emergency Obstetric Care in Africa AJRH (African Journal of 
Reproductive Health) 
2016 
108041 Perceptions of women on workloads in health facilities and 
its effect on maternal health care: A multi-site qualitative 
study in Nigeria 
Midwifery 2017 
108041 Prevalence and risk factors for maternal mortality in referral 
hospitals in Nigeria: a multicenter study 
Reproductive Health BMC 
Reproductive Health 
2017 
108041 Women’s perceptions of reasons for maternal deaths: 
Implications for policies and programs for preventing 
maternal deaths in low-income countries 
Health Care for Women 
International. 
2017 
108041 Maternal death review and outcomes: An assessment in 
Lagos State, Nigeria 
PLOS One 2017 
108041 Prevalence and determinants of childhood mortality in 
Nigeria 
BMC Public Health 2017 
108041 Increasing women’s access to skilled pregnancy care to 
reduce maternal and perinatal mortality in rural Edo State, 
Nigeria: a randomized controlled trial 
BMC Global Health Research 
and Policy 
2018 
108041 Predictors of women’s utilization of primary health care for 
skilled pregnancy care in rural Nigeria 
BMC Pregnancy and Childbirth 2018 
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PROJECT PUBLICATION JOURNAL YEAR 
108041 Assessing the knowledge and skills on emergency obstetrics 
care among health providers: Implications for health systems 
strengthening in Nigeria 
PLOS One 2019 
108041 Gender Inequality as Barrier to Women’s Access to Skilled 
Pregnancy care in Rural Nigeria: A Qualitative Study.  
International Health 2019 
108041 Maternal near miss morbidity: Is this evidence of maternal 
health quality in sub-Saharan Africa.  
BJOG  2019 
108041 Decomposing the rural-urban gap in the factors of under-five 
mortality in sub-Saharan Africa. Evidence from 35 countries. 
BMC Public Health 2019 
108041 Why rural women do not use primary health centres for 
pregnancy care: evidence from a qualitative study in Nigeria 
BMC Pregnancy and Childbirth 2019 
108041 A qualitative study of community elders’ perceptions about 
the underutilization of formal maternal care and maternal 
death in rural Nigeria 
Reproductive Health 2019 
108041 Men’s perception of barriers to women’s use and access of 
skilled pregnancy care in rural Nigeria: a qualitative study 
Reproductive Health 2019 
108508 Maternal and Newborn Mortality: Community Opinions on 
Why Pregnant Women and Newborns are Dying in Natikiri, 
Mozambique.  
International Journal of 
Research 
2019 
108551 Factors associated with short birth interval in low- and 
middle-income countries: a systematic review 
BMC pregnancy and childbirth 2020 
108558 National user fee abolition and health insurance scheme in 
Burkina Faso: How they can be integrated on the road to 
universal health coverage without increasing health 
inequities? 
Journal of Global Health 2020 
Note: All publications in this database are authored by researchers participating in IMCHA grants but not all 
acknowledge IMCHA funding, do not address the issues of the IMCHA-funded project, nor are based on data collected 
under the project or evidence generated by the project. We suggest that IMCHA management review and clean this 
database 
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ANNEX 6. RECOMMENDATIONS OF THE HPRO SITUATION ANALYSES 
COUNTRY/ 
INSTITUTION 
RECOMMENDATIONS OUTLINED IN SITUATION ANALYSES 
West Africa - 
regional 
• Improve capacity to prepare data syntheses, systematic reviews and strategic 
briefing notes 
• Build capacity for requesting, accessing, evaluating, adapting and using evidence  
• Establish frameworks regulations and guidelines for systematic use of data 
• Support the development of policy briefs; support to existing platforms for transfer 
and exchange of knowledge to promote consultative or deliberative processes 
informed by evidence during the strategic programming and planning process 
• Advocate better use of evidence   
West Africa – 
gender & 
equity 
• Target disadvantaged populations that continue to be overlooked in the region.  
• Governments should pursue the scale-up of existing programmes, while modifying 
them to best serve those who possess the greatest needs.  
• Support capacity building for the various actors, integration of gender issues in 
MNCH policy documents, the operationalisation of  gender policies in countries, 
advocacy for gender mainstreaming and equity in MNCH interventions, equity in 
evaluations of policies/strategies and plans in countries and the empowerment of 
women (education, health, education for women, etc.)  
Mali 
• Formalise the transfer of knowledge in MNCH through the establishment of a 
national mechanism under the leadership of Mali's national health directorate 
• Train key research actors on the production of easily consumable "products" for 
policy makers 
• Promote action research and the establishment of a national bibliography of 
research 
• Create a regular space or framework for discussion between researchers and policy 
makers 
• Establish a web platform that will integrate all research findings in the field of 
MNCH in Mali and the policy decisions made based on these findings.  
Nigeria 
• The policymakers were emphatic about the need for capacity building on use of 
research in policy formulation, appropriate dissemination of the research findings to 
relevant stakeholders, and involvement of policymakers in research.  
Senegal • There is a strong need to build capacity on knowledge translation 
• Need to set up a platform where all stakeholders can interact and share evidence 
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COUNTRY/ 
INSTITUTION 
RECOMMENDATIONS OUTLINED IN SITUATION ANALYSES 
Ethiopia 
• Evidence synthesis: The HPRO can support development of dissemination materials 
that communicate the research findings/evidence such as video testimonials.  
• Networking and alliance building. Create networks within the forums organised 
under the Health Sector Development Program (HSDP’s). The IRTs need to work 
closely with national/regional taskforces, technical working groups, advisory 
committees which are forums where evidence can be disseminated to influence 
policy action.  
• Support for national research uptake. The HPRO can advocate on MNCH issues by 
working with IRT policymakers in national consultations such as professional 
associations, periodic discussions in annual conferences among other forums. HPRO 
can support IRTs in translating research outputs into actions and decisions that are 
simple and easy to disseminate through various tools such as policy briefs, 
infographics, blogs, and posters among others.  
• To increase the level of research uptake within stakeholders. HPRO working with 
IRTs can facilitate media engagement by providing training for journalists and   
editors who have a keen interest in reporting health issues. This will increase the 
journalists’ understanding on how to report on MNCH issues from a research and 
policy perspective, thereby acting as advocates for the sector.   
• Ensuring greater impact. The HPRO will work with the IRTs on how to collaborate 
with existing KT networks to prioritise the MNCH agenda nationally. It seems 
policies in this area are linked to bigger international initiatives.  
Malawi 
• Evidence synthesis: Since national research dissemination workshops are funded by 
the National Commission of Research, National AIDS Commission and College of 
Medicine, the IRTs supported by the HPRO can partner with these three institutions 
to convene a similar meeting with the aim of disseminating IMCHA research. 
• Networking and alliance building. The IRTs can participate in the technical working 
group of the Quality Management Unit, a Knowledge Translation Platform Steering 
Committee and national research dissemination workshops to share findings from 
their research as well as influence MNCH policy through this forum since it is 
responsible for streamlining the health care system and creating quality of care 
monitoring structures.  
• Support for national research uptake. The HPRO working with the IRTs can advocate 
for the prioritisation of MNCH issues in the national research agenda through the 
current IMCHA work. The HPROs/IRT can join the Communities of Practice which 
are under the Knowledge Translation Platforms Steering Committee and can engage 
the Ministry of Health on IMCHA research and inform/influence policy through its 
findings. It also a good platform to disseminate findings through various 
publications.   
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COUNTRY/ 
INSTITUTION 
RECOMMENDATIONS OUTLINED IN SITUATION ANALYSES 
Mozambique 
• Entry points to influence MNCH policy making and implementation in Mozambique:  
a) Technical working groups (TWGs) in Mozambique should be considered as ideal 
entry points where in-country research can influence policy-making especially in 
light of the opportunities for research organizations to be represented in these 
TWGs and directly influence MNCH policy-making.  
b) Research and advocacy organisations should use the same TWGs as forums 
where research evidence can be used to inform and reinforce the implementation 
of MNCH strategies and action plans.  
c) The TWGs should also be used as forums where the activities of the numerous 
donors, implementing partners and other stakeholders are discussed, coordinated 
and aligned. This coordination will reduce duplication of efforts and thus enhance 
the impact that will be realized using the existing resources.   
• Enhancement of the transfer of knowledge to key research consumers and 
stakeholders  
a) Research organisations and other producers of research evidence need to 
enhance the dissemination of research evidence to key stakeholders (including 
policymakers) to increase their awareness of the existence and value of the 
research evidence.  
b) The MoH needs to develop and institutionalize knowledge transfer mechanisms 
between the central government level and health units. This is important to ensure 
that research evidence (most of it received by the central government level) and the 
policies it informs is communicated to health units across the country.   
• Capacity building and strengthening of MNCH research advocacy. While research 
organisations can generate research, there is merit in capacity building of these   
research organisations with regards to their communications and advocacy 
expertise. This is important to ensure that research evidence (which is often 
scientific and technical) is communicated appropriately to policymakers (some of 
whom do not have a scientific or technical background). This recommendation 
presents an opportunity for future funding towards the enhancement of the 
research evidence in MNCH policymaking in Mozambique.   
• Capacity building for knowledge translation. While the minimal influence of local 
context in the overall MNCH policy-making process is in part attributable to high 
donor dependence, it is also due to the limited knowledge translation capacity of in-
country stakeholders. In this light, it is recommended that future investments in 
MNCH policy landscape in Mozambique should focus on building the knowledge 
translation capacity of in-country stakeholders.   
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COUNTRY/ 
INSTITUTION 
RECOMMENDATIONS OUTLINED IN SITUATION ANALYSES 
Mozambique 
(cont.) 
• Financing. Domestic financing for health in general and MNCH in particular in 
Mozambique is low. While research organizations are aware of and align their work 
with the National Agenda of Research, there is no financing earmarked for the 
realization of this agenda. There is merit that future investments in MNCH   
policy context in Mozambique should focus on generating funding or aligning 
existing funding with the National Agenda of Research by:  
a) Developing investment cases to make a case of enhanced funding towards MNCH 
by the Government of Mozambique. In light of competing needs that the 
Government of Mozambique has to prioritize there is merit in developing 
investment cases that motivate enhanced domestic financing towards MNCH. These 
investment cases will enable MNCH to compete favorably for local government 
funding against other financing priorities presented to the Government of   
Mozambique.   
b) Improving dialogue between donors and the MoH to ensure that priorities of the 
MoH / Government are regularly communicated to the donors, so that donor 
financing is aligned with the National Agenda of Research. This alignment will also 
reduce redundancies and duplication of funding and initiatives in MNCH by the 
numerous donor-funded implementing partners in Mozambique. 
Tanzania 
• Evidence synthesis. The HPRO can support IRTs through systematic review trainings 
so that they do not have to rely solely on evaluations to generate evidence to 
inform policy.   
• Networking and alliance building. The IRTs can indicate which forums dealing with 
health and MNCH issues they are involved in to ensure they do not work in isolation 
but instead participate in the existing platforms. It is expected that eventually, IRTs 
will be able to disseminate their findings and recommendations in these platforms.  
The IRTs and the HPRO can participate in key national research and policy 
engagement forums to understand the direction of strategies being implemented to 
address MNCH issues in Tanzania.  
• Support for national research uptake. The HPRO will work with the IRTs to 
strengthen their capacity in knowledge translation, working with various policy 
engagement tools such as policy briefs and understanding their impact. This will 
enable IRTs have a strategy of engagement whenever they are involved in   
various policy platforms.  Since there are many MNCH stakeholders the six IRTs 
should work closely with the stakeholders through the various technical working 
groups. The policymakers within each team can distribute their participation based 
on proximity of some of the meetings and relevance to their research area. 
Tanzania is quite receptive to research and the IRTs being supported by the HPRO 
can engage effectively in these forums and also disseminate their   
findings with the hope of informing some of the Ministry of Health strategies. 
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COUNTRY/ 
INSTITUTION 
RECOMMENDATIONS OUTLINED IN SITUATION ANALYSES 
Uganda 
• Evidence synthesis. The IRTs can work with NIMR to engage stakeholders as well as 
research consumers in identifying which areas of IMCHA programme research can 
inform national research priorities.  
• Networking and alliance building. The IRTs can begin engaging with the existing 
technical working groups and meetings in the country.  The HPRO can support them 
by working with them to refine their presentations and key messages.  
• Support for national research uptake. The HPRO will work with the IRTs to 
strengthen their capacity in knowledge translation, working with various policy 
engagement tools such as policy briefs and understanding their impact. This will 
enable IRTs have a strategy of engagement whenever they are involved in various 
policy platforms.  
South Sudan 
• Subscribing to scientific journals  
• Training on research methods 
• Developing collaboration with research institutions and universities (international 
and local)  
• Discuss evidence within the Ministry of Health  
• Providing financial support to attend conferences, scientific events, webinars, 
subscription to scientific journals  
• Finding mechanisms to disseminate the findings from the studies which are taking 
place in South Sudan  
• Strengthening the use of the website of the Ministry of Health  
• Improving the infrastructure of the Ministry of Health (power, internet, archives)  
• Do more lobbying to the health committees at the parliament  
• Fund research  
• Finding mechanisms to disseminate the findings of research at the State and County 
levels  
• Strengthening the use of South Sudan Medical journal 
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ANNEX 7. RECOMMENDATIONS OF THE IMCHA MIDTERM 
EVALUATION 
7.1 FOR THE REMAINDER OF IMCHA: 
GENERAL RECOMMENDATION 
1. Hold country-level meetings among the research teams, including the decisionmakers, in 
countries in which there is more than one research team. Also, consider holding a final meeting 
of all the research teams to share lessons learned. 
2. Hold a final meeting of all the research teams to share lessons learned. The meeting could 
synthesize learning from the different research teams, explore future implementation research 
and explore further scale-up opportunities and collaborations. 
3. Ensure that the summative evaluation of IMCHA includes a wider focus on stakeholders’ views on 
the IMCHA supported projects to be able to better examines the factors and conditions that are 
shaping scale-up of IMCHA interventions. Paying particular attention to South-South 
collaboration in IMCHA would also be valuable. 
GENDER AND EQUITY 
4. Support the teams to do more gender and equity analyses of their existing and evolving data sets 
to maximize the impact of their research on gender and equity issues. 
5. Organize a hands-on set of regional workshops for all the research teams and work with them as 
a group to look at their individual implementation plans to assess how far their strategies 
substantively address underlying causes of gender inequalities and inequities based on different 
axes of power, and to identify what they can do differently for the remainder of the initiative. 
6. Organize capacity-building efforts on equity analysis through a dedicated workshop on how to 
carry out equity analyses. This would help ground the concept, differentiate it from gender 
considerations, and enhance understanding on how it applies in each research project. 
7. Provide the research teams with a vetted roster of gender and equity experts who can support 
the teams in their gender and equity analyses. Place a particular emphasis on experts who have 
prior experience in promoting gender and equity issues in communities. 
INNOVATION AND SCALING 
8. Enlist help from the HPROs in supporting the teams with writing policy briefs and setting up 
stakeholder meetings; consider requesting that the HPROs work with each team individually to 
develop a customized knowledge translation plan for the results of their research. 
9. Require the research teams to submit a plan as a part of their technical reporting, on how they 
are working with the decision-maker co-PIs to influence policies and practices and plan scale-up 
for the rest of IMCHA. 
10. Provide support to the research teams in identifying funders that support further scaling up 
activities after IMCHA has run its course. 
11. Provide grant-writing training to help the research teams seek further funding. 
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12. Investigate whether IDRC and GAC are able to act as a liaison on behalf of the research teams 
with potential future donors. 
HPROS 
13. Continue to provide tailored capacity-building for the research teams, particularly on knowledge 
translation, policymaker outreach, and seeking donor support for further research and scale-up. 
14. Create formal mechanisms to ensure knowledge-sharing between the East and West Africa 
HPROs on a regular basis, perhaps through shared initiatives such as working together to update 
and enhance the IMCHA website to showcase the results of the research teams and to promote 
crosscutting lessons, or collaborating on dissemination materials to be shared across the region, 
including to potential future donors. 
7.2 FUTURE INITIATIVES 
GENERAL 
15. Learn from IMCHA to include more structure at the beginning of the initiative, including offering 
management training. IMCHA grantees included a number of people who were inexperienced in 
managing Canadian grants who would have benefitted from early capacity-building in this area. 
16. Create a template to develop stronger workplans from the outset. This would aid in better 
budgeting. 
COLLABORATION BETWEEN AFRICAN AND CANADIAN RESEARCHERS 
17. Support team-building and the preparation of applications by holding preproposal workshops or 
webinars on developing research proposals. 
18. Explore innovative ways to facilitate ‘matchmaking’ between African and Canadian researchers 
who are interested in collaborating. 
GENDER & EQUITY 
19. Provide applied gender and equity training ideally at the onset of the project to reach a common, 
Initiative-wide understanding of how inequalities play out in reality in communities, and present 
examples on how some of these have been addressed effectively elsewhere, to bring about 
equity and gender-transformative changes. 
HPROS 
20. Define the role of an HPRO-like component in any future initiative that includes such a feature, 
clearly and specifically to all participants from the outset. It is crucial that the expectations for 
collaboration between the HPROs and research teams are explicit and concrete. 
21. Shift the mandate of the HPROs towards offering tailored support to individual research teams 
and require the HPROs to visit each team and work with them to understand their needs and to 
develop an outreach plan. Under this model, HPROs would be compensated based on the 
number of research teams they support. 
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ANNEX 8. EVALUATION MATRIX 
The evaluation matrix follows the structure of Section 2.2.4 of the RfP. The numbered headings 1-4 are transformed into overarching questions defining the 
four evaluation areas. The numbered headings A to G, as well as some of the bulleted questions under heading 2-4 are transformed to main evaluation questions. 
All other bulleted questions are transformed into sub-questions. The bullet list in the RfP include further specifications and sub-sub questions that are not picked 
up in the matrix but that will nevertheless be addressed in the data collection and analysis. 
Evaluation Questions Sub-questions Evaluation Axis Indicators Sources of evidence Methods 
Evaluation Area 1: What are the achievements of IMCHA in relation to the Performance Measurement Framework as well as policy uptake and scale-up of successful 
interventions? 
What is the outcome of 
IMCHA in terms of improved 
maternal newborn and child 
health in targeted countries? 
What are the achievements of 
IMCHA in relation to the eleven 
CoIA MNCH indicators? 
Which unexpected outcomes 
including gender-related outcomes 
were achieved?  
What were the main strategies to 
obtain the achievements? How 
appropriate are these for achieving 
the intended outcomes? 
• Research projects 
• Proportion of funded 
implementation research that 
improved maternal and child 
health outcomes and access 
to primary health care 
services 
• Research teams; PIs & 
Co-PIs 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports, reports to 
GAC 
• Document reviews 
• On-line survey 
• KIIs 
Has IMCHA enhanced the 
production, analysis and 
synthesis of health systems 
implementation research 
prioritising gender and 
equity? 
How were gender and equity 
dimensions integrated by the 
IMCHA research teams?  
How did HPROs contribute to the 
integration of gender and equity in 
research activities, capacity 
building and knowledge 
translation?  
How did IMCHA management 
contribute to the integration of 
gender and equity? 
Did the Midterm Evaluation 
influence the understanding of 
gender and equity issues in the 
research projects? 




• Proportion of projects that 
have at least 75% (three of 
four processes) adequate 
gender dimensions 
• Proportion of health systems 
research outputs and 
syntheses that is gender 
focused 
• Proportion of projects that 
have at least 75% (three of 
four processes) adequate 
equity dimensions 
• Proportion of health systems 
research outputs and 
syntheses that is equity 
focused 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Midterm evaluation 
report 
• Document reviews 
• On-line survey 
• RQ+ evaluation 
• KIIs 
  
IMCHA Summative Evaluation 
hera / Volume 2 (Annexes)/ 25.09.2020 27 
Evaluation Questions Sub-questions Evaluation Axis Indicators Sources of evidence Methods 
To what extent has there 
been enhanced partnering 
and collaboration between 
researchers and decision-
makers on health systems 
strengthening? 
How have the research teams 
and/or HPROs demonstrated 
collaboration with decision-
makers?  
How has IMCHA management 
contributed to this work? 
How did recommendations from 
the Midterm Evaluation influence 
this work? 
What unexpected outcomes 
including gender-related outcomes 
were achieved?  




• Number of projects that 
demonstrate a high level of 
collaboration with decision 
makers (documented by 
project, country and 
regional levels) 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Midterm Evaluation 
Report 
• Document reviews 
• On-line survey 
• RQ+ evaluation 
• KIIs 
To what extent has there 
been enhanced integration 
of health systems research 
findings into primary health 
care policies and practice in 
the selected countries, and 
scale up? 
How have research teams and 
HPROs demonstrated influence on 
policy and programming? 
How successful have research 
teams and HPROs been in scaling 
the research results? 
How has IMCHA management 
contributed to this work? 
How did recommendations from 
the Midterm Evaluation influence 
this work? 
What unexpected outcomes 
including gender-related outcomes 
were achieved? 
• Research projects 
• HRPOs 
• IMCHA management 
• Number (type) of 
influence of IMCHA 
research projects on 
policy and programming 
per project 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Midterm Evaluation Report 
• Document reviews 
• On-line survey 
• KIIs 
To what extent was the 
capacity of researchers and 
research organisations 
strengthened to conduct 
gender and equity informed 
implementation research?3 
How have the HPROs acted on the 
recommendations from the 
formative/situation analyses they 
conducted? 
What unexpected outcomes 
including gender-related outcomes 
were achieved? 
• HPROs 
• Proportion of research 
projects that have 
adequately detailed 
gender and equity 
dimensions 
• Proportion of 
recommendations from 
formative analyses of 
HPROs that were acted on 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Formative/situation 
analyses 
• Document reviews 
• On-line survey 
• KIIs 
   
                                                                        
3 According to the RfP, this question specifically and exclusively refers to Indicator 100.2: “Proportion of recommendations from formative analysis of HPROs acted upon” 
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Evaluation Questions Sub-questions Evaluation Axis Indicators Sources of evidence Methods 
To what extent were 
partnerships and alliances 
between African researchers, 
decision makers and 
Canadian researchers 
strengthened? 
How has the collaboration 
between African and Canadian 
researchers evolved since the 
Midterm Evaluation?  
What unexpected outcomes 
including gender-related outcomes 
were achieved? 
• Research projects 
• Proportion of 
implementation research 
projects that demonstrate 
effective collaboration and 
management. 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Document reviews 
• On-line survey 
• KIIs 
To what extent are decision-
makers better aware and 
able to use research 
evidence? 
How were the findings of IMCHA 
research communicated to the 
project Co-PI decision maker? How 
has the Co-PI decision maker used 
this information? 
What unexpected outcomes 
including gender-related outcomes 
were achieved? 
• Research projects 
• Proportion of IRT decision-
makers’ follow up on 
recommendations from 
research into health 
systems planning fora 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA PMF 
• Grantee publications, 
reports 
• Field reports 
• Document reviews 
• On-line survey 
• RQ+ evaluation 
• KIIs 
Evaluation Area 2: How effective has the management of the Initiative been and what difference has that made to IMCHA achievements? 
How has support from the 
IMCHA management team 
and the M&O Committee 
contributed to the efforts of 
the research teams, the 
HPROs, and the Initiative 
overall? 
How has IMCHA management 
implemented the 
recommendations of the midterm 
evaluation?  
What difference has this made in 
IMCHA achievements? 
• IMCHA management 
• Stakeholder views on the 
extent to which the 
support of the IMCHA 
management team has 
contributed to their work 
• Proportion of Midterm 
Evaluation 
recommendations that 
were implemented by 
IMCHA management 
• Donor partner views on 
the effectiveness of the 
M&O Committee 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA donors 
• Midterm Evaluation report 
• On-line survey 
• KIIs 
How has the M&O Committee 
influenced IMCHA management 
and achievements? 
• IMCHA governance 
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Evaluation Questions Sub-questions Evaluation Axis Indicators Sources of evidence Methods 
Evaluation Area 3: How well has IMCHA been operationalised and how could it be improved on in future undertakings? 
How did the IMCHA model 
contribute to the 
performance of the 
initiative?  
What new lessons can be learnt 
regarding the design and 
implementation of the model of 
the research teams? 
What new lessons can be learnt 
regarding the design and 
implementation of the model of 
HPROs?  
What worked well in the Synergy 
Grants? What were the 
challenges? 
• Research projects 
• HPROs 
• IMCHA management 
• Stakeholder perceptions 
on the effectiveness of the 
IMCHA model 
• Documented evidence on 
aspects of the IMCHA 
model and 
implementation that 
should be improved in 
future 
• Research teams 
• HPROs 
• IMCHA management 
• IMCHA donors 
• On-line survey 
• KIIs 
What new lessons can be learnt 
regarding the design and 
implementation of the partnership 
between CIHR, GAC and IDRC? 
How relevant would an initiative 
such as IMCHA continue to be to 
address the needs of the donor 
partners and their alignment with 
Government of Canada priorities? 
• IMCHA governance 
• Donor perceptions on the 
design and 
implementation of the 
partnership 
• IMCHA donors • KIIs 
Evaluation Area 4: How is the work of IMCHA documented and does it contribute to the legacy of the Initiative? 
How have the research 
teams, HPROs, the IMCHA 
management team and the 
donor partners documented 
their work to contribute to 
the IMCHA legacy? 
How could this be improved in a 
future initiative? 
• Research projects 
• HPROs 
• IMCHA management 
• IMCHA governance 
• Evidence on 
documentation of work 
beyond publications and 
regular reporting. 
• Research teams 
• HPROs 
• IMCHA management 
• Donor partners 
• Document reviews 
• On-line survey 
• KIIs 
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ANNEX 9. METHODOLOGY  
9.1 APPROACH 
In the inception phase, the evaluation team eliminated duplications from the TOR list of 38 evaluation 
questions and organised the remaining in a matrix of 32 sub-questions under 10 main questions in four 
areas of inquiry corresponding to the objectives of the evaluation. For each of these questions, the 
team adopted a results-oriented evaluation approach, assessing the performance of IMCHA against 
the targets of the performance monitoring framework (PMF), as well as a reflexive approach, drawing 
lessons from the processes of project and programme implementation. 
Data to answer the evaluation questions were collected by three main methods and triangulated to 
generate findings responding to each question: 
• Document reviews 
• An on-line survey of researchers and decisionmakers 
• Key informant interviews conducted during project visits, attendance of the IMCHA learning 
workshop in January 2020, a mission to Ottawa and remotely using a voice over internet protocol 
(VOIP) 
A planned evaluation of the quality of project outputs using the IDRC Research Quality Plus (RQ+) 
methodology was cancelled on advice of IDRC, because an agency-wide RQ+ assessment including 
IMCHA projects was commissioned at about the same time as the evaluation. Results from this 
assessment were not yet available at the time of preparing the IMCHA evaluation report. 
The evaluation covered the entire period of IMCHA implementation from the launch in 2014 to the 
end of data collection in May 2020. More weight was, however, assigned to the period following the 
publication of the midterm evaluation report in October 2018. Data collection for the evaluation 
commenced in January and ended in early May 2020. 
9.2 DATA COLLECTION 
DOCUMENT REVIEWS 
A library of technical and administrative IMCHA documents was provided by IDRC including annual 
programme reports, project approval documents (PADs), implementation plans, project progress 
reports, workshop reports and presentations, monitoring (trackify) and financial databases, technical 
reports and project outputs. Additional documents were collected by the evaluation teams during 
project visits or requested from informants interviewed by VOIP. In total, the evaluation collected 385 
documents and entered them into the analysis. 
ONLINE SURVEY 
An online survey questionnaire was developed in December 2019 closely matching the two 
questionnaires for researchers and decisionmakers used in the midterm evaluation. A single 
questionnaire was used for the final evaluation, however it split after initial identification questions 
into two distinct sections for researchers and decisionmakers. The questionnaire was reviewed by 
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IMCHA Management and pretested by hera associates. It was launched in English and French on 
January 6th on the SurveyMonkey platform. A reminder e-mail to invited respondents was sent on 
February 6th and the survey was closed on February 18th. 
Invitations were sent to 131 researchers and decisionmakers who participated in IMCHA-funded 
projects. Researchers of Health Policy and Research Organisations (HPROs) were not invited to 
participate in the survey. An additional 35 invitations were sent on January 23rd to contact addresses 
obtained during the IMCHA learning workshop in Kigali, bringing the total to 166. Respondents were 
assured anonymity. The invited respondents included  
• Current and former Principal Investigators (PIs) and researchers in African institutions 
• Current and former Canadian Co-Principal Investigators (Co-PIs) and researchers 
• Current and former Co-PI decisionmakers  
Of the 166 e-mail invitations, three were returned because the e-mail address was no longer valid or 
there was an automated message that the person had retired or left the organisation.  
• The invitation was successfully sent to 163 potential respondents 
• The survey was opened by 72 respondents (overall response rate: 44%) 
• 13 respondents only completed the profile portion of the survey. They were removed from the 
analysis, which left 59 valid responses (valid response rate: 36%) 
Further information on the profile of respondents is provided in Annex 11. 
KEY INFORMANT INTERVIEWS 
The evaluation team interviewed 97 
stakeholders (47 female and 50 male) in 
individual or group interviews in person 
or via VOIP. The interviews were semi-
structured on the basis of the 
evaluation questions, adapted to each 
of the four main stakeholder groups, 
and further adapted to each individual 
interview context and position of the 
informant. The scripts were provided to 
the interviewee in advance and the 
interviews were recorded for 
transcription after consent was 
obtained. Respondents were assured 
anonymity. 
Key informants in each group were 
sampled by purposive sampling that 
aimed at reaching data saturation for 
each evaluation question. Researchers, 
Stakeholder groups 
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decisionmakers and HPRO staff were interviewed individually or in groups during project visits. Gaps 
were filled with VOIP interviews. All current IDRC staff involved in IMCHA management as well as all 
current members of the IMCHA M&O Committee were interviewed individually or in groups during a 
mission to Ottawa. Only one member of the Governance Committee was available for an interview. 
Projects for site visits were selected by convenience sampling based on travel logistics. Country visits 
were planned by favouring countries with the most projects. The team visited Tanzania, Nigeria and 
Uganda and conducted interviews with APHRC staff in Kenya. A planned visit to one project in Nigeria 
was not authorised by IDRC for security reasons and plans to interview the WAHO team and to visit 
one project in Senegal were abandoned when the West Africa mission had to be cut short because of 
Covid-19 travel restrictions. To fill this gap, additional VOIP interviews were conducted. Sixteen of 28 
implementation research and synergy projects were included in the site visits and interviews. 
Scheduling VOIP interviews with researchers and decisionmakers was difficult as most were already 
deeply involved in the response to Covid-19. Three Co-PI decisionmakers, two PIs, and one Canadian 
Co-PI did not respond to invitations for VOIP interviews. The following projects were visited or covered 
in VOIP interviews. Sixteen Canadian Co-PIs and researchers were interviewed during the mission to 
Ottawa, in the context of the IMCHA learning workshop, or using VOIP. 
Project interviews 
GRANT COUNTRY PI INSTITUTION  
108020 / 108546 Tanzania Ifakara Health Institute On-site 
108022 Tanzania Ifakara Health Institute On-site 
108023 Tanzania University of Dar es Salaam On-site 
108024 / 108547 Tanzania Catholic University of Health and Allied Sciences On-site 
108027 / 108548 Tanzania Tanzanian Training Centre for International Health On-site 
108028 Ethiopia Jimma University VOIP 
108033 / 108550 Uganda BRAC Africa On-site 
108037 / 108553 Burkina Faso Société d'Etudes et de Recherche en Santé Publique VOIP 
108040 / 108552 Nigeria University of Ibadan On-site 
108041 Nigeria Women's Health and Action Research Centre On-site 
107892 (HPRO) Burkina Faso West African Health Organisation VOIP 
107893 (HPRO) Kenya African Population and Health Research Centre On-site 
107893 (HPRO) Uganda Partners in Population and Development On-site 
107893 (HPRO) Tanzania ECSA Heath Community  On-site 
Research Team PIs and Co-PIs contacted and interviewed 
PIS I N.R CANADIAN CO-PIS I N.R DECISIONMAKER CO-PIS I NR 
Abel Bicaba  X Anne Cockcroft    Adamu Ibrahim Gamawa   
Angelo Nyamtema X  Christina Zarowsky   Ahmed Julla   
Bwire Chirangi  X David Goldfarb   Alexander Dimiti   
Celso Belo   Gail Webber X  Anna Nswilla X  
Dismas Matovelo X  Jenn Brenner X  Biratu Yigezu    
Elijo Omoro   John LeBlanc X  Francis Mwanisi   
Ellen Chirwa   Karen Yeates X  Fannie Kachale    
Emmanuel Ochola   Kevin McKague X  Godfrey Mtey  X  
Fatuma Manzi 
Kabanywanyi X 
 Manisha Kulkarni  X  Josef Okware X  
Friday Okonofua X  Oumar Mallé Samb    Julie Erhabor (new Co-PI) X  
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PIS I N.R CANADIAN CO-PIS I N.R DECISIONMAKER CO-PIS I NR 
Jenipher Twebaze X  Phyllis Zelkowitz X  Kunuz Hajibedru  X 
Kondwani Kawaza   Prabhat Jha   Mamadou Ba   
Lakew Abebe 
Gebretsadik X 
 Ronald K. Siemens   Mamadou Namory Traoré   X 
Laurence Touré   Ronald Labonte   Munira Abudou   
Muhammad Yagana   Sanni Yaya X  Oumar Sarr   
Oye Gureje X  Sian Fitzgerald, X  Oumou Diarra   
Robert Tillya X  Slim Haddad  X Pierre Yameogo   X 
Rosalie A. Diop    Valery Ridde   Queen Dube    
Stephen Maluka X  Zubia Mumtaz   Robert Salim X  
Thomas Druetz X  Zulfiqar Bhutta X  Sylvia Mamkwe X  
Wubegzier Mekonnen      Thomas Rutachunzibwa X  
      Tunde Olatunji X  
I = Interviewed; N.R. = No Response 
9.3 DATA ANALYSIS 
The on-line survey responses included Likert and ranking scales as well as narrative responses. The 
data derived from scales were tabulated, proportions were calculated were appropriate and compared 
to proportions reported in the midterm survey.  
The narrative survey responses, the interview transcripts and the collected documents were analysed 
using the qualitative content analysis software MAXQDA. A system of codes and sub-codes for the data 
analysis was developed on the basis of the evaluation matrix using both deductive and inductive 
coding. Main codes and first level sub-codes were based on the evaluation questions. After the 
development of a coding matrix and data import, all interview transcripts and documents were coded. 
Further analysis of retrieved segments was done by the team member responsible for the section using 
methodologies that depended on the number of segments.  
• In the case of large datasets additional sub-sub-codes were established by inductive coding to 
further disaggregate the retrieved data. For instance under the code of ‘influence on policies and 
programmes’ 45 sections were retrieved which were further sub-categorised by informant type 
and level of influence.  
• In the case of small datasets, for instance of only 11 segments retrieved under the code of ‘M&O 
Committee’, the segments were extracted into an Excel file and individually inspected for 
possible grouping into sub-categories. 
While we did not count the numbers of similarities of responses, experiences and reactions 
systematically in all interview transcripts, the methodology allowed us to filter the responses by 
stakeholder type, into those that were unanimous or nearly unanimous, those that were expressed by 
a majority of informants, and those that were expressed by a minority, including single informants. 
Quotes, where relevant, were extracted from the retrieved response segments. They were used in the 
report to either document majority views, views of informants in unique positions to provide the most 
relevant information, or, in some cases outlier opinions. In each case this was indicated in the text of 
the evaluation report.  
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Cross-checking of coded segments by an independent analyst to confirm correct coding was not 
possible because of budget and time constraints of the evaluation. However, each of the four 
evaluation team members read all interview transcripts and reviewed all sections of the report. The 
draft report was reviewed for consistency and internal logic by the Quality Assurer, the Executive 
Director of hera. 
9.4 LIMITATIONS 
Data collection among decisionmakers was challenging. Among the 11 decisionmaker Co-PIs of the 16 
sampled projects, only eight could be joined for interviews, and only 5/29 decisionmakers invited to 
the online survey responded. Changes of designated Co-PIs over the project period as well as changing 
priorities due to the response to Covid-19 towards the end of the evaluation period were likely reasons. 
All but one (newly appointed) interviewed Co-PIs were highly engaged in their project team while this 
may not have been the case among those who did not respond to the survey or to interview invitations 
thereby generating a selection bias. 
All teams of the sampled projects were engaged in final data collection and analysis at the time of the 
evaluation and could not share data on MNCH or service outcomes. Interim data were available for 
several projects but not in a form that could be aggregated across projects. The same applied to 
research publications, with all teams still working on planned or draft documents. 
While some projects could document policy influence at different levels, most knowledge translation 
activities were ongoing at the time of the evaluation missions, with several teams stating that they 
would increase these activities once the research findings were analysed and documented. Policy 
change has a different time frame from implementation and research, and it was arguably too early in 
the programme to expect a documented impact of the research evidence on health policies. 
Limitations due to the differences in the sampling frames for the online surveys conducted for the 
midterm and the final evaluations are discussed in Annex 11. 
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ANNEX 10. ON-LINE SURVEY QUESTIONNAIRE 
This survey is part of the final evaluation of the IMCHA programme, co-funded by Global Affairs Canada 
(GAC), the Canadian Institutes of Health Research (CIHR), and the International Development Research 
Centre (IDRC). Its aim is to assess the overall performance and value added of IMCHA. 
The survey will not take longer than 30 minutes of your time. Please complete the survey as soon as possible 
and before February 15, 2020. Depending on your position and your knowledge of the programme, you 
may find questions that you cannot answer. In this case, please mark ‘don’t know’ and move on to the next 
question. 
By starting the survey, you are agreeing to participate. Your participation is voluntary, and you can stop at 
any time. There are no known risks to participate in this survey. All responses will remain anonymous and 
the information will be saved in a password protected database to be used only for the purpose of the 
IMCHA summative evaluation. If you have questions about your participation in the survey, please contact 
the administrator hera@hera.eu. 
1. In which role or team did you participate in the IMCHA project 
PI or researcher in an African research team  
Co-PI or researcher in the Canadian research team  
Co-PI decision-maker or researcher in a health authority (automatic skip to Question 37)  
 
2. In which country is/was your research team located? (select only one main country) 
Burkina Faso  Malawi  Senegal  
Canada  Mali  South Sudan  
Ethiopia  Mozambique  Tanzania  
Kenya  Nigeria  Uganda  
Other (specify)  
 
3. Did your team receive a synergy grant? 
Yes  No  We did not apply  I don’t know  
 
4. How successful is/was your collaboration with your Canadian / African research partner? 
Very successful  
Somewhat successful  
Neither successful nor unsuccessful  
Somewhat unsuccessful  




5. How successful is/was your collaboration with your decision-maker research partner? 
Very successful  
Somewhat successful  
Neither successful nor unsuccessful  
Somewhat unsuccessful  
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Grounding the research in local context      
Connecting you to other decision-makers      
Integrating gender considerations      
Integrating equity considerations      
Encouraging the use of research findings in policies and practices      
Scaling up the research results      











































































Insufficient engagement or availability of PI      
Insufficient engagement or availability of Canadian Co-PI      
Insufficient engagement or availability by the decision-maker Co-PI       
Insufficient human resources      
Insufficient financial resources      
Insufficient connection to decision-making authorities      




8. What are the most important factors that aid the collaboration between African and Canadian research institutions in 
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10. Is there anything you would have changed in the collaborative relationship between you and your co-researchers or 




11. Which HPRO supports your research project? 
WAHO  APHRC/PPD/ESCA  I do not know  
 


















































Research methods training      
Implementation science training      
Gender sensitivity training      
Equity sensitivity training      
Grounding the research in the local context      
Connecting the team to decision-makers      
Supporting your team to network and share with other teams      
Contributing to knowledge translation of your research      








14. Are / were the efforts by the HPROs and by IDRC for facilitating knowledge sharing across East and West African 
research teams sufficient? 
By IDRC: Yes  By the HPRO: Yes  
 No   No  




15. Do you recommend that IDRC include an HPRO type component in future research programmes? 
Yes  
No  
I do not know  
Please comment: 
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Capacity in preparing grant applications      
Capacity in project monitoring and supervision      
Capacity in research methods      
Capacity in implementation science      
Capacity in knowledge translation      
Capacity in gender analysis and mainstreaming gender in research      
Capacity in equity analysis and mainstreaming equity in research      
Capacity in financial management      




17. Did you participate in a gender and/or equity analysis training during IMCHA? 
Gender analysis: Yes  Equity analysis: Yes  
 No   No  
 I don’t know   I do not know  
 






































Incorporated gender sensitivity training?     
Brought specific gender expertise into the project?     
Ensured that women and girls are beneficiaries of the project?     
Ensured that women and girls are consulted while designing and implementing the project?     
Ensured that women on the team take part in decision-making within the project?     
Included a reference to gender considerations in a research question?     
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20. How helpful is/was the HPRO in integrating gender equality considerations into your project? 
Very helpful  
Somewhat helpful  
Not helpful  




21. Which of these statements about equity apply best to your project? 
All intended beneficiaries of the research are vulnerable and the “equity lens” is therefore automatically applied  
There are differences among potential beneficiaries of the research and efforts are made to focus on the most vulnerable  
Equity considerations are not relevant to my project  










































Incorporated equity training?     
Brought equity expertise into the project?     
Ensured that the project reaches the vulnerable populations in your context?     
Consulted vulnerable populations while designing and implementing the project?     












25. How helpful is/was the HPRO in integrating equity considerations into your project? 
Very helpful  
Somewhat helpful  
Not helpful  
I do not know / not applicable  
Please comment: 
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26. Were you able to translate your findings into policies and practices? 
Yes  
No  
No, but there are prospects for the future  
 
27. [If yes is chosen in previous question, user will be asked the following question]: Please elaborate at what level your 
research findings were translated into policy and practice and give examples 
Sub-national level  
National level  
Regional level  
Please describe the changes ion policies or practices: 
 
 
28. Did your project succeed in scaling up the findings of your research? 
To district level  
To regional/state level  
To national level  
We did attempt to scale-up but were not successful   
Scaling was not an objective of our project (skip to question 31)  
 




30. If your ability to scale up the research findings were hindered, can you rank the factors responsible? (where 1 is the 
most important and 7 the least important factor) 
The decision-maker Co-PI was not sufficiently engaged/involved in the project  
The researchers (PI and Canadian Co-PI) were not sufficiently engaged/ interested in scaling up  
Insufficient connections to decision-making authorities  
Insufficient funding  
Insufficient human resources  
Insufficient knowledge within the team about how to scale up  
Changes in national priorities or policies  
None of these factors apply / I do not know  
 
31. Did your project contribute to an improvement in any of the 11 global monitoring indicators for MNCH in your 
research area or beyond? Which ones? 
Maternal mortality ratio  
Under five child mortality rate  
Chronic childhood malnutrition rate (height for age)  
Met need for contraception  
Antenatal care coverage (at least 4 times)  
Antiretroviral coverage to prevent mother-to-child transmission of HIV  
Skilled attendance at birth  
Postnatal care for mothers and babies within 2 days  
Exclusive breastfeeding for 6 months  
DPT 3 vaccine coverage among children 12-23 months old  
Antibiotic treatment coverage for children under 5 with suspected pneumonia  
Any other public health outcome, including outcomes related to gender equality (please specify)  
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Assistance in refining the research protocol and implementation plan    
Assistance in networking    
Assistance in promoting, publishing and/or presenting the research    
Problem solving of technical or ethical issues you faced during your research    
Assistance in addressing gender equality issues and gender mainstreaming    
Assistance in addressing equity issues    
Assistance in financial reporting    
Assistance in seeking additional research funding for this or future projects    






















































Preparing the implementation plan      
Preparing technical reports      
Preparing financial reports      
Monitoring visits by IDRC Programme Officers      
IMCHA workshops (e.g. Dakar April 2017, Tanzania March 2019, etc.)      
Efforts to optimise performance (e.g. technical support by consultants)      
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The research topic is a key health priority of the country/region       
I am happy with the outcomes of the research       
The collaboration between the African PI and Canadian Co-PI has been important 
to meet the objectives of the project       
The African PI and Canadian Co-PI collaborate as equals       
The involvement of the decision-maker co-PI has been important to meet the 
objectives of the project       
The HPRO has been important to meet the objectives of the project       
Gender considerations are well-integrated into the project       
Equity considerations are well-integrated into the project       
IMCHA provides opportunities to learn about advances in MNCH from other 
African countries       
IDRC has done a good job in monitoring and supervising this project       
 




36. Do you have any additional questions or comments about IMCHA or about this survey? 
 
 
[Automatic skip to end of survey] 
Questions for Co-PI Decision-makers start 
 
 
37. In which country are you working / did you work with the IMCHA project? 
Burkina Faso  Mali  South Sudan  
Ethiopia  Mozambique  Tanzania  
Kenya  Nigeria  Uganda  
Malawi  Senegal  Other (specify)  
  
 
38. At what level of government do you work? 
Local level  State/Regional level  National level  Other (please specify)  
 
 
39. How long have you been involved as a Co-PI in the IMCHA project? 
Since the start  About 3 years  1 to 2 years  Less than 1 year  
 
40. Did your research team receive a synergy grant? 
Yes  No  We did not apply  I don’t know  
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41 How successful is/was your collaboration with your PI and Canadian Co-PI research partners? 
Very successful  
Somewhat successful  
Neither successful nor unsuccessful  
Somewhat unsuccessful  






















































Grounding the research in local context      
Connecting the project to decision-making institutions      
Integrating gender considerations      
Integrating equity considerations      
Encouraging the use of research findings in policies and practices      
Scaling up the research results      











































































Insufficient engagement or availability of the PI      
Insufficient engagement or availability of the Canadian Co-PI      
My own limited engagement or availability to participate      
Insufficient human resources      
Insufficient financial resources      
Insufficient connection to decision-making authorities      
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46. How regularly were you informed on the progress and findings of the research?? 
On a monthly basis (or more frequently)  
On a quarterly basis  
On a yearly basis  
Ad hoc  
Whenever I asked for it  
Not at all informed  
 
47. Have you been able to use information from the research in your work so far? 
Yes  
No  
Please provide examples: 
 
 


















































Research methods training      
Implementation science training      
Gender sensitivity training      
Equity sensitivity training      
Grounding the research in the local context      
Connecting the team to decision-makers      
Supporting your team to network and share with other teams      
Contributing to knowledge translation of your research      
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50. Are / were the efforts by the HPROs and by IDRC for facilitating knowledge sharing across East and West African 
research teams sufficient? 
By IDRC: Yes  By the HPRO: Yes  
 No   No  




51. Do you recommend that IDRC include an HPRO type component in future research programmes? 
Yes  
No  




52. Did you participate in a gender and/or equity analysis training during IMCHA? 
Gender analysis: Yes  Equity analysis: Yes  
 No   No  
 I don’t know   I do not know  
 






































Incorporated gender sensitivity training?     
Brought specific gender expertise into the project?     
Ensured that women and girls are beneficiaries of the project?     
Ensured that women and girls are consulted while designing and implementing the project?     
Ensured that women on the team take part in decision-making within the project?     
Included a reference to gender considerations in a research question?     








55. Which of these statements about equity apply best to your project? 
All intended beneficiaries of the research are vulnerable and the “equity lens” is therefore automatically applied  
There are differences among potential beneficiaries of the research and efforts are made to focus on the most vulnerable  
Equity considerations are not relevant to my project  
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Incorporated equity training?     
Brought equity expertise into the project?     
Ensured that the project reaches the vulnerable populations in your context?     
Consulted vulnerable populations while designing and implementing the project?     
















60. Did your project succeed in scaling up the findings of your research? 
To district level  
To regional/state level  
To national level  
We did attempt to scale-up but were not successful   
Scaling was not an objective of our project (skip to question 63)  
 




62. If your ability to scale up the research findings have been hindered, can you rank the factors responsible? (where 1 is 
the most important and 7 the least important factor) 
You were not sufficiently engaged/ involved in the project  
The researchers (PI and Canadian Co-PI) were not sufficiently engaged/interested in scaling up  
Insufficient connections to decision-making authorities  
Insufficient funding  
Insufficient human resources  
Insufficient knowledge within the team about how to scale up  
Changes in national priorities or policies  
None of these factors apply / I do not know  
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The research topic addresses a key health issue of my country, region or 
district       
My involvement has been important to meet the objectives of the project       
The collaboration between the African PI and Canadian Co-PI has been important 
to meet the objectives of the project       
The HPRO has been important to meet the objectives of the project       
Gender considerations are well-integrated into the project       
Equity considerations are well-integrated into the project       
IMCHA provides opportunities to learn about advances in MNCH from other 
African countries       
IDRC has done a good job in monitoring and supervising this project       
 








Thank you for taking your time to complete this survey 
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ANNEX 11. ON-LINE SURVEY RESULTS 
11.1 OVERVIEW 
The on-line survey was launched in English and French on January 6th with an invitation to 131 
researchers and decisionmakers who participated in IMCHA-funded projects. An additional 35 
respondents were invited to the survey on January 23rd following the IMCHA meeting in Rwanda, 
bringing the total to 166. The list was assembled as follows: 
• Current and former Principal Investigators (PIs) and researchers in African institutions 
• Current and former Canadian Co-Principal Investigators (Co-PIs) and researchers in Canadian 
institutions 
• Current and former Co-PI decisionmakers or researchers in health authorities 
Researchers of Health Policy and Research Organisations (HPROs) were not included. 
The list was prepared from information and contact details provided by IMCHA Management and by 
PIs and Co-PIs of all projects contacted by the evaluation team. A reminder e-mail to all invited 
respondents was sent on February 6th with a final closure of the survey on February 18th. 
Of the 166 e-mail invitations, three were returned because the e-mail address was no longer valid or 
there was an automated message that the person had retired or left the organisation.  
• The invitation was successfully sent to 163 potential respondents 
• The survey was opened by 72 respondents (overall response rate: 44%) 
• 13 respondents only completed the profile portion of the survey. They were removed from the 
analysis, which left 59 valid responses (valid response rate: 36%) 
After the identification questions, the survey questionnaire split into two distinct sections, one for 
African and Canadian researchers, the other for decisionmakers. The analysis covered responses from 
both researchers and decisionmakers.  
Respondents were assured full anonymity of their responses. Where identification questions (location 
of the project, role, sex of the respondent, etc.) could be used to identify individual respondents, they 
were assured that data will only be accessible to the evaluation team and will be anonymised in the 
analysis. Nevertheless, some respondents chose to not answer some of these questions in order to 
assure the anonymity of their response. 
11.1.1 ALIGNMENT WITH THE MIDTERM EVALUATION SURVEY 
For the midterm evaluation, two surveys were conducted in March 2018. One survey was sent to 44 
PIs and Canadian Co-PIs, and a separate survey to 19 Co-PI decisionmakers. A total of 48 responses 
were received, 36 from PIs and Canadian Co-PIs, and 12 from decisionmakers for an overall response 
rate of 76 percent.  
Survey questions and Likert scales of the midterm and final evaluation surveys were closely aligned. 
The comparability of survey results was, however, limited because of differences in the sampling 
frames of the two surveys. The midterm evaluation team surveyed all active PIs and Co-PIs. The units 
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of data collection and analysis were IMCHA projects. The final evaluation team included all members 
and former members of research teams who could be identified in the sampling frame. The units of 
data collection and analysis were therefore all implementers of IMCHA-funded research projects. The 
decision was based on the attempt to give a voice on processes and outcomes of IMCHA-funded 
research to all implementers. Especially on questions about capacity-building this choice mitigated the 
risk of a selection bias, although it also reduced the possibility of analysing results on the basis of 
projects because the numbers of respondents differed among the projects. The differing approaches 
partially explains the lower response rate to the survey conducted for the final evaluation, although 
the total number of responses was higher (59 versus 48). A comparison of the responses to the two 
surveys is nevertheless presented where relevant, although the limitations of the comparability should 
always be kept in mind. 
11.1.2 PRESENTATION OF SURVEY RESPONSES 
Responses to questions formulated in the form of Likert scales are presented in tables with the 
responses to identical questions at midterm added in italics. Proportions are calculated from the tables 
where relevant and presented in the text following the tables. Narrative responses and comments of 
survey participants were extracted into a separate file and analysed together with data from document 
reviews and KIIs using qualitative content analysis. They are summarised in this report. 
11.2 PROFILE OF SURVEY RESPONDENTS 
Responses were received from researchers and decision-makers working in all ten IMCHA programme 
countries. Several projects were implemented in two countries but for only four projects (two in Mali/ 
Burkina Faso and two in Uganda/ South Sudan) the names of researchers or decisionmakers in both 
countries were available. Two survey respondents did not state the country of their research work. 
PROJECT COUNTRY* PROJECTS INVITATIONS 
RESPONSES 
RESPONSE RATE 
AFR CAN DM TOTAL 
Burkina Faso / Mali 3 17 5 3 0 8 47% 
Ethiopia 3 15 3 4 0 7 47% 
Malawi 2 21 2 2 0 4 19% 
Mozambique 2 14 0 2 0 2 14% 
Nigeria 5 28 6 5 2 13 46% 
Senegal 1 8 1 2 0 3 38% 
Tanzania 10 46 10 3 3 16 35% 
Uganda / South Sudan 3 14 3 1 0 4 29% 
Country not stated -.- -.- 1 1 0 2 -.- 
Total 29 163 32 22 5 59 36% 
* Countries for which team members in two countries of at least one multi-country project were invited are aggregated. 
Afr= researchers in African institutions; Can= researchers in Canadian institutions; DM= decisionmakers 
For the two projects in Malawi and in Mozambique, the Canadian Co-PIs provided a large number of 
contact names for Canadian researchers and students (10/21 in Malawi and 8/14 in Mozambique) who 
did not respond to the survey, accounting for the low overall response rate from teams working in 
these two countries. Furthermore, the survey was not offered in Portuguese and we received no 
responses from the Mozambiquan partner.  
IMCHA Summative Evaluation 
hera / Volume 2 (Annexes)/ 25.09.2020 50 
The distribution of response received per region (57% East Africa & 43% West Africa) reflected the 
distribution of research teams (58% East & 42% West). The response rates of researchers working in 
African institutions and in Canadian institutions was about equal; the response rates among 
decisionmakers invited to the survey was, however, much lower. 
ROLE OF RESPONDENTS INVITATIONS RESPONSES RESPONSE RATE 
Researchers in an African institution 80 32 40% 
Researchers in a Canadian institution 54 22 41% 
Decisionmakers 29 5 17% 
Total 163 59 36% 
Compared to the midline evaluation survey, the consolidated response rate among researchers in 
African and Canadian research institutions fell from 82 percent to 40 percent which was expected as 
the midline survey was targeted at persons with leadership roles in the projects who could easily be 
identified and personally encouraged to participate. Reasons for the sharp decrease in the response 
rate by decisionmakers from 63 percent to 17 percent are less clear. Many invited decisionmakers had 
changed position in their administration and were no longer involved in the project but were included 
in the survey. It was anticipated that they were unlikely to participate. Nevertheless, the total number 
of responses from decisionmakers fell from 12 at mid-line to only 5 at end-line which cannot be 
explained by their mobility alone. It does, however, increase the potential response bias of the findings. 
The decisionmakers who are actively engaged with the research projects are more likely to respond to 
the survey than those who are less engaged. This fact would have already biased the findings at 
midterm when 12 of 18 decisionmaker Co-PIs responded. This bias would have been even stronger at 
the final evaluation with only 5 of 29 responding. 
Among those who completed the survey, nearly half (49%) received a synergy grant for their project. 
A large proportion of respondents (19%) did not know whether they received a synergy grant or not, 
and seven percent of respondents reported not applying. A quarter of respondents did not receive 
synergy grants despite applying. 
DID YOU RECEIVE A SYNERGY GRANT? (N=59)  
Yes 29 (49%) 
No 15 (25%) 
We did not apply 4 (7%) 
Unknown 11 (19%) 
Total 59 
11.3 ANALYSIS OF SURVEY RESPONSES 
Most survey questions asked for scoring responses using Likert scales to ensure the survey could be 
completed in 30 minutes. The respondents also had the opportunity to provide comments related to 
each topic. These comments were integrated into the qualitative analysis alongside data from 
document reviews and key informant interviews (KIIs).  
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11.3.1 COLLABORATION BETWEEN CANADIAN AND AFRICAN RESEARCH 
Canadian and African PI/Co-PIs and researchers were asked ‘How successful is/was your collaboration 
with your Canadian or African research partner?’. Fifty-three respondents selected one of five options 
and one respondent was not able to choose. Researchers in African and Canadian research institutions 
rated the collaboration equally with 74 percent of African researchers rating it as very successful and 
26 percent as somewhat successful compared to 73 and 27 percent of Canadian researchers. No 
respondent selected a lower rating. 






Very successful 23 (74%) 16 (73%) 39 (74%) 
Somewhat successful 8 (26%) 6 (27%) 14 (26%) 
Total 31 22 53 
The results are comparable to the results of the survey of PIs and Canadian Co-PIs conducted at 
midterm. At midterm, 75 percent rated the collaboration as very successful and 19 percent as 
somewhat successful. However two respondents rated it as somewhat unsuccessful and Canadian Co-
PIs provided a slightly higher rating than the PIs.  
Thirty-eight respondents provided additional comments in answer to this question. Two respondents 
pointed out that they had previously worked together and that this contributed to a productive 
collaboration in IMCHA. Supporting these statements was a comment from a respondent working in a 
new partnership:  
• Le début fut difficile car nous avons des façons de travailler qui sont tout à fait différents. Il a fallu 
faire beaucoup d'efforts pour arriver à trouver des compromis de façons de faire. 
Most of the comments confirmed the Likert ratings of successful cooperation. Some examples are: 
• The two teams had been working together even before IMCHA project. So it created a smooth 
continuity as we worked together on this project. The preceding understanding of each other’s 
way of work and philosophy about the research work made it easier to coordinate. We knew each 
other's strength and weaknesses. There was harmony and clear demarcation about each other's 
role. The consultative decision making and implementation on ground worked very well. We 
capitalised on each other's strength. 
• Une parfaite collaboration du début jusqu'à la fin du projet 
• C'était une expérience très enrichissante pour moi sur le plan professionnel, pour l'utilisation des 
logiciels d’analyse tels que STATA, QDA Miner 
• It was a great learning experience 
• Fantastic collaboration between our teams--we all learned so much from each other and 
throughout the project, communication was extremely open and smooth. 
A smaller number of respondents mentioned that they experienced constraints of a logistic or 
organisational nature: 
• There were frequent changes of staff in the Canadian partner's institution 
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• Poor internet in the remote site made discussions between us very difficult; we needed face-to-
face meetings to really get things done.  
• While there was a willingness to collaborate on the research and share ideas, there were severe 
practical constraints to do this effectively when the two teams were not physically in the same 
place. Internet connections and language barriers made communication over e-mail/Skype close 
to impossible. I think that severely hindered progress and our ability to realise the full potential of 
the project. 
There were only two truly negative comments on the collaboration, both from African researchers who 
had rated the collaboration as ‘somewhat successful’: 
• Lack of openness from the partner. No full participation in project matters e.g. meetings and 
activities 
• It turned out not a very good collaboration as it ended up creating a feeling of using us to become 
Professors! It was clear that all my collaborators wanted was data. I am blocked from accessing 
anything being worked from our data! 
Researchers and decisionmakers were asked to provide a narrative response to the question about the 
most important factors aiding the cooperation between African and Canadian researchers. Fifty-two 
responses were provided by researchers and all five decisionmakers answered this question. Most 
responses highlighted mutual respect, common goals and transparency as the most important 
elements of cooperation. Four respondents mentioned that this was aided by an existing 
preestablished partnership: 
• Joint work to develop proposal. Good communication. Previous experience of working together.  
Clarity about each other's role. 
• Previous collaboration and shared interests 
• Prior relationships that have established trust among the different partners 
• We already had an established collaboration and great working relationship before this current 
project 
The presence of Canadian researchers at the implementation sites in field visits and placement of 
students was also mentioned by several researchers and by one decision maker. In addition, some 
respondents referred to communications technology: 
• The use of Zoom and WhatsApp for regular IRT meetings enhanced implementation of the project 
Complementarity of expertise was another factor mentioned: 
• Complementarity of areas of expertise. They were good in the quantitative component and we 
were good in the qualitative component 
• Clear and timely communication. Complementary expertise 
And finally, two respondents mentioned the programme management as a factor supporting the 
cooperation: 
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• The follow-up and guidance of the HPRO and of IDRC funder was very useful in ensuring the 
continuity of the project. Otherwise, it would have closed. 
• Les facteurs financiers et techniques c’est à dire l’accompagnement 
11.3.2 COLLABORATION BETWEEN RESEARCHERS AND DECISIONMAKERS 
Decisionmakers were asked: “How successful is/was your collaboration with your PI and Canadian Co-
PI research partners?”; and the African and Canadian researchers were asked: “How successful is/was 
your collaboration with your decisionmaker Co-PI?” They were provided with five response options. 
All five decisionmakers and 50/54 researchers answered the questions. The responses at midterm are 
provided in brackets. 










Very successful 4 20 (10) 6 (4) 52% (39%) 
Somewhat successful 1 11 (6) 8 (7) 38% (36%) 
Neither successful nor unsuccessful  0 (1) 4 (5) 8% (17%) 
Somewhat unsuccessful  0 (1) 0 (2) -.- (8%) 
Unsuccessful  0 (0) 1 (0) 2% (-.-) 
Total 5 31 (18) 19 (18) 50 (36) 
While all decisionmakers and 90 percent of researchers rated the collaboration as very successful or 
somewhat successful, there was a marked difference between the respondents from Canada and those 
working in Africa. Four of 19 Canadian researchers (21%) were ambivalent about the success of the 
collaboration, and one even rated it as unsuccessful. 
The question was not asked of decisionmakers in the midterm survey. Among researchers, however 
an increase in the appreciation of the collaboration was noted. The proportion of researchers who 
rated the collaboration as very or somewhat successful increased from 75 to 90 percent, primarily due 
to increased ratings by Canadian researchers. 
Thirty-seven respondents provided additional comments, many of them positive about the 
collaboration: 
• The [decisionmaker] involved himself very closely into the development of proposal as he was 
keenly interested to learn how the project produces an impact so he could use this evidence to 
roll-out the intervention. With the evidence on impact available [the health authority] has 
endorsed to use the approach and methods for a roll-out of the intervention in the form of a micro 
plan including budget. 
• [The decisionmakers] have been a pillar on how to navigate with policy makers and shed insights 
on the same 
• Always there for advice, and a good link between the project and the government. 
• Très satisfaisante - dans le cadre du volet équité, elle nous a permis de mener ensemble une 
recherche action sur la base des résultats de la recherche dans la perspective d'amender la 
politique nationale et de rendre le processus plus efficace.  
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Some of the assessments were more constrained or highlighted the need to build partnerships with 
decisionmakers at the most functional level: 
• The decisionmakers in the hospitals were easy to access and available all the time. At district 
level, because of multiple activities, meetings were often postponed 
• L'utilisation des évidences produites n'est pas encore dans les habitudes des décideurs 
• We partnered with provincial health but in the end, it would have been better to involve a 
national health decision maker 
The mobility of decisionmakers was commented on as a constraint of the collaboration by several 
respondents: 
• [The decisionmaker] was instrumental in designing a project that would be useful to national 
policymakers and in meeting with them periodically. He was also very wise and understood the 
politics, both regional and national, about scaling up the intervention. [But] he retired soon after 
we were funded and [we did not hear much of him since]. I would have appreciated more 
continuous involvement 
• We had intermittent contact and inconsistent counterparts 
Only two respondents noted a negative experience to the extent of even questioning the model of 
cooperation itself: 
• Bien que le décideur déclare partout vouloir utiliser les résultats de recherche. Sa démarche 
semble aller plutôt en sens inverse dans le sens qu'il ne semble pas du tout se baser sur les 
résultats de recherche pour prendre ses décisions 
• Decision-makers were very busy with their routine work and they didn't pay attention very 
seriously towards the intervention. 
The decisionmakers generally commented on a successful cooperation: 
• I was very close to the PI most of the time, but very rarely with the Canadian Co-PI 
• Worked very closely as a team 
Researchers were asked to provide a narrative response to the question about the most important 
factors aiding their cooperation with decisionmakers. Fifty-one respondents answered this question. 
Many mentioned the alignment of the research theme with government priorities and the importance 
of a shared vision between researchers and decisionmakers. Having regular team meetings with 
participation of the decisionmaker was also considered a factor of successful cooperation by several 
respondents. A previously established relationship and an involvement of the decisionmaker in the 
design of the project was mentioned frequently: 
• Mutual understanding and previous engagement 
• Prior relationships that have established trust among the different partners 
• Close historical relationship between decision-maker and research team 
• The longstanding relationship between researchers and decision-makers 
• Decision-makers being involved in the design or the project 
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• Joint planning of the project, oversight and regular communication/ability to assess findings and 
data 
• Involvement of the decision maker right away from inception to the end of project 
• Having the decision-makers involved from the onset was helpful 
One respondent mentioned the role of the HPRO in supporting the cooperation: 
• The HPRO, through constant calls and follow ups and also especially through trainings, kept the 
team together 
Decisionmakers were asked whether they could use the information from the research in their work. 
Those who answered (3/5) mentioned that they were able to share the findings with decision-making 
authorities at higher (national) level. 
11.3.3 CONTRIBUTION OF DECISIONMAKERS 
Researchers were asked to rate the contribution of decisionmakers to aspects of the project work, and 
decisionmakers were asked to rate their own contributions. Aspects included the grounding of the 
research in local context, the connection to other decisionmakers, the integration of gender and social 
equity aspects in the research, the encouragement of the use of research findings in policy- and 
decision-making, and the scaling of project results. Response options were provided on a four-point 
Likert scale. The same questions were asked at midterm, but a fifth response option, “not helpful yet 
but expect future help” was provided that seemed less relevant for the final evaluation. Responses at 








HELPFUL NOT HELPFUL 
NOT YET BUT MAYBE IN 
FUTURE 
GROUNDING RESEARCH IN LOCAL CONTEXT 
Researchers [51 (35)] 38 (21) 11 (9) 2 (5) 0 (0) -.- (0) 
Decisionmakers [5 (12)] 5 (9) 0 (3) 0 (0) 0 (0) -.- (0) 
CONNECTING TO OTHER DECISIONMAKERS 
Researchers [50 (33)] 26 (12) 16 (14) 7 (6) 1 (1) -.- (0) 
Decisionmakers [5 (12)] 3 (8) 2 (4) 0 (0) 0 (0) -.- (0) 
INTEGRATING GENDER CONSIDERATIONS 
Researchers [46 (33)] 16 (6) 15 (7) 11 (12) 4 (5) -.- (3) 
Decisionmakers [5 (12)] 3 (7) 2 (4) 0 (1) 0 (0) -.- (0) 
INTEGRATING EQUITY CONSIDERATIONS 
Researchers [48 (32)] 19 (8) 19 (8) 9 (11) 1 (5) -.- (0) 
Decisionmakers [5 (12)] 2 (6) 3 (5) 0 (1) 0 (0) -.- (0) 
ENCOURAGING THE USE OF RESEARCH FINDINGS IN POLICIES AND PRACTICES 
Researchers [52 (34)] 31 (13) 16 (10) 4 (6) 1 (0) -.- (5) 
Decisionmakers [5 (12)] 4 (9) 1 (3) 0 (0) 0 (0) -.- (0) 
SCALING UP THE RESEARCH RESULTS 
Researchers [45 (33)] 20 (7) 19 (12) 4 (4) 2 (2) -.- (8) 
Decisionmakers [5 (12)] 5 (8) 0 (2) 0 (1) 0 (0) -.- (1) 
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Across all six areas of cooperation, half of the surveyed researchers (51%) rated the contribution of 
decision-makers as very helpful and 84 percent rated them very and somewhat helpful. This was an 
increase from the ratings at midterm of 36 percent and 69 percent respectively. At midterm, however, 
nine percent of respondents anticipated that the contribution of decisionmakers may declare 
themselves in future, an expectation that appears to have been realised according to the repeat 
survey. In all six areas, the proportion of researchers who rated the contribution of decisionmakers as 
very helpful increased between 14 and 22 percentage points. 
Surveyed decisionmakers rated their contribution somewhat higher, although the calculation of 
proportions is unstable because of small numbers. Three quarters (73%) rated their contribution as 
very helpful, and 100% as very and somewhat helpful. These proportions also increased since midterm 
where they were 65 and 94 percent respectively.   
Researchers rated the contribution of decisionmakers highest for ‘grounding the research in local 
context’ (very effective: 60% at midterm and 75% at final evaluation) and lowest for ‘integrating gender 
considerations’ (very effective: 18% at midterm and 35% at final evaluation). Among decisionmakers, 
the contribution with the lowest proportion of self-assessed high effectiveness was in the area of 
‘integrating equity considerations’ (50% at midterm and 40% at final evaluation). The self-assessment 
in the area of ‘integrating gender considerations’ was only slightly higher. 
Other contributions of the decisionmakers noted by the researchers included: 
• Suggested other areas that ought to be considered in the study 
• Providing material support to ensure project implementation 
• Dissemination of the research findings 
Decisionmakers commented on their own contributions to the project: 
• Working with political leaders to know the priorities of the community members 
• Scale up the results for other districts/ areas and later be owned by the districts teams 
• Sharing findings with federal authorities 
Both the researchers and the decisionmakers were asked whether anything should change in the way 
the collaboration among the researchers and between them and the decisionmakers were conceived 
and implemented. Many of the comments and suggestions were very specific to the relationships 
within the project with some African researchers commenting on poor relationships with their 
Canadian partners: 
• The Canadian lead investigator took a very authoritarian approach throughout the project and in 
my opinion did not respect the African co-investigators or decision-maker Co-PI. 
Several Canadian researchers commented on insufficient research capacity in the African teams or 
insufficient involvement in the setup of the project. A need for capacity strengthening was also 
mentioned by one decisionmaker. 
• The imbalance in terms of capacity (especially research skills and research management skills) 
was evident and posed a major challenge. 
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Specific issues were also mentioned such as visa denials by Canadian missions to African researchers 
for meetings in Canada, and one respondent mentioned delays in the release of funds. Three 
respondents took issue with the lack of transparency in the way the research grants were split between 
the two partners: 
• IDRC should ensure that we are copied on each other's financial reports. We don't have to have a 
say on how they are constructed or spent but it is good to have another set of eyes and we won't 
be surprised by new initiatives. I imagine this sharing occurred in teams that have a natural 
collaboration but what about the teams where the PI is more authoritarian than collaborative? 
• In spite of being funded separately, partners should have one common financial report to increase 
transparency and accountability. 
• La gestion des fonds uniquement d'un côté (que ce soit africain ou canadien) est un problème. 
Some respondents, however, noted that they would not change anything: 
• Not really. The model is excellent, but I think it is individuals. 
• Non. Nous avons une longue tradition de collaboration et tout se passe bien en équipe 
11.3.4 BARRIERS TO RESEARCH IMPLEMENTATION 
Survey respondents and decisionmakers were asked to rate the importance of barriers experienced in 
the implementation of the projects using a four-point Likert scale. The types of barriers and the scale 
options were identical to those used in the midterm survey. The responses are summarised in the 
table, with midterm results in italics.  
BARRIERS: VERY IMPORTANT  SOMEWHAT 
IMPORTANT 
MINIMALLY 
IMPORTANT  NOT A BARRIER 
INSUFFICIENT ENGAGEMENT OR AVAILABILITY OF PI 
Researchers [50 (32)] 2 (5) 5 (8) 4 (4) 39 / 78% (15 / 47%) 
Decisionmakers [5 (9)] 1 (0) 0 (3) 1 (1) 3 / 60% (5 / 56%) 
INSUFFICIENT ENGAGEMENT OR AVAILABILITY OF CANADIAN CO-PI 
Researchers [43 (29)] 2 (1) 5 (6) 3 (7) 33 / 77% (15 / 52%) 
Decisionmakers [4 (11)] 0 (1) 1 (2) 0 (3) 3 / 75% (5 / 45%) 
INSUFFICIENT ENGAGEMENT OR AVAILABILITY BY THE DECISIONMAKER CO-PI 
Researchers [50 (33)] 3 (2) 6 (10) 12 (6) 29 / 58% (15 / 45%) 
Decisionmakers [5 (11)] 0 (1) 0 (1) 1 (4) 4 / 80% (5 / 45%) 
INSUFFICIENT HUMAN RESOURCES 
Researchers [51 (33)] 6 (6) 10 (11) 12 (5) 23 / 45% (11 / 33%) 
Decisionmakers [5 (10)] 0 (2) 2 (4) 1 (2) 2 / 40% (2 / 20%) 
INSUFFICIENT FINANCIAL RESOURCES 
Researchers [47 (33)] 6 (7) 6 (10) 12 (5) 23 / 49% (11 / 33%) 
Decisionmakers [5 (10)] 0 (2) 2 (5) 1 (2) 2 / 40% (1 / 10%) 
INSUFFICIENT CONNECTION TO DECISION-MAKING AUTHORITIES 
Researchers [49 (33)] 1 (5) 10 (7) 13 (8) 25 / 51% (13 / 39%) 
Decisionmakers [5 (10)] 0 (3) 0 (4) 1 (1) 4 / 80% (2 / 20%) 
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At midterm and for the final evaluation, human resources and financial constraints were identified as 
the most important barriers by researchers and decisionmakers. Among researchers, 31 percent rated 
human resources shortages, and 26 percent financial resources shortages as very or somewhat 
important; at midterm, it was 52 percent for both. On average, only half as many researchers noted 
very important or somewhat important barriers to implementation on any of the issues at the final 
evaluation compared to midterm (21% versus 40%). An identical pattern was observed among the 
responses of decisionmakers, although the small number of respondents in both surveys makes the 
calculation of proportions highly unstable. 
Additional constraints mentioned by the researchers in narrative comments related primarily to 
financial and human resource constraints. A decisionmaker also commented on insufficient funds to 
finance his or her participation in all project activities. Security issues were also mentioned by two 
respondents and the difficult logistics of reaching the project communities by one. Other comments 
were: 
• During the last phase of the project we faced some difficulty due to financial constraints faced by 
the government for its commitment on sustainability. This is a key barrier in resource constraint 
settings for sustaining and scaling research interventions even if they show a clear significant 
impact. 
• We had delays with implementing our study and had to work hard to catch up with the shortfalls 
• Earmarking of funds which restricted us from approaching this maternal child health project in a 
holistic and community-centred way 
• From what I gather the structure of the funding system hindered progress more than facilitated it. 
I'm not sure that the HPRO was of much use. Perhaps using those funds to enable a longer 
duration for implementation studies would have yielded better results. 
11.3.5 HPRO EFFECTIVENESS 
Researchers and decisionmakers were asked about the effectiveness of HPRO support. Only in the final 
evaluation survey, respondents were asked to select the collaborating HPRO. Further sub-categorising 
the group of five decisionmakers who responded to the survey is, however, not useful. Furthermore, 
the available database from the midterm survey does not include data on the project country or the 
relevant HPRO. The table therefore combines the responses relating to both HPROs. The Likert scale 
at midterm included one additional option of future effectiveness. 
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RESEARCH METHODS TRAINING 
Researchers [37 (33)] 11 (11) 16 (14) 73% (45%) 4 (1) 6 (4)  (3) 
Decisionmakers [5 (11)] 4 (8) 0 (2) 80% (91%) 1 (1) 0 (0)  (0) 
IMPLEMENTATION SCIENCE TRAINING 
Researchers [36 (30)] 12 (7) 14 (13) 72% (67%) 2 (3) 8 (4)  (3) 
Decisionmakers [5 (9)] 3 (5) 2 (3) 100% (89%) 0 (1) 0 (0) (0) 
GENDER SENSITIVITY TRAINING 
Researchers [35 (28)] 14 (4) 11 (12) 71% (57%) 6 (5) 4 (4)  (3) 
Decisionmakers [5 (11)] 3 (6) 0 (3) 60% (82%) 2 (0) 0 (1)  (1) 
EQUITY SENSITIVITY TRAINING 
Researchers [34 (30)] 12 (4) 10 (11) 65% (50%) 7 (5) 5 (6)  (4) 
Decisionmakers [5 (11)] 3 (5) 1 (4) 80% (82%) 1 (0) 0 (1)  (1) 
GROUNDING THE RESEARCH IN THE LOCAL CONTEXT 
Researchers [39 (31)] 18 (9) 9 (12) 69% (68%) 4 (4) 8 (4)  (2) 
Decisionmakers [5 (11)] 3 (8) 1 (2) 80% (91%) 1 (1) 0 (0) (0) 
CONNECTING THE TEAM TO DECISIONMAKERS 
Researchers [41 (33)] 19 (14) 11 (8) 73% (67%) 5 (4) 6 (5)  (2) 
Decisionmakers [5 (12)] 2(8) 3 (4) 100% (100%) 0 (0) 0 (0) (0) 
SUPPORTING YOUR TEAM TO NETWORK AND SHARE WITH OTHER TEAMS 
Researchers [45 (33)] 20 (9) 11 (12) 69% (64%) 6 (4) 8 (7) (1) 
Decisionmakers [5 (12)] 3 (7) 2 (5) 100% (100%) 0 (0) 0 (0)  (0) 
CONTRIBUTING TO KNOWLEDGE TRANSLATION OF YOUR RESEARCH 
Researchers [44 (32)] 22 (10) 10 (9) 73% (59%) 6 (4) 6 (4)  (5) 
Decisionmakers [5 (12)] 4 (9) 1 (2) 100% (92%) 0 (0) 0 (0)  (1) 
Overall, a greater proportion of researchers rated the HPRO support as very effective or somewhat 
effective in the final evaluation survey than in the midterm survey (71% versus 64%). However nine 
percent of respondents at midterm anticipated that effectiveness of HPRO support would improve 
over time. At the final evaluation, HPRO support for ‘connecting the team to decision-makers’ and 
‘contribution to knowledge translation’ was ranked highest, closely followed by ‘research methods 
training’. At midterm, ‘grounding the research in the local context’ was followed by ‘connecting the 
team to decisionmakers’ and then by ‘networking and sharing with other teams’. Support for ‘equity 
sensitivity training’ received the lowest proportion of scores for effectiveness. 
Decisionmakers responding to the final and midterm survey found the support of the HPROs generally 
effective. The effectiveness of gender sensitivity training was scored lowest, but meaningful 
calculations of responses are not possible because of the small number of respondents. 
Narrative comments in response to this question did not offer any additional activity or area of HPRO 
effectiveness. Many Canadian respondents noted that they did not know enough about the work of 
the HPROs in order to comment on their effectiveness.  
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Although the East and West Africa HPRO worked under identical terms of reference, they had very 
different institutional structures. We therefore analysed the responses from all respondents (African 
researchers, Canadian researchers and decisionmakers) about their perception of HPRO effectiveness 
by region of their project. 
PROJECT REGION VERY EFFECTIVE  SOMEWHAT EFFECTIVE MINIMALLY EFFECTIVE  NOT EFFECTIVE 
RESEARCH METHODS TRAINING 
West Africa [18] 28% 33% 17% 22% 
East Africa [24] 42% 42% 8% 8% 
IMPLEMENTATION SCIENCE TRAINING 
West Africa [19] 32% 37% 5% 26% 
East Africa [22] 41% 41% 5% 14% 
GENDER SENSITIVITY TRAINING 
West Africa [15] 50% 17% 17% 17% 
East Africa [19] 36% 36% 23% 5% 
EQUITY SENSITIVITY TRAINING 
West Africa [18] 44% 28% 0% 28% 
East Africa [21] 33% 29% 38% 0% 
GROUNDING THE RESEARCH IN THE LOCAL CONTEXT 
West Africa [19] 42% 21% 5% 32% 
East Africa [25] 52% 24% 16% 8% 
CONNECTING THE TEAM TO DECISIONMAKERS 
West Africa [20] 40% 20% 15% 25% 
East Africa [26] 50% 38% 8% 4% 
SUPPORTING YOUR TEAM TO NETWORK AND SHARE WITH OTHER TEAMS 
West Africa [20] 40% 25% 15% 20% 
East Africa [30] 50% 27% 10% 13% 
CONTRIBUTING TO KNOWLEDGE TRANSLATION OF YOUR RESEARCH 
West Africa [20] 55% 10% 15% 20% 
East Africa [29] 52% 31% 10% 7% 
Researchers and decisionmakers in East Africa generally perceived the HPRO support to be more 
effective than in West Africa. However there were nuances. For instance the gender and equity training 
provided in West Africa was perceived as more effective. The largest differences were reported for 
research methods and implementation science training which was perceived as much more effective 
in East than in West Africa, a response that does not surprise as the East Africa HPRO consortium was 
led by a research institution. 
Researchers and decisionmakers were asked for suggestions of what else HPROs could do in support 
of the research projects. Thirty-eight researchers and four decisionmakers answered this question. 
None of them suggested any additional role or activity except for one respondent who though that 
HPROs should have a role in monitoring and evaluation of the projects. Several Canadian researchers 
commented that they would have liked to have more information about HPRO activities. Most 
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comments by African researchers and decisionmakers asked for the HPROs to work closer with the 
projects, and especially with decision-making authorities: 
• More proactive role in facilitating liaison at national and regional level especially directly with 
government policy makers to ensure lessons learnt from the projects and successful interventions 
with impact are taken up for national and regional roll-out and sustained within the mainstream 
government system 
• Site visit, Regular meeting, involve more stakeholders during their meeting, PI could suggest the 
topic/training, 
• Being closer to the projects by e.g. visiting individual teams and sites 
• Help us connect nationally sooner 
• More engagements with state and federal authorities for more publicity 
All respondents were then asked about their opinion on whether to include an HPRO-type component 
in future implementation research programmes. Fifteen Canadian researchers answered this question, 
four of them admitting that they did not have sufficient information about the work of the HPROs. 
Another nine were supportive, however all but one with some limitations: 
• I think there is room for improvement, but it seems like a worthwhile investment. 
• Yes, but I think too much funding was given to the HPRO's for training that took our staff away 
from research duties. I think the balance should be on funding for the projects with less funding 
for HPRO's 
Two Canadian respondents did not see much use in the HPRO model: 
• Given financial constraints, I think the budget for the HPRO might have been more usefully shared 
across the funded sites. 
• Il faut plutôt appuyer les équipes de recherche et les décideurs entre eux et ne pas passer par ces 
HPRO dont la bureaucratie non efficiente fait perdre de l'argent à une recherche et une prise de 
décision qui en aurait besoin 
Among the 16 African researchers who answered this question, ten gave the HPRO a strong 
endorsement, as did the two decisionmakers who responded: 
• This is an excellent model in terms of supporting implementation, challenges that develop in 
project implementation and guidance in influencing policy with the research project 
• Oui, pour plus de succès dans le déroulement et des attentes du projet 
The remaining six comments were also positive but suggested improvements in HPRO performance: 
• Their participation in research programmes supports the positive collaboration with other 
research teams in the country and with national decision makers but they need to improve on 
this. 
11.3.6 IMCHA CONTRIBUTION TO CAPACITY-DEVELOPMENT 
Survey questions on the IMCHA contribution to institutional capacity differed between the midterm 
survey and the survey for the final evaluation, although the capacity fields or areas were identical. 
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While at midterm, the PIs and Canadian Co-PIs were asked to indicate if there was a contribution to 
capacity by marking a field associated with each area, in the final evaluation survey the respondents 
were given a choice to rate the contribution on a four-point Likert scale from ‘not at all’ to ‘a major 
extent’. Among the African researchers who responded to this question, only one or two selected the 
option ‘not at all’ in some of the areas, and none selected the option ‘minimally’ in any area. Although 
the results of the two surveys are presented in the same table, they cannot be compared because: 
• Respondents in 2020 included African researchers at all levels in the projects and not only the PIs 
as in 2018; 
• The formulation of the question differed and the response option of ‘some contribution’ in the 
2020 survey is not considered in the table; and 
• It is not clear whether the respondents who did not mark the field in the 2018 survey meant that 
there was no contribution, or that they did not know; i.e. the denominator is uncertain. 
For the results of the final evaluation, only the proportions of those who responded that capacity was 
strengthened ‘to a major extent’ are listed in the table. For the midterm survey, the proportion of 
respondents who marked that capacity was built in this area is listed. The number of respondents is 
indicated in brackets. 
CAPACITY IN … STRENGTHENED / MAJOR EXTENT (% RESPONDENTS 2020) 
STRENGTHENED  
(% RESPONDENTS  2018) 
… preparing grant applications 70% [27] 50% [18] 
… project monitoring and supervision 70% [30] 56% [18] 
… research methods 74% [31] 72% [18] 
… implementation science 82% [38] 61% [18] 
… knowledge translation 74% [31] 33% [18] 
… gender analysis / mainstreaming 41% [29] 56% [18] 
… equity analysis / mainstreaming 38% [29] 39% [18] 
… financial management 50% [28] 33% [18] 
While there are limitations of comparison, the responses to the final evaluation survey indicate that 
among African researchers, there is a perception that IMCHA contributed to capacity-strengthening to 
a major extent in most areas, but only moderately in the areas of gender and equity analysis and 
mainstreaming. There appears to be scope for further support in these areas. 
Additional capacity gains were listed by eight African researchers, including in publishing research 
results in high-impact journals, in networking and sharing experience across the region and with 
decisionmakers, electronic data collection and systematic review methods. Canadian research team 
members were less positive about capacity gains with most stating that they had competent teams 
and did not expect to build further capacity through IMCHA. One Canadian researcher, however, 
responded that ‘IMCHA was helpful by emphasising the partnership with decisionmakers right from the 
beginning’. 
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11.3.7 GENDER ANALYSIS AND MAINSTREAMING 
All respondents were asked about the extent to which their project included aspects or activities 
related to gender equality. The three response options for each activity were ‘no’, ‘to some extent’, 
and ‘consistently’. At midterm the same question was asked, however the response options were ‘no’, 
‘yes’, and ‘plan to do so in future’. The table presents the combined responses of all researchers and 
decisionmakers.  



























Gender sensitivity training 13 13 27 53 10 28 6 44 
Include gender expertise in team 8 20 27 55 10 29 6 45 
Women / girls as beneficiaries 1 10 46 57 0 33 3 36 
Women / girls consulted  4 21 28 53 4 35 2 41 
Women in decision-making in proj. 5 12 39 56 3 41 1 45 
Include gender in research quest. 3 13 39 55 3 39 2 44 
The responses to both surveys indicate an awareness of respondents about actions to strengthen 
gender integration their research projects. At midterm, between 64 and 91 percent of respondents 
declared that these aspects were included in their projects, and between two and 14 percent planned 
to do so in future. At the final evaluation survey, between 75 and 95 percent declared that these 
aspects were included at least to some extent, while consistent inclusion was less ranging from 51 to 
81 percent. A clear trend cannot be inferred from these data. 
Twenty-one respondents to the final evaluation survey listed additional methods for integrating 
gender considerations in their project. Several of them, however, were only precisions of the answers 
provided in the table. Two respondents referred to the gender balance in the research teams, and 
seven respondents mentioned that they included men in the research population: 
• We included the concerns of men in women's decision to seek maternity care, and worked with 
men to promote women's use of skilled pregnancy care 
Some interesting comments included in the responses were: 
• Inclusion of elderly women in the study sample 
• Alors que cela n'est pas toujours facile ; beaucoup de femmes de notre projet sont des femmes [ ?] 
• Our project explicitly focused on studying gender issues in health social enterprises 
Researchers were asked in the final evaluation survey about the extent to which HPROs were helpful 
in integrating gender equality considerations in their project. Only about a third of respondents (31%) 
rated the support from HPROs as very helpful. Among African researchers it was about 40 percent 
while it was only one out of 11 Canadian respondents.  
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WERE HPROS HELPFUL FOR GENDER INTEGRATION? NOT HELPFUL SOMEWHAT HELPFUL VERY HELPFUL 
African researchers [25] 3 12 10 
Canadian researchers [11] 5 5 1 
Total [31] 8 17 11 
To some extent these assessments may have been influenced by exposure to gender training, which 
was provided by HPROs following the midterm evaluation, but also by IMCHA Management at the 
inception and midterm workshops. 15/28 (54%) of African researchers stated that they had 
participated in a training workshop on gender while it was only 7/24 (29%) of Canadian researchers. 
Only three Canadian research team members provided additional comments on HPRO support in 
gender integration with one of them noting that the gender training provided by the HPRO was ‘rather 
constrained in approach and not very helpful - in some ways, it was confusing for the participants.’ 
Most African researchers who provided additional comments mentioned the gender analysis training 
workshops without, however, including statements about their quality. The only other two comments 
about the helpfulness of HPROs in gender integration were rather negative: 
• The HPRO dwelt a lot on policy issues and networking. Gender equality was not discussed very 
much, probably because our groups had women as the focal point and the HPRO thought that it 
was not necessary to emphasise too much on male issues. 
• L’appui de l’HPRO dans ce domaine comme dans d'autres est resté très épisodique et 
anecdotique. 
Researchers and decisionmakers were asked to mention barriers they experienced in the gender 
integration in their project. The largest proportion noted that they experienced no barriers, but the 
responses documented considerable insecurity and differences in understanding of concepts such as 
gender analysis, gender integration or gender equality. This was also expressed in the comment of one 
Canadian researcher: 
• Gender equality might not mean the same thing for researchers in Canada and Africa or the 
people participating in the study. 
Five researchers in African and Canadian teams noted that they lacked training or guidance on how to 
integrate gender considerations in their project, while one member in a Canadian team noted that the 
Canadian Co-PI considered gender issues irrelevant and actively supressed efforts in gender analysis.  
• I think for me it is more because I never had that training to make it easier to do so 
• Lack of familiarity with how to do this. 
Four researchers noted that it was difficult to reach men with their project activities. This supports the 
impression that among some teams, inviting men to participate in maternity and childcare was 
considered a key intervention for gender integration: 
• Reluctance by male partners to participate in group activities 
• We believe we focussed on gender equality. Trying to engage men was a challenge. 
The lack of clear definitions and the unease with the concept of gender integration and its application 
is reflected in the response of one researcher who mentioned that ‘talking about "gender" without 
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acknowledging the power dynamics of gender differences in the project area’ was a barrier to gender 
integration. The lack of clarity about gender integration in the conceptualisation of the projects was 
noted by one respondent: 
• The design was not clear on gender issues since the beginning. It was a bit challenge to introduce 
gender issues along the way. 
Others mentioned social and cultural factors in a very general way, and two respondents thought that 
male dominance in the investigation teams constituted a barrier to gender integration. One 
decisionmaker mentioned insufficient funds as a barrier to gender integration. 
11.3.8 EQUITY ANALYSIS AND MAINSTREAMING 
In order to assess how respondents viewed the relevance of integrating an equity dimension in their 
project, they were asked about their agreement with three statements.  
 AGREE 
1. All intended beneficiaries are vulnerable and the “equity lens” is therefore automatically applied 28 
2. There are differences among beneficiaries and efforts are made to focus on the most vulnerable 25 
3. Equity considerations are not relevant to my project 1 
Five respondents marked that none of these statements applied to their project. There was a 
difference in the responses of Canadian researchers, African researchers and decisionmakers. While 
all decisionmakers and the majority of the Canadian researchers (10/19) selected the first statement, 
a majority of African researchers (17/30) selected the second. 
Among the five researchers who responded that neither of the three statements applied, one noted 
that there was awareness of social inequities, but that they were not analysed, while another noted 
that the project’s aim to achieve universal coverage was a solution to overcome social inequities.  
Similar to the question about gender integration, all respondents were asked about the extent to which 
their project included aspects or activities related to social equity. The three response options for each 
activity were ‘no’, ‘to some extent’, and ‘consistently’. At midterm the same question was asked, 
however the response options were ‘no’, ‘yes’, and ‘plan to do so in future’. The table presents the 
combined responses of all researchers and decisionmakers.  



























Incorporated equity training in the 
project 16 16 14 46 16 19 8 43 
Brought equity expertise into the 
project 13 20 15 48 11 25 5 41 
Ensured that vulnerable 
populations were reached 2 7 43 52 0 34 2 36 
Consulted vulnerable populations 
in design and implementation  7 13 29 49 6 32 4 42 
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The responses to both surveys indicate an awareness of respondents about actions to strengthen the 
social equity dimensions of their research projects. At midterm, between 44 and 94 percent of 
respondents declared that these aspects were included in their projects, and between six and 19 
percent planned to do so in future. Overall, this was just slightly lower than for the aspects of gender 
integration. At the final evaluation survey, between 65 and 86 percent responded that these aspects 
were included at least to some extent, while consistent inclusion was less ranging from 30 to 83 
percent. In both surveys, almost all respondents declared that their project reached vulnerable 
populations, correlating with the agreement with the statements listed in the preceding question. 
Social equity expertise and equity training were reported by a much smaller proportion of respondents 
indicating scope for work in the future. 
Among the ten respondents who reported the inclusion of other aspects or activities related to social 
equity in their project, four mentioned data collection and analysis.  
• We collected data on multiple measures of social equity so that we can conduct analyses to 
identify associations between multiple factors and our study outcomes. 
Two respondents mentioned the promotion of male involvement in maternity care and other project 
activities, confirming the finding at midterm that grantees had difficulties differentiating between the 
concepts of gender and equity integration. 
The question on the most important measures taken for the integration of equity considerations was 
answered by 41 researchers and decisionmakers, with some replies of ‘I don’t remember’ or ‘I don’t 
know’. Other responses were already covered in the four options provided in the table of social 
integration such as contracting experts with expertise in the area or ensuring that vulnerable groups 
are reached; and others again mentioned the involvement of men in maternity service provision. A 
research focus on social inequity was explicitly mentioned by six respondents: 
• We considered different stratifiers such us wealth, residence type, distance to facility at the 
analysis stage. 
• We collected data through cross-sectional surveys to generate a household wealth index. We also 
collected data on religion, ethnicity, geographic location, social support and decision-making. We 
further collected qualitative data on perceptions of health equity, barriers and challenges. 
In response to the questions about barriers for the integration of equity considerations in the project, 
37 researchers and decisionmakers entered comments, 11 of them noting that they did not experience 
any barriers. Social and cultural factors were mentioned by five without further details. Two 
respondents noted that project funds for meaningful research in social equity were insufficient: 
• More time and appropriate funding as well as better intervention design would have allowed a 
more meaningful consultation with the community about how best the interventions could 
address women/families' health care service access issues. 
Logistic barriers to reach highly vulnerable communities or groups were mentioned by five 
respondents, one of them also linking this to resource constraints: 
• Travel to the most remote communities presents logistic and security challenges. 
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• L'insécurité dans certaines zones du pays a nécessité des ajustements. 
A lack of interest in exploring social equity issues in MNCH services by some project partners were 
mentioned by three respondents: 
• Negative attitude of some local leaders who had high expectation of financial gains from the 
project. 
• Not everybody is interested in promoting social equity. 
• Opportunities for gathering relevant information were consistently missed because of a lack of 
interest by the lead Canadian researcher. 
Researchers were asked in the final evaluation survey about the extent to which HPROs were helpful 
in integrating social equity in their project. Perceptions of the helpfulness of HPROs in equity 
integration was somewhat lower than perceptions about gender integration. Only about a quarter of 
respondents (26%) rated the support from HPROs as very helpful, among African researchers it was 
about one third (32%) and among Canadian researchers only one out of nine. 
WERE HPROS HELPFUL FOR EQUITY INTEGRATION? NOT HELPFUL SOMEWHAT HELPFUL VERY HELPFUL 
African researchers [22] 5 10 7 
Canadian researchers [9] 6 2 1 
Total [31] 11 12 8 
Fewer researchers reported that they attended equity training than those who attended gender 
training. Among African researchers it was 10/24 (42%) and among Canadian researchers 4/24 (17%). 
The few narrative comments on the question of HPRO helpfulness all referred to training 
opportunities. 
11.3.9 KNOWLEDGE TRANSLATION AND SCALING 
All African and Canadian researchers stated that their research findings were either already translated 
into policies or practices (27/53) or that there were prospects of translation for the future (26/53). 
Among the 27 who already reported knowledge translation, 11 mentioned the regional level, ten 
mentioned the national level and six a sub-national level. Among the five decisionmakers who 
responded, four stated that they had already used information provided by the research in their work. 
The five decisionmakers who participated in the survey stated they were involved in translating the 
research findings into policies and practice by disseminating and sharing information. Twenty-eight 
researchers provided details on how their research findings were translated into policies or practice. 
While many of them noted that policy changes were still under discussion or in preparation, several 
mentioned results that had already been achieved: 
• [The health service authority] adopted the home visit methods and strategy to develop a micro-
plan for state-wide roll-out of the scheme. 
• The Ministry of Health has adopted the curriculum for CEmONC [piloted by the project] for 
training care providers in the whole country 
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• Le équipes cadre de district supervisent désormais les formations des Distributeurs 
communautaires par les infirmiers chefs de poste avant le début de chaque campagne de chimio-
prévention du paludisme saisonnier. 
• At the district level, the government has started to incorporate birth kit distribution which we 
started in our project. 
• Mental health is now integrated into PHC services. 
In answer to the question about successful scaling of the research findings, the reported numbers for 
each level appear very high and do not correlate with the reports on successful knowledge translation. 
The question may not have been understood in the same way by all respondents. Multiple responses 
were allowed 
DID YOUR PROJECT SUCCEED IN SCALING UP THE FINDINGS OF YOUR RESEARCH?  
To district level 20 
To provincial or state level 9 
To national level 17 
To regional level 9 
We did attempt to scale-up but were not successful 2 
Scaling was not an objective of our project 13 
When asked about what approaches were taken to scale up the project results, 12 researchers referred 
to the final dissemination of results in workshops and publications, several of them noting that it was 
too soon as data analysis had still not been completed. Five respondents highlighted the continued 
engagement with policy- and decisionmakers throughout the project as an approach to successful 
scaling: 
• The project team shared the successes and failures with the decisionmakers and managers at 
regional and district levels every 6 months. 
• The government was strongly involved at all stages, from planning onwards. They took over 
management of the intervention in one area during the life of the project. 
• We have continued to meet with policy makers at district and regional level to ask them to 
consider how to scale up the findings from the project. 
• Nous avons impliqué une personne ressource du PNLP dans notre équipe afin d'assurer un partage 
continu des résultats mais aussi de tenir compte des besoins du PNLP [National Malaria 
Programme] 
Capacity-building of service providers was mentioned by two respondents, while two also mentioned 
formal agreements with health service authorities to promote application of results at scale: 
• We have a memorandum of understanding with the policymakers at state level to work with the 
state in mental health integration. 
One decisionmaker and 17 researchers, ten African and seven Canadian, reported that they 
encountered barriers to scaling. Among them 12 ranked the factors that hindered their efforts in order 
of importance. At midterm, 31 of 36 researchers answered this question, ranking factors that may 
hinder scaling by importance as follows: 
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RANK OF FACTORS THAT HINDERED 
 SCALING (2020)  
RANK OF FACTORS THAT MAY HINDER  
SCALING (2018) 
1 Insufficient connections to decision-making 
authorities  1 Lack of funding 
2 Insufficient funding 
 2 Lack of human resources 
3 The decision-maker Co-PI was not sufficiently 
engaged/involved in the project  3 Changes in national priorities or policies 
4 Changes in national priorities or policies  4 Lack of interest by your team’s decision-maker co-PI 
5 Insufficient human resources  5 Lack of connections to other important decision-makers 
6 Insufficient knowledge within the team about 
how to scale up  
6 Lack of knowledge within the team about 
how to scale up 
7 The researchers were not sufficiently engaged/ 
interested in scaling up  7 Lack of interest by the researcher PI / co-PI 
11.3.10 CONTRIBUTIONS TO ULTIMATE OUTCOMES 
The researchers were asked whether their project contributed to improvements in the 11 ultimate 
outcome indicators of IMCHA. Multiple choices were possible. The 54 researchers in African and 
Canadian institutions selected the indicators they felt were improved by their project with frequencies 
ranging from nine to 59 percent. African researchers generally rated the contribution higher than 
Canadian researchers. Eleven researchers (5 African and 6 Canadian) did not select any of the 
indicators, stating that they either had not yet analysed their data or that the achievement of these 
outcomes was not an objective of their project: 
• Too early to tell, as changes based on findings are still to be determined 
• Ce n'était pas l'objectif de ce programme de recherche 





Maternal mortality ratio 22 (69%) 10 (45%) 32 (59%) 
Under 5 mortality rate 21 (66%) 10 (45%) 31 (57%) 
Antenatal care coverage (4 times) 18 (56%) 11 (50%) 29 (54%) 
Skilled attendance at birth 18 (56%) 11 (50%) 29 (54%) 
Postnatal care within 2 days 17 (53%) 11 (50%) 28 (52%) 
Exclusive breastfeeding for 6 months 12 (38%) 6 (27%) 18 (33%) 
DPT3 vaccine coverage 7 (22%) 6 (27%) 13 (24%) 
Met need for contraception 9 (28%) 3 (14%) 12 (22%) 
Chronic childhood malnutrition 8 (25%) 2 (9%) 10 (19%) 
ARV coverage for prevention of mother-to-child HIV transmission 5 (16%) 0 (0%) 5 (9%) 
Antibiotic treatment of children with suspected pneumonia 3 (9%) 2 (9%) 5 (9%) 
Twenty researchers included statements of additional outcomes including 
• Improved spousal communication on pregnancy and childbirth related issues 
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• Reduced domestic violence and intimate partner violence 
• Improved attitudes of health workers towards women in antenatal and maternity services 
• Reduced neonatal and perinatal mortality 
• Increased male involvement in maternal and child health 
11.3.11 IMCHA MANAGEMENT 
To collect views of the research teams on the management of IMCHA, the respondents were asked 
what assistance and support they received from IDRC Programme Officers.4 The responses were 
compared to those provided in the midterm survey which are presented in italics. 
ASSISTANCE OR SUPPORT RECEIVED IN … YES NO % YES 
… refining the research protocol and implementation plan 31 (18) 8 (15) 79% (55%) 
… networking 34 (26) 6 (9) 85% (74%) 
… promoting, publishing and/or presenting the research 37 (21) 5 (12) 88% (64%) 
… solving of technical or ethical issues you faced during your research 18 (-) 15 (-) 55% (-) 
… team problem solving - (15) - (18) - (45%) 
… addressing gender equality issues and gender mainstreaming 27 (-) 8 (-) 77% (-) 
… addressing equity issues 17 (-) 11 (-) 61% (-) 
… financial reporting 30 (23) 7 (12) 81% (66%) 
… seeking additional research funding for this or future projects 13 (-) 15 (-) 46% (-) 
For all parameters for which data at midterm and final evaluation were available, respondents noted 
an increase in support or assistance from IDRC. The highest level of assistance was reported for 
publishing and presenting research findings, which did, of course, increase as the research projects 
reached higher levels of maturity towards the end of the IMCHA initiative. 
Respondents were also asked to rate the helpfulness of the means and the content of the support or 
assistance from IDRC on a four-point Likert scale. At midterm, the same areas were covered but a five-
point scale was used. The midterm responses are presented in italics, and the proportion of ‘very 
helpful’ ratings are compared between the midterm and the final evaluation survey. 




















































… preparing the implementation plan 3 (3) 4 (3) - (3) 8 (7) 25 (20) 63% (56%) 
… preparing technical reports 1 (1) 5 (3) - (4) 9 (11) 26 (17) 63% (47%) 
… preparing financial reports 2 (1) 4 (4) - (2) 7 (11) 25 (18) 66% (50%) 
… monitoring visits by IDRC Prog. Officers 1 (1) 6 (17) - (4) 8 (3) 17 (11) 53% (31%) 
… IMCHA workshops 1 (2) 2 (3) - (3) 7 (9) 25 (18) 71% (51%) 
… optimising performance (technical support) 3 (1) 4 (1) - (9) 4 (9) 22 (9) 67% (31%) 
… communication with IDRC Prog. Officers - (1) - (0) - (4) - (10) - (20) - (57%) 
                                                                        
4 In the review of the evaluation report, IMCHA management stated that management was provided by IMCHA POs rather 
than IDRC POs. We did not change the wording, however, because it reflects the wording used in the questionnaires used at 
midterm and for the final evaluation. 
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As with the proportion of respondents who reported that they received assistance from IDRC, the 
rating of the helpfulness of this assistance also increased. Workshops were rated most often as very 
helpful as a means of supporting the research projects. Monitoring visits were rated the lowest, but 
this would also have been influenced by the fact that several projects in conflict areas were never 
visited because of Canadian government travel regulations. 
Few additional comments on the helpfulness of IMCHA management were provided by respondents, 
two expressing appreciation about assistance in networking with global actors and two commenting 
on the general responsiveness and support provided by IDRC Programme Officers. One respondent, 
however, felt that IDRC was ‘too intrusive’. 
11.3.12 OVERALL IMCHA EXPERIENCE 
All respondents were asked to note their level of agreement with a number of summary statements 
about the IMCHA initiative. Some statements were formulated differently for researchers and 
decisionmakers as per the midterm survey. Options to state the level of agreement were provided on 
a five-point Likert scale. Responses from the midterm survey are provided in italics. 




NOR DISAGREE AGREE STRONGLY AGREE 
% AGREE OR 
STRONGLY AGREE 
THE RESEARCH TOPIC IS A KEY HEALTH PRIORITY OF THE COUNTRY/REGION  
0 (0) 0 (0) 0 (0) 12 (6) 46 (38) 100% (100%) 
THE COLLABORATION BETWEEN AFRICAN AND CANADIAN RESEARCHERS WAS KEY  
0 (0) 1 (1) 3 (1) 16 (15) 38 (27) 93% (95%) 
THE HPRO WAS IMPORTANT TO MEETING THE OBJECTIVES OF THE PROJECT  
5 (1) 5 (6) 11 (11) 14 (14) 15 (12) 58% (59%) 
GENDER CONSIDERATIONS WERE WELL-INTEGRATED IN THE PROJECT  
0 (2) 3 (1) 7 (2) 19 (18) 28 (21) 82% (89%) 
SOCIAL EQUITY CONSIDERATIONS WERE WELL-INTEGRATED IN THE PROJECT  
0 (1) 2 (1) 6 (3) 24 (22) 26 (17) 86% (89%) 
IMCHA PROVIDED OPPORTUNITIES TO LEARN ABOUT ADVANCES IN MNCH FROM OTHER AFRICAN COUNTRIES 
1 (0) 1 (2) 6 (4) 16 (12) 28 (26) 85% (86%) 
IDRC HAS DONE A GOOD JOB IN MONITORING AND SUPERVISING THIS PROJECT 






NOR DISAGREE AGREE STRONGLY AGREE 
% AGREE OR 
STRONGLY AGREE 
MY INVOLVEMENT HAS BEEN IMPORTANT TO MEET THE OBJECTIVES OF THE PROJECT 
0 (0) 0 (0) 0 (1) 0 (2) 5 (5) 100% (88%) 
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NOR DISAGREE AGREE STRONGLY AGREE 
% AGREE OR 
STRONGLY AGREE 
I AM HAPPY WITH THE OUTCOMES OF THE RESEARCH 
0 (0) 2 (2) 2 (3) 18 (17) 30 (14) 92% (86%) 
THE AFRICAN PI AND CANADIAN CO-PI COLLABORATED AS EQUALS 
1 (1) 3 (4) 6 (1) 11 (8) 29 (22) 80% (83%) 
THE INVOLVEMENT OF THE DECISION-MAKER CO-PI WAS IMPORTANT TO MEET THE OBJECTIVES OF THE PROJECT 
0 (0) 2 (3) 5 (6) 20 (11) 25 (16) 87% (75%) 
All respondents were asked about their opinion of what could have been done to improve the IMCHA 
initiative. Two respondents entered unqualified endorsements for the excellence of the IMCHA 
initiative (‘everything was excellent’), while twelve respondents noted that the initiative should have a 
longer timeframe and more funding. One respondent noted that the long process of developing the 
implementation plans took valuable time from research implementation. 
More meetings and opportunities to share experiences across projects were mentioned as potential 
improvements by several respondents.  
More clarity in the funding expectations from the start would, according to one respondent have 
improved the outcomes, specifically the need to incorporate gender and economic analyses from the 
outset. 
HPROs were mentioned by five respondents, with two asking for a more active engagement of the 
HPROs in research projects, one noting that the role of HPROs should be better defined, and two 
indicating that the funds allocated to HPROs could be better spent. 
The partnership between African and Canadian research institutions and the selection of these 
partners was the subject of six comments. Two respondents thought that more effort should be 
invested in assuring the quality of the Canadian Co-PIs and their availability to invest time in the 
project. More clarification about the role of each partner was asked for by one respondent, while 
another stated that a sustainable partnership between African and Canadian institutions could only be 
achieved by funding and working directly through Canadian institutions. On the other hand, one 
respondent asked for a stronger focus on South-South partnerships. 
Three respondents mentioned the need for a sustainability plan, while another three commented on 
the reporting systems and tools which, according to them, were not adapted to the context and not 
suitable for a research programme. 
Greater sponsorship and participation of students and inclusion of support for a PhD programme was 
mentioned by three respondents. 
11.3.13 FINAL COMMENTS 
Final comments on the IMCHA initiative were largely very positive. Here are just some excerpts: 
• IMCHA has been a valuable contribution to MCH in Africa 
• Thankful for the opportunity to be part of the IMCHA family. It has been a great experience 
IMCHA Summative Evaluation 
hera / Volume 2 (Annexes)/ 25.09.2020 73 
• IMCHA was wonderful regarding flexibility in terms of budgets and technical support 
• IMCHA touches the core maternal and child health problems and provide solutions through 
research findings 
• C'est une initiative exceptionnelle. Alors que tous les organismes se focalisent sur des solutions de 
type "magic bullet", le CRDI a encore l'audace de financer des projets qui renforcent les systèmes 
de santé, améliorent l'équité, cherchent des solutions aux problèmes fondamentaux de genre 
• Nous avons beaucoup apprécié la grande souplesse du CRDI concernant les modifications 
budgétaires d'un semestre à l'autre (changement de lignes et autres), cela nous a permis de nous 
adapter au mieux aux réalités et situations rencontrées, pour plus d’efficacité 
• Overall, I think this is a great initiative 
• I think the way IMCHA was designed should be maintained as it brings decision makers and 
researchers on the same table and agreeing on issues that will be of benefit to respective 
communities 
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ANNEX 12. KEY INFORMANTS INTERVIEWED 
NAME PROJECT / STAKEHOLDER GROUP INSTITUTION / POSITION TYPE OF INTERVIEW 
Adamu Charles 108024/108547/Tanz. Bugando Hosp Group 
Adrijana Corluka IDRC/GAC/CIHR IDRC / Programme Officer Group 
Alaba Oyekan 108040/108552 Nigeria Univ. of Ibadan / Supervisor Group 
Alla Shayo 108027/108548/Tanz. TTCIH/ Anaesthesia Training Group 
Angelo Nyantema 108027/108548/Tanz. TTCIH / Senior Lecturer Face-to-face 
Anna Nswilla 108020/108546/ Tanz. Gov of Tanzania / AD Health Serv. Face-to-face 
Annah Konugisha 108033 Uganda BRAC / Field Researcher Group 
Arjan De Haan IDRC/GAC/CIHR IDRC / Dir. Inclusive Economies Face-to-face 
Asteria Mathias 108024/108547/Tanz. - Group 
Aziz Ahmad 108020/108546/ Tanz. Ifakara / Research Officer Face-to-face 
Benedict Eilegbogan 108041 Nigeria Chief Ewatto Ward Group 
Bonifacio Maendeleo 108024/108547/Tanz. CUHAS / Lecturer Face-to-face 
Brian Igboin 108041 Nigeria WHARC / Programme Officer Group 
Catherine Francis 108024/108547/Tanz. - Group 
Catherine Kyobutungi 107892 / HPRO East APHRC / PI Face-to-Face 
Chakupewa Joseph 108023/Tanzania Univ. Dar es Salaam / PHD Stud. Group 
Chioma Ekwo 108041 Nigeria WHARC / Programme Officer Group 
Cosmas Masolwa 108024/108547/Tanz. - Group 
Dismas Matovelo 108024/108547/Tanz. Bugando Hosp. / PI VOIP 
Dolapo Abiona 108040/108552 Nigeria Univ. of Ibadan / Supervisor Group 
Dominique Charron  IDRC/GAC/CIHR IDRC / VP Prog. & Partnerships Face-to-face 
Dorcas Mandera 108033 Uganda BRAC / Field Supervisor Group 
Edward Kataika  107893/HPRO East ECSA / Director of Programmes Face-to-face 
Elibariki Mkumbo 108020/108546/ Tanz. Ifakara / Research Officer Group 
Ermel Johnson 107892 HPRO West WAHO VOIP 
Eva Nakimula 107893 HPRO East PPD / Co-PI Face-to-Face 
Fatuma Manzi 108023/Tanzania Ifakara / Professor Face-to-face 
Frank Magofi 108023/Tanzania NHI Dodoma / Prog. Officer Phone 
Friday Okonofua 108041 Nigeria WHARC / PI Face-to Face 
Gail Weber 108026/108545/Tanz. Univ. of Ottawa / Researcher Face-to-face 
Girles Shabari 108024/108547/Tanz. CUHAS / R, M&E Face-to-face 
Godfrey Mtey 108027/108548/Tanz. TTCIH Group 
Heidi Monk IDRC/GAC/CIHR IDRC / Programme Officer Face-to-face 
Issiaka Sombié 107892 HPRO West WAHO / PI VOIP 
James Ward Khakshi 108033 Uganda BRAC / Researcher Group 
Janeth Bulemela 108027/108548/Tanz. TTCIH / Paediatrician Group 
Jenipher Musoke 108033/108550 Uganda BRAC / PI Face-to-Face 
Jennifer Hatfield 108024/108547/Tanz. Univ. of Calgary / Associate Dean VOIP 
Jennifer Mitchel 108024/108547/Tanz. Univ. Calgary / Professor VOIP 
Jesca Nsungwa 108033 Uganda MOH Uganda Face-to-Face 
John Le Blanc 108027/108548/Tanz. Dalhousie University / Professor Face-to-face 
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NAME PROJECT / STAKEHOLDER GROUP INSTITUTION / POSITION TYPE OF INTERVIEW 
Josef Okware 108033 Uganda MOH Uganda Face-to-Face 
Joyce Mathias 108024/108547/Tanz. - Group 
Joyce Seto IDRC/GAC/CIHR GAC/ M&O Committee Group 
Julie Erhabor 108041 Nigeria Edo State PHCDA / Co-PI Group 
Julieth Kabirigi 108024/108547/Tanz. CUHAS / Paediatrician Group 
Karen Yates 108022/Tanzania Queen´s University / Professor VOIP 
Kevin McKague 108033/108550 Uganda Cape Breton University / Can Co-PI VOIP 
Lakew Gebretsadik 108028/Ethiopia Jimma University / Ass Prof. VOIP 
Lauren Gelfand 107892 / HPRO East APHRC / (ex) PI Face-to-Face 
Livingstone Makanga 108033 Uganda MOH Uganda / Co-PI Face-to-Face 
Lola Kola 108040/108552 Nigeria Univ. of Ibadan / Co-PI Group 
Loretta Ntiomo 108041 Nigeria WHARC / Research Coordinator Group 
Lynette Kamau 107892 / HPRO East APHRC / Project Officer Face-to-Face 
Manisha Kulkarni 108028/Ethiopia Univ. of Ottawa / Can Co-PI Face-to-face 
Marie-Gloriose Ingabire IDRC/GAC/CIHR IDRC / Programme Officer Group /VOIP 
Mohamed Mdaraka 108027/108548/Tanz. TTCIH/ Accountant Group 
Montasser Kamal IDRC/GAC/CIHR IDRC / Programme Leader MCH Face-to-face 
Mwanaidi Malakuzi 108020/108546/ Tanz. Ifakara / Research Officer Group 
Nafissatou Diop IDRC/GAC/CIHR IDRC (IMCHA)/ Programme Officer Group 
Neda Faregh 108040/108552 Nigeria Jewish General Hosp. / Researcher Group 
Nicole Bergen 108028/Ethiopia Univ. of Ottawa / PhD Student Face-to-face 
Ogungbagbe Julius 108041 Nigeria WHARC / Data Analyst Group 
Omary Kilume 108027/108548/Tanz. TTCIH Group 
Omowumni Oluwaseun 108041 Nigeria WHARC / Programme Officer Group 
Oye Gureye 108040/108552 Nigeria Univ. of Ibadan / PI Group  
Pascale Bruneau IDRC/GAC/CIHR IDRC / Grants Administrator Face-to-face 
Paul Japhet 108023/Tanzania Univ. Dar es Salaam / PHD Stud Group 
Pendo Ndaki 108024/108547/Tanz. CUHAS / Lecturer Face-to-face 
Peter Okembe 108041 Nigeria Chief Okpeke Ward Group 
Phyllis Zelkowitz 108040/108552 Nigeria JGH / Research Director / Can Co-PI Group 
Qamar Mahmod IDRC/GAC/CIHR IDRC / Programme Officer Group 
Rachelle Desrochers IDRC/GAC/CIHR CIHR / M&O Committee Face-to-Face 
Rober Masasila 108024/108547/Tanz. - Group 
Robert Salim Mahimbo 108023/Tanzania Iringa Region / Reg. Med. Off. Face-to-face 
Robert Tillya 108022/Tanzania Ifakara / PI Face-to-face 
Rosalia Arope 108020/108546/ Tanz. Mtwara Region / Rep. Hlth. Coord. Face-to-face 
Salma Mang´ong´o 108020/108546/ Tanz. Ifakara / Research Officer Group 
Sana Naffa IDRC/GAC/CIHR IDRC (IMCHA)/ Programme Officer Group 
Sanni Yaya 108041 Nigeria Univ. of Ottawa / Can Co-PI Face-to-Face 
Sarah Harrison 108550 Uganda Consultant VOIP 
Sian Fitzgerald 108023/Tanzania HealthBridge / Can Co-PI VOIP 
Stephen Maluka 108023/Tanzania Univ. Dar es Salaam / Professor Face-to-face 
Sylvia Mamkew 108020/Tanzania Mtwara Region / Reg. Med. Off. Face-to-face 
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NAME PROJECT / STAKEHOLDER GROUP INSTITUTION / POSITION TYPE OF INTERVIEW 
Thomas Druetz 108553 Burkina Faso Univ. Montreal / Can Co-PI VOIP 
Thomas Rutachunzibwa 108024/108547/Tanz. Mwanza Region / Reg. Med. Off. Face-to-face 
Trina Loken IDRC/GAC/CIHR GAC / M&O Committee Group 
Tunde Ayinde 108040/108552 Nigeria Univ. of Ibadan / Psychiatrist Group 
Tunde Olatunje 108040/108552 Nigeria Oyo State PHC Dev. Board / Co-PI Face-to-Face 
Veronica Joseph 108024/108547/Tanz. - Group 
Victoria Yohani 108024/108547/Tanz. CUHAS / Researcher Group 
Wilson Imongan 108041 Nigeria WHARC / Executive Director Group 
Yusufu Kionga 108020/108546/ Tanz. Ifakara / Research Officer Group 
Zamo Yoni Julius 108020/108546/ Tanz. Ifakara / Research Officer Group 
Zawadi Mboma - Ifakara / Grants Officer Group 
Zebron Abel 108027/108548/Tanz. TTCIH / ICT Manager Group 
Zulfikar Bhutta 108028/108546 SickKids Centre / Can Co-PI VOIP 
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ANNEX 13.  QUESTIONS / THEMES FOR KEY INFORMANT INTERVIEWS 
The following table lists the questions and themes to be included in semi-structured interviews with 
key informants in different relationships to the Initiative. It is based on the evaluation questions in the 
terms of reference. Not all questions are relevant for each respondent. Interviews will be time-limited, 
and the interviews will prioritise the collection of in-depth over comprehensive data. Final interview 
scripts for each stakeholder group will therefore be developed after a document review and a 













































1. Briefly explain how and since when you have been involved 
in the IMCHA Initiative       
2. What are the main achievements of IMCHA in relation to 
MNCH? [probe for 11 CoIA indicators]      
3. What were the main strategies to achieve these outcomes?       
4. Were any unexpected outcomes achieved? Any outcomes in 
relation to gender?      
5. Was your capacity to conduct gender and/or equity informed 
implementation research improved as a result of the IMCHA 
Initiative? How?    
   
6. How did you integrate gender dimensions in your project/the 
HPRO activities/the overall IMCHA Initiative?       
7. Which strategies were successful and why?       
8. What helped or hindered integration of gender dimensions?      
9. How did you integrate equity dimensions in your project/the 
HPRO activities/the overall IMCHA Initiative?       
10. Which strategies were successful and why?       
11. What helped or hindered integration of equity dimensions?      
12. Did the midterm evaluation influence the way in which you 
integrated either gender or equity dimensions?       
13. Did IMCHA management contributed to improved 
integration of either gender or equity dimensions?      
14. How has your collaboration with African/Canadian [select 
relevant category] researchers evolved in the last year?      
15. What factors helped or hindered this collaboration and why?       
16. How and at what level did you collaborate with decision 
makers?        
17. What factors helped or hindered collaboration with decision 
makers?       
18. Did the MTR influence the way in which you collaborated 
with decision makers?       
19. Did IMCHA management contributed to improved 
collaboration with decision makers?      
20. Were there any unexpected outcomes in relation to 
collaboration and partnering? [probe for gender related 
outcomes]    
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21. How were the research findings communicated to Co-PI 
decision makers?       
22. Were the findings used? How did the findings influence 
policy and programming in your country or region?      
23. What factors helped or hindered integration of research 
findings in policies and practices?       
24. Did the MTR influence the way in which the research findings 
were used to influence policy and practices?       
25. Did IMCHA management contributed to influencing policy 
and practices?      
26. Were any unexpected outcomes achieved? [probe for gender 
related outcomes]      
27. How has the support from the management team facilitated 
your work?       
28. Did you notice any change in the support provided by the 
management team after the findings from the midterm 
evaluation? [if yes, ask what difference it made in relation to 
achievements]  
     
29. How effective was the IMCHA Management & Operations 
committee at influencing the overall management and 
achievements of the Initiative? 
     
30. What and how did specific components of the IMCHA model 
(RTs, HPROs, collaboration between both, Synergy grants) 
contribute to IMCHA achievements?       
31. What worked well in the Synergy Grants? What were the 
challenges?      
32. What aspect of the IMCHA model can/should be improved 
for future initiatives?       
33. What aspect of the IMCHA partnership do you value most?       
34. Does an initiative such as IMCHA continue to be aligned with 
your organisational priorities?       
35. How can the partnership be strengthened for a future 
initiative?       
36. How have you documented the work realised through 
IMCHA, beyond publications and regular reporting?       
37. How could documentation of work be improved in a future 
initiative?       
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ANNEX 14. ASSESSMENT OF OUTCOME-LEVEL RESULTS OF THE IMCHA PMF 
EXPECTED RESULTS INDICATORS INDICATOR DEFINITIONS TARGETS ASSESSMENT 
Ultimate Outcome 
Improved maternal, 
newborn and child health 
outcomes in targeted 
countries 
Proportion of funded 
implementation research 
that improved maternal 
and child health outcomes 
and access to primary 
health care services 
Any of the 11 
accountability indicators 
improved  
50% of the 
implementation research 
demonstrate 
improvement in any of 
the 11 accountability 
indicators 
The target was met: Project 
contributions or potential contributions 
to improved maternal and child health 
outcomes could not be measured 
directly for many projects, while others 
were still in the final data collection 
and analysis phase and data were not 
yet available. However, all projects 
provided sufficient information to infer 
such contributions. 
Intermediate Outcomes 
1. Enhanced production, 
analyses and syntheses of 
health systems 
implementation research 
prioritising gender and 
equity 
1.1 Proportion of total 
projects that have at least 
75% (three of four 
processes) adequate 
gender and equity 
dimensions 
Review of research 
design, data collection 
tools, data analysis and 
dissemination tools that 
appropriately integrate 
gender and equity 
dimensions. 
All research projects have 
>75 % (three of four 
processes) adequate 
gender and equity 
dimensions 
The target was not met: 15/28 projects 
(54%) integrated adequate gender 
dimensions, and 7/28 (25%) adequate 
equity dimensions in at least three 
research processes. 
1.2 Proportion of health 
systems research outputs 
and syntheses that are 
gender and equity 
focused 
Nature of contribution of 
the IRT research to the 
field 
75% of outputs include 
gender and equity 
focused 
analyses/syntheses  
The target is not likely to be met: 
Research outputs, including gender and 
equity analyses were still being 
generated at the time of the 
evaluation. Among 98 outputs from 22 
projects that were available for 
analysis, 44 (46%) included a gender 
focus and 21 (22%) an equity focus. 
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EXPECTED RESULTS INDICATORS INDICATOR DEFINITIONS TARGETS ASSESSMENT 
2. Enhanced partnering 
and collaboration 
between decisionmakers 
and researchers on health 
systems strengthening in 
the selected 
countries/regions 
2.1 Number of total 
projects per country that 
demonstrate high level of 
collaboration with 
decision maker 
(documented by project, 
country and regional 
levels) 
Documentation of ‘best 
practices’ or stories of 
effective collaborations as 
a result of IMCHA at 
country or regional levels. 
with the national focal 
point for MNCH  
Minimum of one per 
country 
The indicator as defined was not 
assessed: The decisionmaker is defined 
as the ‘national focal point for MNCH’. 
Most projects communicated their 
activities and preliminary results at this 
level, but for others this was not the 
main respondent at national 
government level.  
3. Enhanced integration of 
health systems research 
findings into primary 
health care policies and 
practice in selected 
countries 
3.1 Number (type) of 
influence of IMCHA 
research projects on 
policy and programming 
per project 
Includes documentation 
(formal and informal) of 





20 The target was likely met: Although it 
was too early in the programme to 
assess this outcome, the target of 20 
was already reached. All sampled 
projects had made presentations of 
research results in national fora and 
most had plans for further discussions 




capacity of researchers 
and research 
organisations to conduct 
gender and equity 
informed health systems 
implementation research 
100.1   Proportion of total 
research projects that 
have adequately detailed 
gender and equity 
dimensions 
As determined by 
technical review (expert 
opinion) of gender and 
equity dimensions in the 
research design, tools and 
analyses  
75 percent of research 
projects have adequate 
mechanisms identified to 
support gender and 
equity analyses 
It was too soon to assess the 
performance against this indicator: 
Information on design and tools was 
available for 20/28 projects. Among 
these 19 (95%) included data collection 
plans or tools for gender analysis and 
seven (35%) for equity analysis. 
Outputs from 22/28 projects were 
available. Among these 18/22 (82%) 
had produced at least one output that 
included a gender dimension and 5/22 
(23%) an equity dimension. However, 
several teams were planning further 
gender and equity analyses. 
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EXPECTED RESULTS INDICATORS INDICATOR DEFINITIONS TARGETS ASSESSMENT 
100.2 Proportion of 
recommendations from 
formative analyses of 
HPROs acted upon 
Based on tracking of 
recommendations and 
follow up actions 
>75 % of total 
recommendations acted 
on 
Recommendations that were directed 
at HPROs were acted on and the target 
was therefore met: The formative 
analyses issued 46 recommendations 
with many sub-recommendations, not 
all of them directed at IMCHA partners 
and not all of them actionable. 
Quantifying the proportion of all 
recommendations that were acted 
upon is therefore not possible. 
Recommendations and actions were 
not formally tracked, however, 
actionable recommendations directed 
at HPROs (aggregated in six main 
groups) were acted on. 
200. Strengthened 





200.1 Proportion of 
implementation research 
projects that demonstrate 
effective collaboration 
and management 
Reflects quality of 
engagement among 
implementation research 
team members and 
stakeholders against 
objectives and outcomes 
of research projects 
75 percent of research 
projects demonstrate 
good practices in 
governance and 
coordination  
The target is a compound target. It 
was met, depending on how it is 
interpreted: The collaboration 
between African and Canadian 
researchers was rated as successful by 
74% of African and 73% of Canadian 
researchers. Engagement between PIs 
and Canadian Co-PIs in all sampled 
projects (16/28 projects; 9/20 Canadian 
Co-PIs; 10/21 PIs) ranged from strong 
to acceptable. However, none of 8 
interviewed decisionmaker Co-PIs 
stated that they had a direct 
engagement with Canadian Co-PIs and 
only 2/9 interviewed Canadian Co-PIs 
mentioned a strong engagement with 
decisionmaker Co-PIs.  
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EXPECTED RESULTS INDICATORS INDICATOR DEFINITIONS TARGETS ASSESSMENT 
300. Increased awareness 
and understanding of 
research evidence by 
decisionmakers at the 
primary healthcare level. 
300.1 Proportion of IRT 
decision-makers’ follow 
up on recommendations 
from research into health 
systems planning forum(s) 
The focus of this 
engagement will be 
detailed in the 
Implementation Plan and 
will have formal or 
informal outputs 
documented  
100 % of decision makers 
follow up on 
recommendations from 
research  
The 100% target was reached among 
the decisionmakers for whom contacts 
could be established by the 
evaluation, but many could not be 
reached: 7/8 interviewed 
decisionmaker Co-PIs stated that they 
followed up or intended to follow up 
on the research evidence. (One was 
new and not very aware of the project). 
However, not all decisionmakers 
responded to requests for interviews 
and only 5 responded to the on-line 
survey. 
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ANNEX 15. PMF WITH COMMENTS ON STATUS AT THE MIDTERM EVALUATION 
Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
Ultimate Outcome 
Improved maternal, 
newborn and child health 
outcomes in targeted 
countries. 
Proportion of funded 
implementation research 
that improved maternal 
and child health 
outcomes and access to 
primary health 
care services 
Any of the 11 
accountability indicators 
improved 1* 
50% of the implementation 
research demonstrate 
improvement in any of the 
11 accountability indicators 
Interview evidence indicated that IMCHA 
had contributed to improved antenatal 
care coverage and more skilled 
attendants at birth 
Intermediate outcomes 
1. Enhanced 
production, analyses and 
synthetises of health systems 
implementation research 
prioritizing gender and equity 
1.1 Proportion of total 
projects that 
have at least 75% (three of 
four processes) adequate 
gender and equity 
dimensions. 
Review of research 
design, 
data collection 
tools, data analysis and 
dissemination tools that 
appropriately integrate 
gender and equity 
dimensions. 
All research projects have > 
75 % (three of 
four processes) adequate 
gender and equity 
dimensions. 
Survey results found that 92% of 
researchers said they 
ensured that women and 
girls are beneficiaries of the project; 
89% said women and girls are 
consulted while designing and 
implementing the project; 86% said 
they included a reference to gender 
considerations in a research question. 
For equity, 94% of respondents said 
they had ensured that the project 
reaches vulnerable populations; 69% 
said that they ensured that vulnerable 
populations are consulted while 
designing and implementing the 
project; and 63% said they brought 
equity expertise to the 
project. 
1.2 Proportion of health 
systems research outputs 
and syntheses that is 
gender and equity 
focused. 
Nature of contribution 
of the IRT research to 
the field2 
75% of outputs include 
gender and equity focused 
analysis/synthesis 
Too early to estimate. 
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Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
2. Enhanced partnering and 
collaboration between 
decision makers and 
researchers on health systems 
strengthening in the selected 
countries/regions. 
2.1 Number of total 
projects per country that 
demonstrate high level of 
collaboration with decision 
maker (documented by 
project, country and 
regional levels). 
Documentation of ‘best 
practices’ or stories of 
effective collaborations 
as a result of IMCHA at 
country or regional 
levels. with the national 
focal point for MNCH 
Minimum of one per 
country 
Survey results showed that 44% of 
researchers strongly agreed with the 
statement that ‘The involvement of 
decision-maker co-PI has been 
important to meet the objectives of 
the project’ and 31% agreed with the 
statement. 
3. Enhanced integration of 
health systems research 
findings into primary health 
care policies and practice in 
selected countries. 
3.1 Number (type) of 
influence of IMCHA 
research projects on policy 
and programming per 
project 
Includes documentation 
(formal and informal) of 
reference to research 
findings/recommendati
ons in country-led 
technical decision-
making platforms.  
20 Survey results showed that all but one 
researcher had plans in place to 
translate the findings into policies and 
practices. Interview evidence showed 
that a few projects already had 
accomplished that. 
Immediate outcomes  
100. Strengthened capacity of 
researchers and research 
organization s to conduct 
gender and equity informed 
health systems 
implementation research 
100.1 Proportion of total 
research projects that 
have adequately detailed 
gender and equity 
dimensions 
As determined by 
technical review (expert 
opinion) of gender and 
equity dimensions in the 
research design, tools 
and analysis. 
75 percent of research 
projects have adequate 
mechanisms identified to 
support gender and equity 
analysis. 
While the survey showed that 
attempts were being made to 
incorporate gender and equity 
dimensions, interview evidence 
showed that those attempts were at 
times superficial, and were not likely 
to empower women and vulnerable 
groups. 
100.2 Proportion of 
recommendations from 
formative analysis of 
HPROs acted upon. 
Based on tracking of 
recommendations and 
follow up actions. 
>75 % of total 
recommendations acted on 
Survey results showed that only 11% 
of researchers felt that the HPROs had 
been very effective in gender 
sensitivity training while 33% felt they 
had been effective. 
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Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
200 Strengthened 
partnerships and alliances 
between African researchers, 
decision--- makers and 
Canadian researchers. 
200.1 Proportion of 
implementation research 
projects that demonstrate 
effective collaboration and 
management. 
Reflects quality of 
engagement among 
implementation 
research team members 
and stakeholders 
against objectives and 
outcomes of research 
projects. 
75 percent of research 
projects demonstrate good 
practices in governance and 
coordination 
Survey results found that 75% of the 
research respondents felt that the 
collaboration between the African PIs 
and the Canadian co---PIs was very 
successful. 
An additional 19% said it was 
successful. 
The survey results showed that 39% of 
the researchers felt their 
collaboration with 
decision-maker co-PIs was 
very successful and an 
additional 36% felt it was successful. 
300. Increased awareness and 
understanding of research 
evidence by decision makers 
at the primary healthcare 
level. 
300.1 Proportion of IRT 
decision--- makers’ follow 
up on recommendations 
from research into health 
systems planning forum(s). 
The focus of this 
engagement will be 
detailed in the 
Implementation Plan 
and will have formal or 
informal outputs 
documented  
100 % of decision makers 
follow up on 
recommendation s from 
research 
Interview and survey evidence 
showed that the decision-maker co-
PIs were starting to promote 
implementation of IMCHA results in 
their ministries. 
Many projects are still producing 
evidence, so these activities are not 
yet in full force. 
Outputs 
110. Funding provided to IRTs 
to conduct policy relevant 
gender and equity sensitive 
health systems 
implementation research. 
110.1 Number (and title) 
of health systems analysis 
and synthesis that is 
gender and/or equity 
focused produced by IRTs. 
Analyses and syntheses 
include peer--- review 
and working papers 
produced. 
20 Not included in the mid---term 
evaluation. 
120. Funding provided to 
research teams that include 
emerging researchers. 
120.1 Number of funded 
IRTs housed in research 
institutions. 
Based on type of 
organizations in funded 
research. 
20 Not included in the mid---term 
evaluation. 
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Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
120.2 Number of emerging 
researchers involved in the 
IRT research. 
Emerging researchers 
include students and 
those who are relatively 
new to the health 
systems field. (< 5 years 
pursuing research 
agenda from most 
recent qualifying 
degree). 
In reporting template – 
masters, PHD, Post 
docs, new investigators. 
35  
The mid---term evaluation showed 
that IMCHA had a strong capacity--- 
building focus, but it did not count the 
number of emerging researchers 
involved in IRT research. 
130. Synergistic research 
opportunities identified and 
supported. 
130.1 Number 
of synergistic research 
opportunities identified 
and funded (West and East 
Africa separately) 
Number of 
grants submitted and 
funded per region and 
source of origin. 
WA: three funded 
EA: three funded 
Not included in the mid---term 
evaluation. 
140. Training, networking and 
exchanges of HPROs and IRTs 
is undertaken to strengthen 
the capacity of organization s 
funded through IMCHA 
140.1 Number of 
individuals who received 
training/networking and 
exchange opportunities 
(by type and by 
participant). 
Differentiated by IRT 
and HPRO in East 
Africa/West Africa (by 
type of training and by 
type of participant).5 
40 Not included in the mid---term 
evaluation. 
140.2 Number of 
networking and exchange 
opportunities supported 
Through IMCHA 
Differentiate by who is 
funding exchange and 
who is supported in 
Exchange (number and 
type). 
10 The interview evidence emphasised 
that IMCHA had played an important 
networking role. 
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Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
210. Collaborative 
mechanisms established 
between IRTs and HPROs. 
210.1 Number of type of 
communication between 
IRTs and HPROs. 
Communication may 
include skype/phone/e 
mail and in--- country 
visits (formal and 
informal). 
Needs to document 
substantive 
issues. 
Quarterly contact Not included in the mid---term 
evaluation. 
220. HPROs and IRTs facilitate 
regional and national decision 
makers to engage in IMCHA 
implementation research. 
220.1 Number of new 
partnerships/collaboration
s between decision--- 
makers and researchers on 
health systems 
strengthening. 
Formal or informal 
collaborations with 
MOU or supporting 
documents with 
aggregation per country 
and per region 
20  
All IMCHA projects involve 
partnerships/collaborations between 
decision---makers and researchers on 
health systems strengthening. 
Interview evidence showed some of 
them pre---dated the IMCHA 
initiative. 
220.2 Number of existing 
partnerships/collaboration
s enhanced between 
decision--- makers and 





change in collaboration 
– formal or 
informal per country 
and per region. 
15 Not included in the mid---term 
evaluation. 
230. Linkages formed outside 
of the IMCHA initiative by 
HPROs, IRTs with like- minded 
organizations 
230.1 Number of times 
HPROs and/or IRTs 
established connection 
with organizations outside 
of IMCHA (West and East 
Africa separately). 
Formal linkages with 
supporting documents 
or description of 
engagement (i.e. 
minutes of meeting, 
agenda, email). To be 
aggregated for East and 
West Africa (and as 
appropriate by 
country). 
Number not defined – to 
track cumulative efforts 
Not included in the mid---term 
evaluation. 
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Expected Results Indicators 
Indicator 
Definitions 
Targets Comments on status at midterm 
240. Research teams lead by 
African researchers and 
decision makers and Canadian 
co- PIs are funded. 
240.1 Number of IRTs with 
at least one Canadian 
researcher, one African 
researcher and one African 
decision 
maker. 
Review the status of PI, 
co-PI and decision-
maker against the 
criteria in the call for 
proposals 
100 % aligned 
representation 
All of the IRTs had at least one 
Canadian researcher, one African 
researcher and one African decision---
maker. 
310. Evidence based policy 
and practice promoted by IRTs 
and HPROs 
310.1 Number (and 
description) of evidence--- 
based policy and practice 
promoted by IRTs and 
HPROs (for East and West 
Africa). 
Documentation (formal 
or informal) of example 
of evidence---based 
policy and practice 
promoted at country or 
regional level. 
Minimum of one per 
research project funded 
Several projects reported that they 
had contributed to evidence-based 
policy and practice. 
320. Knowledge translation 
activities and products 
targeting relevant local, 
national and regional decision 
makers conducted. 
320.1 Frequency (by type) 
of knowledge translation 
activities (at national and 
regional levels). 
Knowledge translation 




– this can be formal and 
informal. 
Yearly exchange at country 
and regional levels. 
 
Not included in the mid---term 
evaluation. 
320.2 Number (by type) of 
activities organised by 
HPROs to promote IRT 
research (for East and 
West Africa separately). 
Activities reported here 
may overlap with the 
connections reported on 
under 320.1 and 230.1 
but are expected to 
measure a distinct 
aspect of HPROs 
support. 
One or more regional 
exchange platform per year 
Both HPROs provided interview 
evidence of frequent activities to 
promote research in their regions. 
 
